Processing 00000000.tx.1: Endosomal Proteolysis of Internalized Insulin at the C-terminal Region of the B Chain by Cathepsin D* Franois Authier, Mourad Mtioui, Sylvie Fabrega, Mostafa Kouach, and Gilbert Briand From the INSERM U510, Facult de Pharmacie Paris XI, 92296Chtenay-Malabry, France and Laboratoire de Spectromtrie de Masse, Facult de Mdecine, 59000Lille, France Received for publication, October 23,2001, and in revised form, December 20,2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The endosomal compartment of hepatic parenchymal cells contains an acidic endopeptidase, endosomal acidic insulinase, which hydrolyzes internalized insulin and generates the major primary end product A1-21-B1-24 insulin resulting from a major cleavage at residues PheB24-PheB25. 

Phrase: "Endosomal Proteolysis of Internalized Insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "at the C-terminal Region"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205147:Region [Spatial Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the B Chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "by Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "* Franois Authier,"

Phrase: "Mourad Mtioui,"

Phrase: "Sylvie Fabrega,"

Phrase: "Mostafa Kouach,"

Phrase: "and"

Phrase: "Gilbert Briand From the INSERM U510,"

Phrase: "Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "92296Chtenay-Malabry,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "and"

Phrase: "Laboratoire de Spectromtrie de Masse,"

Phrase: "Facult de Mdecine,"

Phrase: "59000Lille,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "October 23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "2001,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 20,"

Phrase: "2001  ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The endosomal compartment of hepatic parenchymal cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C2349967:Compartment of cell [Anatomical Structure]
           Cell compartment
   781   C2336292:Compartment of endosome [Body Space or Junction]
   757   C1948049:Cell (compartment) [Spatial Concept]
   748   C1185625:Compartment [Body Space or Junction]
   748   C2986730:Compartment [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an acidic endopeptidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "endosomal acidic insulinase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "which"

Phrase: "hydrolyzes"

Phrase: "internalized insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "generates"

Phrase: "the major primary end product A1-21-B1-24 insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   791   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   791   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   791   C1579433:Insulin [Pharmacologic Substance]
   735 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   708 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "resulting from a major cleavage"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0010813:cleavage [Cell Function]
   760   C0205164:Major [Qualitative Concept]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C0678226:resulting [Functional Concept]
   760   C1330957:cleavage [Cell Function]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "at residues PheB24-PheB25."
Processing 00000000.tx.2: This study addresses the nature of the relevant endopeptidase activity in rat liver that is responsible for most receptor-mediated insulin degradation in vivo. 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "addresses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the nature of the relevant endopeptidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "in rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "that"

Phrase: "is"

Phrase: "responsible for most receptor-mediated insulin degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.3: The endosomal activity was shown to be aspartic acid protease cathepsin D (CD), based on biochemical similarities to purified CD in 1) the rate and site of substrate cleavage, 2) pH optimum, 3) sensitivity to pepstatin A, and 4) binding to pepstatin A-agarose. 

Phrase: "The endosomal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "aspartic acid protease cathepsin D (CD),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   911   C0949755:ASPARTIC ACID D [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1332805:CATHEPSIN D [Gene or Genome]
   804   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "based on biochemical similarities"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205474:Biochemical [Functional Concept]
   770   C1527178:Based [Functional Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737   C2348205:Similarity [Qualitative Concept]

Phrase: "to purified CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "site of substrate cleavage,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2945843:Site of [Qualitative Concept]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "pH optimum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2698651:Optimum [Qualitative Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "sensitivity to pepstatin A,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "binding to pepstatin A-agarose."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036681:Agarose [Carbohydrate]
   760   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.4: The identity of the protease was immunologically confirmed by removal of greater than 90% of the insulin-degrading activity associated with an endosomal lysate using polyclonal antibodies to CD. 

Phrase: "The identity of the protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0424215:Identity [Mental Process]
   760   C2003939:Identity [Finding]

Phrase: "was"

Phrase: "immunologically"

Phrase: "confirmed by removal of greater"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0015252:Removal [Therapeutic or Preventive Procedure]
   760   C0443228:greater [Quantitative Concept]
   760   C0728940:Removal [Therapeutic or Preventive Procedure]
   760   C0750484:Confirmed [Idea or Concept]
   760   C1704243:Greater [Quantitative Concept]
   726 E C0549177:Great [Quantitative Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "than 90%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "of the insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "associated with an endosomal lysate"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C1881488:Lysate [Physical Object]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal antibodies to CD."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   797   C0369095:antibodies d [Immunologic Factor]
   773   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.5: Moreover, the elution profile of the endosomal acidic insulinase activity on a gel-filtration TSK-GEL G3000 SWXL high performance liquid chromatography column corresponded exactly with the elution profile of the immunoreactive 45-kDa mature form of endosomal CD. 

Phrase: "Moreover,"

Phrase: "the elution profile of the endosomal acidic insulinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1979963:Profile [Laboratory Procedure]
   742   C2003903:Profile [Functional Concept]

Phrase: "on a gel-filtration TSK-GEL G3000 SWXL high performance liquid chromatography column"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   801   C0684296:Chromatography.column [Laboratory Procedure]
   788   C1185738:Column [Body Part, Organ, or Organ Component]
   788   C1706132:Column [Idea or Concept]
   716   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Chromatography

Phrase: "corresponded"

Phrase: "exactly with the elution profile of the immunoreactive 45-kDa mature form"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   736   C0205286:Mature [Temporal Concept]
   736   C0348078:Form [Qualitative Concept]
   736   C0376315:Form [Manufactured Object]
   736   C1441565:Elution [Laboratory Procedure]
   736   C1522492:Form [Functional Concept]
   736   C1532717:kDa [Quantitative Concept]
   736   C1979963:Profile [Laboratory Procedure]
   736   C2003903:Profile [Functional Concept]

Phrase: "of endosomal CD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.6: Using nondenaturating immunoprecipitation and immunoblotting procedures, other endosomal aspartic acid proteases such as cathepsin E and -site amyloid precursor protein-cleaving enzyme (BACE) were ruled out as candidate enzymes for the endosomal degradation of internalized insulin. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nondenaturating immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "immunoblotting procedures,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "other endosomal aspartic acid proteases such as cathepsin E"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C2717969:Aspartic Acid Proteases [Amino Acid, Peptide, or Protein,Enzyme]
           Aspartic Protease
   745   C0072325:protease E [Amino Acid, Peptide, or Protein,Enzyme]
   745   C1423848:protease E [Gene or Genome]
   742   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   742   C1947941:Proteases [Enzyme]

Phrase: "and -"

Phrase: "site amyloid precursor protein-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "cleaving"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(BACE)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "were"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "candidate enzymes for the endosomal degradation of internalized insulin."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   745   C0678637:enzyme degradation [Laboratory Procedure]
   742   C0014442:Enzymes [Enzyme,Organic Chemical]
   742   C0014445:enzymes [Functional Concept]
Processing 00000000.tx.7: Immunofluorescence studies showed a largely vesicular staining pattern for internalized insulin in rat hepatocytes that colocalized partially with CD. 

Phrase: "Immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a largely vesicular staining pattern for internalized insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "in rat hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "colocalized"

Phrase: "partially with CD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.8: In vivo pepstatin A treatment was without any observable effect on the insulin receptor content of endosomes but augmented the phosphotyrosine content of the endosomal insulin receptor after insulin injection. 

Phrase: "In vivo pepstatin A treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C1515655:In Vivo [Spatial Concept]
           vivo
   804   C0039798:treatment [Functional Concept]
   804   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]

Phrase: "was without any observable effect"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1280500:Effect [Qualitative Concept]
   760   C1421478:WAS [Gene or Genome]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the insulin receptor content"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   734   C1334133:INSULIN RECEPTOR [Gene or Genome]

Phrase: "of endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "but"

Phrase: "augmented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:Augmented [Quantitative Concept]

Phrase: "the phosphotyrosine content of the endosomal insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "after insulin injection."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0199782:Insulin injection [Therapeutic or Preventive Procedure]
  1000   C0586328:Insulin injection [Therapeutic or Preventive Procedure]
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1828121:Injection [Functional Concept]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.9: These results suggest that CD is the endosomal acidic insulinase activity which catalyzes the rate-limiting step of the in vivo cleavage at the PheB24-PheB25 bond, generating the inactive A1-21-B1-24 insulin intermediate.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "the endosomal acidic insulinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "catalyzes"

Phrase: "the rate-limiting step of the in vivo cleavage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1261552:Step [Conceptual Entity]
   742   C1704379:Step [Functional Concept]
   742   C1705117:Step [Quantitative Concept]
   742   C2825408:Step [Manufactured Object]

Phrase: "at the PheB24-PheB25 bond,"

Phrase: "generating"

Phrase: "the inactive A1-21-B1-24 insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "intermediate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.10: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Proteins entering the endocytic pathway encounter an increasingly hydrolytic environment imposed by a progressive decrease in pH and an increase in protease concentrations (reviewed in Ref. 1). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "entering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522196:ENTER [Functional Concept]

Phrase: "the endocytic pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "encounter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Encounter [Behavior]
  1000   C1512346:encounter [Health Care Activity]
  1000   C1947978:Encounter [Behavior]

Phrase: "an increasingly hydrolytic environment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014406:Environment [Spatial Concept]

Phrase: "imposed by a progressive decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205329:Progressive [Functional Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "in pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "an increase in protease concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "("

Phrase: "reviewed in Ref. 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0140145:REF-1 [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332102:REF-1 [Gene or Genome]
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.11: Ultimately, most are degraded in lysosomes to small peptides and free amino acids. 

Phrase: "Ultimately,"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "are"

Phrase: "degraded in lysosomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0024369:Lysosomes [Cell Component]
   790   C1881707:DEGRADED [Phenomenon or Process]
   756 E C2984253:Lysosome [Functional Concept]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "to small peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "free amino acids."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.12: For some, degradation takes place early in the endocytic pathway. 

Phrase: "For some,"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "takes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "place"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "early in the endocytic pathway."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1279919:Early [Temporal Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.13: This is the case for polypeptide hormones such as insulin (2-4), glucagon (5), and parathyroid hormone (6) and growth factors such as the epidermal growth factor (7) and insulin-like growth factor-I (IGF-I)1 (8) as well as endocytosed protein antigens for major histocompatibility class II presentation (9) and plant toxins (10). 

Phrase: "This"

Phrase: "is"

Phrase: "the case for polypeptide hormones"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0868928:Case [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "such as insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "parathyroid hormone"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0030520:Parathyroid Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1882913:PARATHYROID HORMONE [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C3536885:Parathyroid Hormone [Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   861   C0030518:Parathyroid, NOS [Body Part, Organ, or Organ Component]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "growth factors such as the epidermal growth factor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0242275:Epidermal Growth Factors [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]

Phrase: "(7"

Phrase: ")"

Phrase: "and"

Phrase: "insulin-like growth factor-I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(8"

Phrase: ")"

Phrase: "as well as"

Phrase: "endocytosed protein antigens for major histocompatibility class II presentation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0019630:Class II Major Histocompatibility Antigens [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Class II Histocompatibility Antigens
           Class II Antigens
   762   C0019628:Histocompatibility Antigens [Immunologic Factor]
   748   C1291777:Protein antigen [Immunologic Factor]
   745   C0206431:Antigen Presentation [Cell Function]
   742   C0003320:Antigens [Immunologic Factor]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "plant toxins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0032086:plant toxins [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]
   861   C0032098:Plant [Plant]
   861   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]
   768 E C0006038:Botany [Occupation or Discipline]
   750 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.14: In liver parenchyma the endosomal degradation of internalized insulin is thought to occur after acidification of the endosomal lumen by a soluble enzyme termed endosomal acidic insulinase (EAI) (2, 3, 11), although this protease has yet to be identified. 

Phrase: "In liver parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0736268:Liver parenchyma [Body Part, Organ, or Organ Component]
   861   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "the endosomal degradation of internalized insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur after acidification of the endosomal lumen"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   822   C1179919:Lumen of the Endosome [Cell Component]
           Lumen of endosome
           endosome lumen
   804   C1522931:endosomal lumen acidification [Molecular Function]
   748   C0524461:Lumen [Body Space or Junction]
   748   C1282864:Lumen [Body Space or Junction]
   748   C1301906:Lumen [Qualitative Concept]
   748   C1522821:acidification [Cell Function]
   748   C1551056:Lumen [Quantitative Concept]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   748   C2987513:Acidification [Phenomenon or Process]

Phrase: "by a soluble enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "endosomal acidic insulinase (EAI)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "this protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "has"

Phrase: "yet to"

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.15: EAI, which was easily extracted by hypotonic shock from hepatic endosomes, displayed an acidic pH optimum for insulin binding and degradation (2, 3, 11). 

Phrase: "EAI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "which"

Phrase: "was"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "extracted by hypotonic shock"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "from hepatic endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an acidic pH optimum for insulin binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2698651:Optimum [Qualitative Concept]

Phrase: "and"

Phrase: "degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243125:degradation [Functional Concept]
  1000   C0699900:Degradation [Organism Function]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "11"

Phrase: ")."
Processing 00000000.tx.16: The events leading to the endosomal proteolysis of internalized insulin by EAI involve initial binding of the C-terminal region of the B chain of insulin to EAI followed by two initial proteolytic cleavages at PheB24-PheB25 and PheB25-TyrB26 peptide bonds (11). 

Phrase: "The events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441471:Events [Event]
  1000   C3541888:Events [Classification]

Phrase: "leading to the endosomal proteolysis of internalized insulin"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0332152:Leading [Temporal Concept]
   744   C0597304:Proteolysis [Molecular Function]
   744   C1522538:Leading [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "by EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "involve"

Phrase: "initial binding of the C-terminal region of the B chain of insulin"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   763   C1149341:C-terminal binding [Molecular Function]
   749   C1623517:insulin binding [Molecular Function]
   735   C0243122:binding [Functional Concept]
   735   C1145667:Binding [Activity]
   735   C1167622:Binding [Molecular Function]

Phrase: "to EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "followed by two initial proteolytic cleavages"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0205265:Initial [Temporal Concept]
   753   C0205448:Two [Quantitative Concept]
   753   C0597304:Proteolytic [Molecular Function]
   753   C1279901:Initial [Qualitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]
   753   C1947941:proteolytic [Enzyme]
   719   C0010813:cleavage [Cell Function]
   719   C0596311:Cleavage [Phenomenon or Process]
   719   C1330957:cleavage [Cell Function]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "at PheB24-PheB25"

Phrase: "and"

Phrase: "PheB25-TyrB26 peptide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.17: This is followed by the hydrolysis of seven peptide bonds in the C terminus of the insulin B chain and, in the central region of the insulin A and B chains, via an ordered sequential pathway. 

Phrase: "This"

Phrase: "is"

Phrase: "followed by the hydrolysis of seven peptide bonds"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0020291:Hydrolysis [Natural Phenomenon or Process]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0205453:Seven [Quantitative Concept]
   737   C0678595:peptide bond [Natural Phenomenon or Process]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "in the C terminus"

Phrase: "of the insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "in the central region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0454907:Central region [Geographic Area]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the insulin A"

Phrase: "and"

Phrase: "B chains,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:chains [Manufactured Object]
   861   C1524075:Chains [Idea or Concept]

Phrase: "via an ordered sequential pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.18: The high IC50 value of insulin for EAI (2-4105 M) and the high proteolytic activity and affinity of EAI for insulin B chain and a B22-30 insulin fragment suggest that EAI is a nonspecific peptidase whose physiological substrates other than insulin within the endosomal apparatus have yet to be defined (11). 

Phrase: "The high IC50 value of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "for EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "(2-4105"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "M)"

Phrase: "and"

Phrase: "the high proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C0597304:Proteolytic [Molecular Function]
   827   C1561536:*Activity [Idea or Concept]
   827   C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "affinity of EAI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "for insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "a B22-30 insulin fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "is"

Phrase: "a nonspecific peptidase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1947941:Peptidase [Enzyme]

Phrase: "whose physiological substrates other than insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1710236:Substrate [Manufactured Object]

Phrase: "within the endosomal apparatus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]
   789   C0034850:Endosome [Cell Component]

Phrase: "have"

Phrase: "yet to"

Phrase: "be"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.19: In support of this, we have recently demonstrated that cathepsin B, a general cysteine protease, down-regulates internalized epidermal growth factor and glucagon within rat liver endosomes (5, 7) and internalized IGF-I in MCF-7 and H-59 tumor cells (8) by inducing proteolytic cleavages of these ligands. 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this,"

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "that cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "a general cysteine protease,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "internalized epidermal growth factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "glucagon within rat liver endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")"

Phrase: "and"

Phrase: "internalized IGF-I in MCF-7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1334089:IGF I [Gene or Genome]
   753   C0021966:I- [Inorganic Chemical]
   753   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "H-59 tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")"

Phrase: "by inducing proteolytic cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0010813:cleavage [Cell Function]
   793   C0596311:Cleavage [Phenomenon or Process]
   793   C1330957:cleavage [Cell Function]

Phrase: "of these ligands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]
Processing 00000000.tx.20: Previous attempts to purify and identify EAI have been made using the radiolabeled peptide [125I-TyrA14]insulin to measure endosomal hydrolysis of insulin by monitoring the increase in soluble counts after precipitation of radioactive insulin with cold trichloroacetic acid (2, 3). 

Phrase: "Previous attempts to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1516084:Attempt [Event]

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "and"

Phrase: "identify"

Phrase: "EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "have"

Phrase: "been"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the radiolabeled peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "[125I-TyrA14"

Phrase: "]insulin to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "endosomal hydrolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "by monitoring"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150369:Monitoring [Health Care Activity]
  1000   C1516647:monitoring [Research Activity]

Phrase: "the increase in soluble counts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "after precipitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0032931:Precipitation [Natural Phenomenon or Process]
  1000   C0032932:Precipitation [Molecular Function]
  1000   C1642401:% precipitation [Quantitative Concept]
  1000   C2584299:Precipitation [Natural Phenomenon or Process]

Phrase: "of radioactive insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "with cold trichloroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: Based on the trichloroacetic acid precipitation assay, endosomal proteolysis of [125I-TyrA14]insulin was partially inhibited by chelating agents, thiol reagents, pepstatin A, leupeptin, and bacitracin (2). 

Phrase: "Based on the trichloroacetic acid precipitation assay,"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   778   C0040900:Trichloroacetic Acid [Organic Chemical,Pharmacologic Substance]
   748   C0001128:Acid [Chemical]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0032931:Precipitation [Natural Phenomenon or Process]
   748   C0032932:Precipitation [Molecular Function]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1527178:Based [Functional Concept]
   748   C1642401:% precipitation [Quantitative Concept]
   748   C1705938:Based [Idea or Concept]
   748   C2584299:Precipitation [Natural Phenomenon or Process]
   714 E C0002055:base [Inorganic Chemical]
   714 E C0178499:Base [Chemical Viewed Functionally]
   714 E C1880279:Base [Biomedical or Dental Material]

Phrase: "endosomal proteolysis of [125I-TyrA14"

Phrase: "]insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "partially"

Phrase: "inhibited by chelating agents,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0007974:Chelating Agents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C3537131:Chelating [Molecular Function]
   737   C0450442:Agent [Chemical Viewed Functionally]
   737   C1254351:Agent [Pharmacologic Substance]
   737   C1521826:Agent [Intellectual Product]

Phrase: "thiol reagents,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038738:Thiol Reagents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "pepstatin A,"

Phrase: "leupeptin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.22: However, none of the protease inhibitors was individually capable of completely inhibiting [125I-TyrA14]insulin proteolysis, suggesting the contribution of more than one protease to the processing of radioactive insulin. 

Phrase: "However,"

Phrase: "none of the protease inhibitors"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   773 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   760   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0243077:inhibitors [Chemical Viewed Functionally]
   760   C0456148:None [Quantitative Concept]
   760   C0549184:None [Quantitative Concept]
   760   C1947941:Protease [Enzyme]
   726 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "individually capable of completely"

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "[125I-TyrA14"

Phrase: "]insulin proteolysis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0597304:Proteolysis [Molecular Function]
   789 E C1947941:proteolytic [Enzyme]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the contribution of more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880177:Contribution [Activity]

Phrase: "than one protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "to the processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "of radioactive insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.23: Later, using an alternate approach based on reverse-phase (RP) HPLC and mass spectrometry analysis in which hydrolysis was measured by the generation of degradation products from unlabeled HI, we elucidated the entire structure of nine early insulin intermediates generated within hepatic endosomes, all of which contained the A14 tyrosine residue in their sequence and displayed a molecular mass higher than 3125Da (11). 

Phrase: "Later,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an alternate approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "based on reverse-phase (RP) HPLC"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1527178:Based [Functional Concept]
   760   C1555029:Reverse [Idea or Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "mass spectrometry analysis in which hydrolysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "measured by the generation of degradation products"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0079411:Generation [Temporal Concept]
   748   C0243125:degradation [Functional Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0699900:Degradation [Organism Function]
   748   C1514468:Products [Entity]
   748   C3146294:Generation [Activity]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "from unlabeled HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "we"

Phrase: "elucidated"

Phrase: "the entire structure of nine early insulin intermediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0678594:Structure [Spatial Concept]

Phrase: "generated within hepatic endosomes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C3146294:Generated [Activity]

Phrase: "all of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444868:All [Quantitative Concept]
   790   C3539085:All [Idea or Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the A14 tyrosine residue in their sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "higher than 3125Da"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.24: Indeed, all of the early insulin intermediates identified in this study were not trichloroacetic acid-soluble (11). 

Phrase: "Indeed,"

Phrase: "all of the early insulin intermediates"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0444868:All [Quantitative Concept]
   753   C1279919:Early [Temporal Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C3539085:All [Idea or Concept]
   719   C0205103:Intermediate [Spatial Concept]
   719   C1550465:intermediate [Idea or Concept]
   719   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "identified in this study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "not trichloroacetic acid-soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1749467:soluble [Cell Component]
   812   C1948047:Soluble [Qualitative Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.25: Consequently, the trichloroacetic acid solubility of radioactive products, which greatly underestimates actual degradation, reflects additional and/or further processing of transient insulin intermediates and their late transformation into short end products and/or free amino acids by endosomal proteases that are possibly distinct from EAI. 

Phrase: "Consequently,"

Phrase: "the trichloroacetic acid solubility of radioactive products,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0037628:Solubility [Qualitative Concept]

Phrase: "which greatly"

Phrase: "underestimates"

Phrase: "actual degradation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "additional"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Additional [Functional Concept]
   928 E C1883712:Addition [Functional Concept]

Phrase: "and/or"

Phrase: "further processing of transient insulin intermediates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1158354:insulin processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "their late transformation into short end products"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0040682:Transformation [Cell Function]
   748   C1510411:Transformation [Pathologic Function]
   748   C1705163:Transformation [Research Activity]

Phrase: "and/or"

Phrase: "free amino acids by endosomal proteases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756 E C2917660:Amino Acid [Pharmacologic Substance]
   753   C0001128:Acids [Chemical]
   753   C0332296:free [Functional Concept]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719 E C0202406:Acid [Laboratory Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "possibly distinct from EAI."
Processing 00000000.tx.26: These concerns were addressed in this study by using native HI as the substrate and RP HPLC to improve the specificity of the degradation assay and identify the nature of EAI. 

Phrase: "These concerns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2699424:Concerns [Idea or Concept]

Phrase: "were"

Phrase: "addressed in this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   737   C0376649:Address [Intellectual Product]
   737   C1442065:Address [Spatial Concept]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "native HI as the substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "RP HPLC to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0008562:HPLC [Laboratory Procedure]

Phrase: "improve"

Phrase: "the specificity of the degradation assay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "identify"

Phrase: "the nature of EAI."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]
Processing 00000000.tx.27: An early time point of HI digestion was always chosen for RP HPLC analysis, when the two primary products A1-21-B1-24 and A1-21-B1-25 insulin were the most abundant. 

Phrase: "An early time point of HI digestion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C2348792:Time Point [Temporal Concept]
   748   C0040223:Time [Temporal Concept]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "was"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "chosen for RP HPLC analysis,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C2986798:Phase Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1555029:Reverse [Idea or Concept]
   753   C1707391:Chosen [Activity]

Phrase: "when"

Phrase: "the two primary products A1-21-B1-24"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   795   C0205225:Primary [Qualitative Concept]
   795   C0205448:Two [Quantitative Concept]
   795   C0439631:Primary [Therapeutic or Preventive Procedure]
   795   C1514468:Products [Entity]
   762 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "A1-21-B1-25 insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "the most abundant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346714:Abundant [Qualitative Concept]
Processing 00000000.tx.28: These improvements in the methodology used to evaluate the proteolytic activity have allowed us to identify the role of the aspartic acid protease cathepsin D in the endosomal processing of insulin.  

Phrase: "These improvements in the methodology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C2986411:Improvement [Conceptual Entity]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]

Phrase: "have"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the role of the aspartic acid protease cathepsin D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]

Phrase: "in the endosomal processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.29: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Peptides, Antibodies, Protein Determination, Enzyme Assays, and Materials-- A chain and B chain from bovine insulin, human insulin, and bovine cathepsin D (EC 3.4.23.5), 15units/mg, were from Sigma. 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "Antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Protein Determination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "Enzyme Assays,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C2717977:Enzyme Assays [Laboratory Procedure]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "and"

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "--"

Phrase: "A chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "B chain from bovine insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   760   C0337112:Chain [Manufactured Object]
   760   C1524075:Chain [Idea or Concept]

Phrase: "human insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "bovine cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(EC 3.4.23.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0022202:EC 5 [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0024188:EC 4 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "15units/mg,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.30: Rabbit anti-mouse cathepsin D R291 (5), sheep anti-human cathepsin D M8147 (12, 13), rabbit anti-rat cathepsin B 7183(5, 7, 14), and rabbit anti-rat cathepsin L R958 (5, 15) were obtained from Dr. 

Phrase: "Rabbit anti-mouse cathepsin D R291"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "sheep anti-human cathepsin D M8147"

Phrase: "(12,"

Phrase: "13"

Phrase: ")"

Phrase: ","

Phrase: "rabbit anti-rat cathepsin B 7183"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   858   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1332804:CATHEPSIN B [Gene or Genome]
   799   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0034493:Rabbit [Mammal]
   799   C0034693:Rat, NOS [Mammal]
   799   C0034721:Rat [Mammal]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "14"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rabbit anti-rat cathepsin L R958"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "15"

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.31: J.S.Mort (Shriners Hospital for Crippled Children, Montreal, Quebec) and used to immune-deplete samples of native mature enzymes as described previously (5, 7). 

Phrase: "J.S.Mort (Shriners Hospital for Crippled Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0020017:Children's hospital [Health Care Related Organization]
   744   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   744   C1510665:Hospital [Qualitative Concept]

Phrase: "Montreal,"

Phrase: "Quebec"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034390:Quebec [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "used to immune-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0439662:Immune [Functional Concept]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "samples of native mature enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.32: Rabbit polyclonal antisera directed against N- and C-terminal -site amyloid precursor protein-cleaving enzyme (BACE) peptides were obtained from Dr. 

Phrase: "Rabbit polyclonal antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against N-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "C-terminal -site amyloid precursor protein-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   861   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   839   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0011560:Amyloid [Pathologic Function]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1709634:Precursor [Idea or Concept]

Phrase: "cleaving"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(BACE) peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.33: R.W.Doms (University of Pennsylvania School of Medicine, Philadelphia, PA) and have been described previously (16). 

Phrase: "R.W.Doms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3539821:DOM [Gene or Genome]

Phrase: "(University of Pennsylvania School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.34: Affinity-purified goat antibody raised against human cathepsin E (sc-6508), which cross-reacts with cathepsin E of rat origin, was purchased from Santa Cruz Biotechnology Inc. 

Phrase: "Affinity-purified goat antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised against human cathepsin E"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0054867:Cathepsin E [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1413812:CATHEPSIN E [Gene or Genome]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0086418:Human [Human]
   760   C0442818:Raised [Quantitative Concept]

Phrase: "(sc-6508"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "cross-reacts with cathepsin E of rat origin,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0054867:Cathepsin E [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1413812:CATHEPSIN E [Gene or Genome]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0079946:origin [Classification]
   744   C0439659:Origin [Temporal Concept]
   744   C1550512:origin [Intellectual Product]
   744   C2828360:Cross [Conceptual Entity]
   739   C0010364:Genetic Cross [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "purchased from Santa Cruz Biotechnology Inc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   753   C0869011:purchased [Activity]
Processing 00000000.tx.35: Mouse monoclonal antibody 9B12 directed against the human insulin-degrading enzyme (17) was a kind gift from Dr. 

Phrase: "Mouse monoclonal antibody 9B12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the human insulin-degrading enzyme"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "(17"

Phrase: ")"

Phrase: "was"

Phrase: "a kind gift from Dr."
Processing 00000000.tx.36: R.A.Roth (Stanford University, Stanford, CA). 

Phrase: "R.A.Roth"

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA)."
Processing 00000000.tx.37: Polyclonal IgG against the human insulin receptor -subunit and mouse monoclonal anti-phosphotyrosine (clone 4G10) were purchased from Upstate Biotechnology Inc. 

Phrase: "Polyclonal IgG against the human insulin receptor -subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C2702333:Human IgG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "mouse monoclonal anti-phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(clone 4G10"

Phrase: ")"

Phrase: "were"

Phrase: "purchased from Upstate Biotechnology Inc."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]
Processing 00000000.tx.38: Mouse monoclonal antibody directed against the rat early endosome antigen 1(EEA1) was purchased from Transduction Laboratories. 

Phrase: "Mouse monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "directed against the rat early endosome antigen 1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0298073:early endosome antigen 1 [Amino Acid, Peptide, or Protein,Receptor]
   833   C1414266:EARLY ENDOSOME ANTIGEN 1 [Gene or Genome]
   770   C0887883:Early endosome [Cell Component]
   767   C1514732:Rat-1 [Cell]
   744   C0003320:Antigen [Immunologic Factor]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0034850:Endosome [Cell Component]
   744   C1279919:Early [Temporal Concept]
   711   C0439851:Direct [Qualitative Concept]
   711   C1947931:Direct [Qualitative Concept]

Phrase: "(EEA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414266:EEA1 [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "purchased from Transduction Laboratories."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0022877:Laboratories [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C1160185:transduction [Organism Function]
   770   C1619828:Laboratories [Intellectual Product]
   737 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.39: Horseradish peroxidase-conjugated goat anti-rabbit IgG and goat anti-mouse IgG were from Bio-Rad. 

Phrase: "Horseradish peroxidase-conjugated goat anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0034493:Rabbit [Mammal]

Phrase: "and"

Phrase: "goat anti-mouse IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "were from Bio-Rad."
Processing 00000000.tx.40: The protein content of isolated fractions was determined by the method of Lowry et al. 

Phrase: "The protein content of isolated fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined by the method of Lowry et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.41: (18). 

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.42: N-Acetyl--D-glucosaminidase was assayed with p-nitrophenyl N-acetyl--D-glucosaminide as substrate according to Touster et al. 

Phrase: "N-Acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017724:Glucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "assayed with p-nitrophenyl N-acetyl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminide as substrate"

Phrase: "according to Touster et al."
Processing 00000000.tx.43: (19). 

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.44: Acid phosphatase was assayed as described by Trouet (20). 

Phrase: "Acid phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001128:Acid [Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0202406:Acid [Laboratory Procedure]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "was"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "described by Trouet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.45: Nitrocellulose membranes and the Enhanced Chemiluminescence (ECL) detection kit were from Amersham Biosciences, Inc. 

Phrase: "Nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "the Enhanced Chemiluminescence (ECL) detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "were from Amersham Biosciences,"

Phrase: "Inc."
Processing 00000000.tx.46: Protein G-Sepharose was from Amersham Biosciences, Inc. 

Phrase: "Protein G-Sepharose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0036681:Sepharose [Carbohydrate]
   734   C0060916:protein g [Amino Acid, Peptide, or Protein]

Phrase: "was from Amersham Biosciences,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "Inc."
Processing 00000000.tx.47: CA074, which is a highly selective irreversible cathepsin B inhibitor, was purchased from Peptides International. 

Phrase: "CA074,"

Phrase: "which"

Phrase: "is"

Phrase: "a highly selective irreversible cathepsin B inhibitor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "purchased from Peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   790   C0869011:purchased [Activity]

Phrase: "International."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]
Processing 00000000.tx.48: Pepstatin A, pepstatin A-agarose, EDTA, 1,10-phenanthroline, E64, N-ethylmaleimide, p-hydroxymercuri phenylsulfonic acid, iodoacetamide, phenylmethylsulfonyl fluoride, and benzamidine were from Sigma. 

Phrase: "Pepstatin A,"

Phrase: "pepstatin A-agarose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]

Phrase: "EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "E64,"

Phrase: "N-ethylmaleimide,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015101:N-Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Ethylmaleimide

Phrase: "p-hydroxymercuri phenylsulfonic acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "iodoacetamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "benzamidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.49: HPLC grade acetonitrile and trifluoroacetic acid were obtained from J.T.

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441800:Grade [Classification]
  1000   C0919553:Grade [Classification]
  1000   C3244287:grade [Finding]

Phrase: "acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "and"

Phrase: "trifluoroacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040982:Trifluoroacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained from J.T."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.50: Baker Inc. 

Phrase: "Baker Inc."
Processing 00000000.tx.51: All other chemicals were obtained from commercial sources and were of reagent grade. 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "obtained from commercial sources"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1516719:Commercial Sources [Classification]
   770   C0449416:sources [Finding]
   770   C0680536:commercial [Intellectual Product]
   770   C1301820:Obtained [Functional Concept]
   770   C3272563:Commercial [Intellectual Product]
   737 E C1705919:Source [Idea or Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "were of reagent grade."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0441800:Grade [Classification]
   770   C0919553:Grade [Classification]
   770   C3244287:grade [Finding]
Processing 00000000.tx.52: Animals and Injections-- Male Sprague-Dawley rats, body weight 180-200 g, were obtained from Charles River France (St. Aubin Les Elbeufs, France) and were fasted for 18h before sacrifice. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "Injections"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0021485:injections [Therapeutic or Preventive Procedure]
  1000   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
  1000   C1828121:Injections [Functional Concept]
   966 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "--"

Phrase: "Male Sprague-Dawley rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "body weight 180-200 g,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from Charles River France"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0016674:France [Geographic Area]
   760   C0337050:River [Natural Phenomenon or Process]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "(St. Aubin Les Elbeufs,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "fasted for 18h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1442448:18H [Temporal Concept]
   756   C0015663:Fast [Finding]
   756   C0456962:Fast [Qualitative Concept]

Phrase: "before sacrifice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0681205:Sacrifice [Idea or Concept]
Processing 00000000.tx.53: Native insulin (15g/100 g of body weight) in 0.4ml of 0.15M NaCl was injected within 5s into the penis vein under light anesthesia with ether. 

Phrase: "Native insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(15g/100 g of body weight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "in 0.4ml"

Phrase: "of 0.15M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "was"

Phrase: "injected within 5s"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552119:5s [Body Part, Organ, or Organ Component]
   756   C1720154:Inject [Functional Concept]

Phrase: "into the penis vein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "under light anesthesia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0475746:Light anaesthesia [Finding]
   861   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   861   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   745 E C0002932:Anaesthetic [Pharmacologic Substance]

Phrase: "with ether."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014994:Ether [Organic Chemical,Pharmacologic Substance]
  1000   C0014996:Ether, NOS [Organic Chemical,Pharmacologic Substance]
  1000   C1161324:ether [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.54: In some experiments, rats received an intraperitoneal injection of 2mg of pepstatin A in 0.4ml of 12.5% Me2SO, 0.15M NaCl 1h before HI injection. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "an intraperitoneal injection of 2mg of pepstatin A"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C0442120:Intraperitoneal [Spatial Concept]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "in 0.4ml"

Phrase: "of 12.5% Me2SO,"

Phrase: "0.15M NaCl 1h before HI injection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1442450:1H [Temporal Concept]
Processing 00000000.tx.55: Isolation of Subcellular Fractions from Rat Liver-- Subcellular fractionation was performed using established procedures (2, 3, 5, 7, 11, 21-23). 

Phrase: "Isolation of Subcellular Fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "from Rat Liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "--"

Phrase: "Subcellular fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1656251:subcellular fractionation [Laboratory Procedure]
   861   C0016640:fractionation [Laboratory Procedure]
   861   C0524811:fractionation [Therapeutic or Preventive Procedure]
   861   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "established procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "11,"

Phrase: "21-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.56: After injection of human insulin, animals were sacrificed, and livers were rapidly removed and minced in isotonic ice-cold homogenization buffer as previously described (2, 3, 5, 7, 11, 21-23). 

Phrase: "After injection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "of human insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "sacrificed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: ","

Phrase: "and"

Phrase: "livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "minced in isotonic ice-cold homogenization buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0456963:Ice cold [Qualitative Concept]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0234192:Cold [Physiologic Function]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "11,"

Phrase: "21-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.57: Lysosomes were prepared by isopycnic centrifugation of the light mitochondrial fraction in a discontinuous metrizamide gradient according to the method of Wattiaux et al. 

Phrase: "Lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "were"

Phrase: "prepared by isopycnic centrifugation of the light mitochondrial fraction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0007705:Centrifugation, Isopycnic [Laboratory Procedure]
   762   C1264633:Fraction of [Quantitative Concept]
           Fraction
   742   C0007703:Centrifugation [Laboratory Procedure]
   742   C0023693:Light [Natural Phenomenon or Process]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1306462:Light [Functional Concept]
   742   C1554103:Fraction [Idea or Concept]
   742   C1881376:Light [Qualitative Concept]
   708   C1521827:Prepare [Functional Concept]

Phrase: "in a discontinuous metrizamide gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]

Phrase: "according to the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Wattiaux et al."
Processing 00000000.tx.58: (24). 

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.59: Lysosomes (L2 fraction) were collected at the 1.109-1.135 g/ml metrizamide interface (24). 

Phrase: "Lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(L2 fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "at the 1.109-1.135 g/ml metrizamide interface"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1708533:Interface [Manufactured Object]
   793   C2698172:Interface [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.60: The endosomal fraction was isolated by discontinuous sucrose gradient centrifugation and collected at the 0.25-1.0 M sucrose interface (2, 3, 5, 7, 11, 21-23). 

Phrase: "The endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "isolated by discontinuous sucrose gradient centrifugation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0007703:Centrifugation [Laboratory Procedure]
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0205409:Isolated [Functional Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0439599:Discontinuous [Temporal Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   753   C1444662:Discontinuous [Finding]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "collected at the 0.25-1.0 M sucrose interface"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0441923:M+ [Intellectual Product]
   739   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   739   C1516695:Collected [Idea or Concept]
   739   C1516698:Collected [Functional Concept]
   739   C1708533:Interface [Manufactured Object]
   739   C2698172:Interface [Intellectual Product]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "11,"

Phrase: "21-23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.61: The soluble extract from the endosomal fractions was isolated by freeze/thawing in 5mM sodium phosphate, pH 7.4,and disrupted in the same hypotonic medium using a small Dounce homogenizer (15strokes with Type A pestle) followed by centrifugation at 300,000gav for 30min as described previously (2, 3, 5, 7, 11, 25). 

Phrase: "The soluble extract from the endosomal fractions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "isolated by freeze/thawing"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0016701:Freeze [Natural Phenomenon or Process]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737   C1710378:Thaw [Laboratory Procedure]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "in 5mM sodium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "disrupted in the same hypotonic medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0241938:Hypotonic [Pathologic Function]
   753   C0332454:Disrupted [Qualitative Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0445247:Same [Qualitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a small Dounce homogenizer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0181200:homogenizer [Medical Device]

Phrase: "(15strokes with Type A pestle"

Phrase: ")"

Phrase: "followed by centrifugation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0007703:Centrifugation [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "at 300,"

Phrase: "000gav for 30min"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "11,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.62: Endosomal fractions isolated after the injection of HI were suspended at 1.5mg/ml in 62.5mM Tris/HCl, pH 6.8,2% SDS, 10% glycerol, 2% -mercaptoethanol and heated at 100C for 2min. 

Phrase: "Endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "isolated after the injection of HI"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   753   C0018619:HI [Geographic Area]
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C0205409:Isolated [Functional Concept]
   753   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1412082:HI [Gene or Genome]
   753   C1412316:HI [Gene or Genome]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1548221:Isolated [Idea or Concept]
   753   C1828121:Injection [Functional Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "were"

Phrase: "suspended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1553389:suspended [Idea or Concept]
  1000   C1553403:suspended [Idea or Concept]
  1000   C1705537:Suspended [Functional Concept]

Phrase: "at 1.5mg/ml in 62.5mM Tris/HCl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439526:/mL [Quantitative Concept]

Phrase: "pH 6.8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "2% SDS,"

Phrase: "10% glycerol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "2% -mercaptoethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025402:2-Mercaptoethanol [Organic Chemical]
           Mercaptoethanol

Phrase: "and"

Phrase: "heated at 100C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 2min."
Processing 00000000.tx.63: Samples were then subjected to SDS-PAGE, followed by Western blotting to determine the integrity and phosphotyrosine content of the internalized insulin receptor. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "followed by Western blotting to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0332283:Followed by [Temporal Concept]
           followed
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "determine"

Phrase: "the integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205266:integrity [Qualitative Concept]
  1000   C0872403:integrity [Individual Behavior]
  1000   C1947912:Integrity [Qualitative Concept]

Phrase: "and"

Phrase: "phosphotyrosine content of the internalized insulin receptor."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
Processing 00000000.tx.64: Immunoblot Analysis-- Electrophoresed samples were transferred to nitrocellulose membranes (0.45106 m) for 60min at 380mA in transfer buffer containing 25mM Tris base and 192mM glycine. 

Phrase: "Immunoblot Analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "--"

Phrase: "Electrophoresed samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(0.45106"

Phrase: "m) for 60min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "at 380mA"

Phrase: "in transfer buffer containing 25mM Tris base"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0041175:Tris-base [Organic Chemical,Pharmacologic Substance]
   799   C0002055:base [Inorganic Chemical]
   799   C0178499:Base [Chemical Viewed Functionally]
   799   C1880279:Base [Biomedical or Dental Material]
   727 E C0205112:Basal [Spatial Concept]
   716 E C0016617:Foundation [Organization]
   716 E C1626935:Bases [Quantitative Concept]

Phrase: "and"

Phrase: "192mM glycine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0522461:Glycine [Plant]
Processing 00000000.tx.65: The membranes were blocked by a 3-h incubation with 5% skim milk or 2% bovine serum albumin (for phosphotyrosine immunoblots) in 10mM Tris-HCl, pH 7.5,300mM NaCl, and 0.05% Tween 20.

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked by a 3-h incubation"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C0041119:h 3 [Element, Ion, or Isotope]
   753   C0028778:Blocked [Pathologic Function]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0332206:Blocked [Functional Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "with 5% skim milk"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0349375:Skim milk [Food]
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "or"

Phrase: "2% bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   861   C0728877:serum albumin [Laboratory or Test Result]
   812   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0007452:Bovine [Mammal]
   812   C0229671:Serum [Body Substance]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "("

Phrase: "for phosphotyrosine immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "in 10mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "300mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.05% Tween 20."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.66: The membranes were then incubated with primary antibody (rabbit polyclonal antisera against either mouse cathepsin D R291 diluted 1:1500, human BACE diluted 1:1000 or rat cathepsin L R958 diluted 1:200, affinity-purified polyclonal antibodies to insulin receptor diluted 1:1000, monoclonal anti-phosphotyrosine diluted 1:2500) in the above buffer for 16h at 4C. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with primary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(rabbit polyclonal antisera against either mouse cathepsin D R291"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1500,"

Phrase: "human BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412727:BACE [Gene or Genome]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 or rat cathepsin L R958"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200,"

Phrase: "affinity-purified polyclonal antibodies to insulin receptor"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   788   C0443876:Insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0021644:Insulin Antibodies [Immunologic Factor]
   774   C0034805:antibodies receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   757   C0003255:Antibody Affinity [Molecular Function]
   748   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   745   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   714 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "monoclonal anti-phosphotyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2500"

Phrase: ")"

Phrase: "in the above buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 16h"

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.67: After incubation, the blots were washed 3times with 0.5% skim milk or 0.2% bovine serum albumin (for phosphotyrosine immunoblots) in 10mM Tris-HCl, pH 7.5,300mM NaCl, and 0.05% Tween 20over a period of 1h at room temperature. 

Phrase: "After incubation,"

Phrase: "the blots"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3times with 0.5% skim milk"

Phrase: "or"

Phrase: "0.2% bovine serum albumin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   840   C0728877:serum albumin [Laboratory or Test Result]
   804   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0007452:Bovine [Mammal]
   804   C0229671:Serum [Body Substance]
   804   C1140701:bovine [Mammal]
   804   C1546774:Serum [Intellectual Product]
   804   C1550100:Serum [Body Substance]

Phrase: "("

Phrase: "for phosphotyrosine immunoblots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020985:Immunoblot [Laboratory Procedure]

Phrase: ")"

Phrase: "in 10mM Tris-HCl,"

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "300mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.05% Tween 20over"

Phrase: "a period of 1h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439531:/period [Temporal Concept]
   770   C1948053:Period [Temporal Concept]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.68: The bound immunoglobulin was detected using horseradish peroxidase-conjugated goat anti-rabbit IgG for the polyclonal antibody or horseradish peroxidase-conjugated goat anti-mouse IgG for the monoclonal anti-phosphotyrosine antibody. 

Phrase: "The bound immunoglobulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "horseradish peroxidase-conjugated goat anti-rabbit IgG for the polyclonal antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   772   C0063351:IGG-horseradish peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C2754943:IgG antibody [Cell Component]
   738   C0034493:Rabbit [Mammal]

Phrase: "or"

Phrase: "horseradish peroxidase-conjugated goat anti-mouse IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   829   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "for the monoclonal anti-phosphotyrosine antibody."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.69: In Vitro Proteolysis of Native Peptides-- Soluble endosomal extract (ENs) (1 ng) was incubated for varying lengths of time at 37C with 5105 M human insulin, insulin A chain, or insulin B chain in 200106 liters of 50mM citrate-phosphate, pH 4,in the presence or absence of protease inhibitors. 

Phrase: "In Vitro Proteolysis of Native Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "--"

Phrase: "Soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "(1 ng)"

Phrase: "was"

Phrase: "incubated for varying lengths of time"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0040223:Time [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1444754:Lengths [Quantitative Concept]
   753   C3541383:Time [Temporal Concept]
   719 E C1706316:LENGTH [Research Activity]

Phrase: "at 37C"

Phrase: "with 5105 M human insulin,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin A chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "insulin B chain in 200106 liters of 50mM citrate-phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0337112:Chain [Manufactured Object]
   739   C1524075:Chain [Idea or Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "pH 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of protease inhibitors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.70: The samples were then acidified with acetic acid (15%) and immediately loaded onto a RP HPLC column. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "acidified with acetic acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "loaded onto a RP HPLC column."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1555029:Reverse [Idea or Concept]
   748   C1706132:Column [Idea or Concept]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.71: In some experiments, ENs was immunodepleted of active insulin-degrading enzyme, cathepsin L, cathepsin B, or cathepsin D before the digestion step by incubating ENs (0.15mg/ml) with antibodies coated to protein G-Sepharose for 16h at 4C in 800106 liters of 20mM sodium phosphate buffer, pH 7.

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "immunodepleted of active insulin-degrading enzyme,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Active [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "cathepsin L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332807:CATHEPSIN L [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "cathepsin D before the digestion step"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1332805:CATHEPSIN D [Gene or Genome]
   753   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by incubating ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "(0.15mg/ml) with antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "coated to protein G-Sepharose"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   781   C1423498:coat-protein [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0439267:g% [Quantitative Concept]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "for 16h"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "in 800106 liters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475211:liter [Quantitative Concept]

Phrase: "of 20mM sodium phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.72: The fractions were then centrifuged for 5min at 10,000gav, and the resultant supernatants were adjusted to pH 4with citrate-phosphate buffer and used in the HI degradation assay. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged for 5min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "at 10,"

Phrase: "000gav,"

Phrase: "and"

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "adjusted to pH 4with citrate-phosphate buffer"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   774   C0492253:PH BUFFER [Medical Device]
   774   C3256468:citrate buffer [Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0008857:Citrate [Organic Chemical]
   748   C0020283:[pH] [Quantitative Concept]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   748   C0450407:ph+ [Finding]
   748   C0450408:ph++ [Finding]
   748   C0450409:ph+++ [Finding]
   748   C0456081:Adjusted [Functional Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "used in the HI degradation assay."
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0018619:HI [Geographic Area]
   753   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   753   C0243073:assay [Qualitative Concept]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C1273517:used [Finding]
   753   C1412082:HI [Gene or Genome]
   753   C1412316:HI [Gene or Genome]
   753   C1510438:Assay [Laboratory Procedure]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.73: The reaction was terminated by the addition of 15% acetic acid and immediately assayed by RP HPLC. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by the addition of 15% acetic acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0000985:Acetic acid [Organic Chemical]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   744   C1553404:terminated [Idea or Concept]
   744   C1883712:Addition [Functional Concept]
   744   C2348570:Terminated [Functional Concept]

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "assayed by RP HPLC."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1555029:Reverse [Idea or Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.74: Native HI, insulin A chain, and insulin B chain were also digested in vitro with bovine cathepsin D.

Phrase: "Native HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "insulin A chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "in vitro with bovine cathepsin D."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.75: Insulin peptides (5105 M) were incubated with 0.025units/ml cathepsin D in 0.1M citrate-phosphate, pH 4.

Phrase: "Insulin peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(5105"

Phrase: "M)"

Phrase: "were"

Phrase: "incubated with 0.025units/ml cathepsin D"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1332805:CATHEPSIN D [Gene or Genome]
   774   C0439446:mL/d [Quantitative Concept]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0439526:/mL [Quantitative Concept]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 0.1M citrate-phosphate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.76: After 5-60 min of incubation at 37C, the proteolytic reaction was stopped by adding acetic acid (15%), and the samples were immediately analyzed by RP HPLC. 

Phrase: "After 5-60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "of incubation"

Phrase: "at 37C,"

Phrase: "the proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by adding acetic acid"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0000985:Acetic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   760   C1272691:stopped [Qualitative Concept]
   726   C1883712:Add [Functional Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]
   704 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "analyzed by RP HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.77: HPLC Separation of Human Insulin, Insulin A Chain, and Insulin B Chain Peptides-- RP HPLC was performed on a Beckman Coulter System Gold model 127liquid chromatograph equipped with a Rheodyne sample injector fitted with a 500-l loop and a microBondapak C18 column (Waters, 0.3930cm; 105 m particle size). 

Phrase: "HPLC Separation of Human Insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "Insulin A Chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "Insulin B Chain Peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   756   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]

Phrase: "--"

Phrase: "RP HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "was"

Phrase: "performed on a Beckman Coulter System Gold model 127liquid chromatograph"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   757   C0026339:Model System [Intellectual Product,Research Device]
   757   C3161035:Model System [Intellectual Product]
           Model
   739   C0018026:Gold [Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0302647:chromatograph [Medical Device]
   739   C0449913:System [Functional Concept]
   739   C0884358:Performed [Functional Concept]
   739   C1304897:Gold [Functional Concept]
   739   C1553451:System [Manufactured Object]
   739   C1704459:System [Medical Device]
   706 E C2947996:Perform [Pharmacologic Substance]

Phrase: "equipped with a Rheodyne sample injector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0181342:Injector [Medical Device]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "fitted with a 500-l loop"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0036572:Fit [Sign or Symptom]
   753   C0419518:Loop [Medical Device]
   753   C0424576:Fit [Finding]
   753   C0445022:Loop [Spatial Concept]
   753   C2349186:Fit [Activity]

Phrase: "and"

Phrase: "a microBondapak C18 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(Waters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   966 E C0599638:WATER [Substance]
   966 E C1550678:Water [Inorganic Chemical]
   916 E C0443350:Watery [Qualitative Concept]

Phrase: "0.3930cm"

Phrase: "; 105 m particle size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030608:Particle Size [Quantitative Concept]
   812   C0456389:size [Spatial Concept]
   812   C0597177:Particle [Chemical Viewed Structurally]

Phrase: ")."
Processing 00000000.tx.78: Samples were chromatographed using a mixture of 0.1% trifluoroacetic acid in water (solvent A) and 0.1% trifluoroacetic acid in acetonitrile (solvent B) with a flow rate of 1ml/min. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "chromatographed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0302647:chromatograph [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mixture of 0.1% trifluoroacetic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439962:Mixture [Substance]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "A)"

Phrase: "and"

Phrase: "0.1% trifluoroacetic acid in acetonitrile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "B) with a flow rate of 1ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.79: Elution was carried out using two sequential linear gradients of 0-15% solvent B (5min) and 15-39% solvent B (32min) followed by an isocratic elution of 39% solvent B (13min). 

Phrase: "Elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two sequential linear gradients of 0-15% solvent B (5min"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0812409:gradients [Quantitative Concept]
   706 E C0439182:% gradient [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "15-39% solvent B (32min"

Phrase: ")"

Phrase: "followed by an isocratic elution of 39% solvent B (13min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0332283:Followed by [Temporal Concept]
           followed
   739   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]
   739   C1441565:Elution [Laboratory Procedure]
   706 E C1719822:Follow [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.80: Eluates were monitored on-line for absorbance at 214nm with a LC-166 spectrophotometer (Beckman Coulter). 

Phrase: "Eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "on-line for absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   770   C1720176:On [Functional Concept]
   770   C1720294:On [Intellectual Product]

Phrase: "at 214nm"

Phrase: "with a LC-166 spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Beckman Coulter"

Phrase: ")."
Processing 00000000.tx.81: Binding of Endosomal Acidic Insulinase to Pepstatin A-agarose-- ENs (0.15mg/ml) was incubated for 15h at 4C with pepstatin A-agarose in 20mM citrate-phosphate buffer, pH 7.

Phrase: "Binding of Endosomal Acidic Insulinase to Pepstatin A-agarose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0243122:binding [Functional Concept]
   742   C1145667:Binding [Activity]
   742   C1167622:Binding [Molecular Function]

Phrase: "--"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(0.15mg/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "was"

Phrase: "incubated for 15h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with pepstatin A-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]

Phrase: "in 20mM citrate-phosphate buffer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C3256468:citrate buffer [Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.82: After centrifugation at 20,000gav for 5min, the resultant supernatant was tested for its ability to degrade 106 M HI in 300mM citrate-phosphate buffer, pH 4,at 37C for varying amounts of time, and samples were immediately analyzed by RP HPLC. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 20,"

Phrase: "000gav for 5min,"

Phrase: "the resultant supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "tested for its ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "106 M HI in 300mM citrate-phosphate buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0018619:HI [Geographic Area]
   744   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   744   C1412082:HI [Gene or Genome]
   744   C1412316:HI [Gene or Genome]

Phrase: "pH 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "at 37C"

Phrase: "for varying amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "analyzed by RP HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.83: Characterization of Endosomal Acidic Insulinase Using Gel-filtration HPLC-- ENs was loaded onto a TSK-GEL G3000 SWXL HPLC column (Tosoh Corp., 0.7830cm) equilibrated at 4C with 50mM sodium phosphate buffer, pH 6.

Phrase: "Characterization of Endosomal Acidic Insulinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Gel-filtration HPLC-- ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "loaded onto a TSK-GEL G3000 SWXL HPLC column"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   742   C0008562:HPLC [Laboratory Procedure]
   742   C0017243:Gel [Biomedical or Dental Material]
   742   C1185738:Column [Body Part, Organ, or Organ Component]
   742   C1382104:Gel [Substance]
   742   C1706132:Column [Idea or Concept]
   742   C1708715:Loaded [Activity]
   742   C1823517:TSK [Gene or Genome]
   708 E C1550025:Load [Idea or Concept]
   708 E C1704782:Load [Manufactured Object]

Phrase: "(Tosoh Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "0.7830cm"

Phrase: ")"

Phrase: "equilibrated at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0450376:4c [Intellectual Product]

Phrase: "with 50mM sodium phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.84: The column was washed with 30ml of sodium phosphate buffer, pH 6,using a flow rate of 0.5ml/min. 

Phrase: "The column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "was"

Phrase: "washed with 30ml of sodium phosphate buffer,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   814   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   778   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   778   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1548982:Washed [Idea or Concept]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   714 E C0441648:Wash [Activity]

Phrase: "pH 6,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a flow rate of 0.5ml/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2826285:Flow Rate [Quantitative Concept]
   748   C0806140:Flow [Natural Phenomenon or Process]
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.85: Eluates were monitored on-line for absorbance at 214nm with an LC-166 spectrophotometer (Beckman Coulter). 

Phrase: "Eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "on-line for absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   770   C1720176:On [Functional Concept]
   770   C1720294:On [Intellectual Product]

Phrase: "at 214nm"

Phrase: "with an LC-166 spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Beckman Coulter"

Phrase: ")."
Processing 00000000.tx.86: Each fraction (0.5ml) was immediately adjusted to pH 4with 0.5M citrate-phosphate buffer and evaluated for insulin-degrading activity by incubating with 5105 M HI at 37C for 10min. 

Phrase: "Each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(0.5ml"

Phrase: ")"

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "adjusted to pH 4with 0.5M citrate-phosphate buffer"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   764   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   762   C0492253:PH BUFFER [Medical Device]
   762   C3256468:citrate buffer [Pharmacologic Substance]
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0008857:Citrate [Organic Chemical]
   742   C0020283:[pH] [Quantitative Concept]
   742   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   742   C0031701:phosphate [Organophosphorus Compound]
   742   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]
   742   C0450407:ph+ [Finding]
   742   C0450408:ph++ [Finding]
   742   C0450409:ph+++ [Finding]
   742   C0456081:Adjusted [Functional Concept]
   742   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "evaluated for insulin-degrading activity"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   797   C1145751:insulin activity [Molecular Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0220825:Evaluated [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1561536:*Activity [Idea or Concept]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by incubating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:incubating [Laboratory Procedure]

Phrase: "with 5105 M HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0018619:HI [Geographic Area]
   827   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   827   C1412082:HI [Gene or Genome]
   827   C1412316:HI [Gene or Genome]

Phrase: "at 37C"

Phrase: "for 10min."
Processing 00000000.tx.87: The reaction was stopped by the addition of 15% acetic acid, and samples were analyzed by RP HPLC or subjected to SDS-PAGE followed by Western blotting to determine their cathepsin D content. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by the addition of 15% acetic acid,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0000985:Acetic acid [Organic Chemical]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   744   C1272691:stopped [Qualitative Concept]
   744   C1883712:Addition [Functional Concept]
   711 E C1947925:Stop [Activity]
   711 E C2746065:Stop [Temporal Concept]

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by RP HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "or"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "followed by Western blotting to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0332283:Followed by [Temporal Concept]
           followed
   790 E C0949466:Western Blot [Laboratory Procedure]
   760   C1705493:Western [Spatial Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "determine"

Phrase: "their cathepsin D content."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]
Processing 00000000.tx.88: In some experiments, fractions eluted from the gel-filtration HPLC column that contained insulin-degrading activity with the highest specific activity (fraction 20; see Fig. 4A) were incubated for 15h at 4C with pepstatin A-agarose in 75mM citrate-phosphate buffer, pH 7.

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "eluted from the gel-filtration HPLC column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0008559:Gel Filtration [Laboratory Procedure]
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0016107:filtration [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1382104:Gel [Substance]
   748   C1706132:Column [Idea or Concept]

Phrase: "that contained insulin-degrading activity with the highest specific activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C1145751:insulin activity [Molecular Function]
   741   C0020459:high insulin [Disease or Syndrome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1561536:*Activity [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(fraction 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "were"

Phrase: "incubated for 15h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with pepstatin A-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]

Phrase: "in 75mM citrate-phosphate buffer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C3256468:citrate buffer [Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.89: After centrifugation at 20,000gav for 5min, the bound proteins were subjected to SDS-PAGE and Western blot analysis. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 20,"

Phrase: "000gav for 5min,"

Phrase: "the bound proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "Western blot analysis."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]
Processing 00000000.tx.90: Mass Spectrometry-- Samples were prepared and analyzed using ion spray mass spectrometry and HPLC electron spray ionization mass spectrometry coupling as previously described (11). 

Phrase: "Mass Spectrometry"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0037813:Mass Spectrometry [Laboratory Procedure]
   861   C0436196:Spectrometry [Laboratory Procedure]
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "--"

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ion spray mass spectrometry"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   812   C0022023:Ion [Element, Ion, or Isotope]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C1700702:ION [Functional Concept]
   812   C1704413:{Spray} [Quantitative Concept]
   812   C2003858:Spray [Functional Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "HPLC electron spray ionization mass spectrometry coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1948027:Coupling [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.91: Hepatocyte Culture-- Primary hepatocytes were isolated from male Sprague-Dawley rats weighing 180-200 g. 

Phrase: "Hepatocyte Culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "--"

Phrase: "Primary hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "isolated from male Sprague-Dawley rats"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   833   C0034715:Rats, Sprague-Dawley [Mammal]
   790   C2699239:Sprague-Dawley [Mammal]
   753   C0024554:Male [Finding]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0086582:male [Population Group]
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C1706180:Male [Qualitative Concept]
   753   C1706428:Male [Qualitative Concept]
   753   C1706429:Male [Organism Attribute]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "weighing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305866:Weighing [Diagnostic Procedure]

Phrase: "180-200 g."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.92: Hepatocytes were prepared by collagenase perfusion and purified by Percoll gradient centrifugation (26) as modified by Balavoine et al. 

Phrase: "Hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "prepared by collagenase perfusion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0031001:Perfusion [Therapeutic or Preventive Procedure]
   770   C0162745:COLLAGENASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   737   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "purified by Percoll gradient centrifugation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0430994:Percoll gradient centrifugation [Laboratory Procedure]
   760   C0007703:Centrifugation [Laboratory Procedure]
   760   C0070386:Percoll [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]
   760   C1998793:Purified [Functional Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "as"

Phrase: "modified by Balavoine et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0205349:Modified By [Qualitative Concept]
   760   C0392747:Modified [Functional Concept]
Processing 00000000.tx.93: (27). 

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.94: Viability was >85% by trypan blue exclusion. 

Phrase: "Viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "was >"

Phrase: "85% by trypan blue exclusion."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C1260957:Blue [Qualitative Concept]
   760   C1565627:Trypan [Organic Chemical]
   760   C2828389:Exclusion [Activity]
Processing 00000000.tx.95: Hepatocytes were suspended in William's E medium (Invitrogen) supplemented with 10% fetal bovine serum, 1% penicillin/streptomycin, and 1% glutamine and plated on type-I collagen-coated glass coverslips. 

Phrase: "Hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "suspended in William's E medium"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C1259588:William's medium E [Organic Chemical,Pharmacologic Substance]
   760   C0009458:Medium [Intellectual Product]
   760   C0439536:Medium [Quantitative Concept]
   760   C1553389:suspended [Idea or Concept]
   760   C1553403:suspended [Idea or Concept]
   760   C1705217:Medium [Substance]
   760   C1705537:Suspended [Functional Concept]
   760   C3244283:medium [Intellectual Product]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "supplemented with 10% fetal bovine serum,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007452:Bovine [Mammal]
   753   C0015965:Fetal [Embryonic Structure]
   753   C0229671:Serum [Body Substance]
   753   C0521457:Fetal [Functional Concept]
   753   C1140701:bovine [Mammal]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "1% penicillin/streptomycin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "1% glutamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "plated on type-I collagen-coated glass coverslips."
Meta Candidates (Total=18; Excluded=3; Pruned=0; Remaining=15)
   800   C0041455:Type 1 Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793 E C1167375:collagen type I [Cell Component]
   770   C0441729:Type I [Classification]
   767   C0946099:glass type [Finding]
   744   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   744   C0017596:Glass [Manufactured Object]
   744   C0021966:I- [Inorganic Chemical]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0332307:Type [Qualitative Concept]
   744   C1167364:collagen [Cell Component]
   744   C1522408:Coated [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C1947936:Glass [Medical Device]
   711   C0005971:Plate [Medical Device]
   711 E C0453946:Coat [Manufactured Object]
   711   C1139930:plate [Medical Device]
   711 E C2987482:Coat [Body Part, Organ, or Organ Component]
   711   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.96: Immunofluorescence-- Hepatocytes grown on glass coverslips were washed once with phosphate-buffered saline (PBS) before incubation with serum-free William's E medium containing 2M human insulin. 

Phrase: "Immunofluorescence"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "--"

Phrase: "Hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "grown on glass coverslips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017596:Glass [Manufactured Object]
   770   C1947936:Glass [Medical Device]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "once with phosphate-buffered saline (PBS)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   760   C1720092:Once [Intellectual Product]
   760   C1948045:Once [Temporal Concept]

Phrase: "before incubation"

Phrase: "with serum-free William's E medium containing 2M human insulin."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   891   C0428357:Serum insulin [Laboratory Procedure]
   891   C1261415:serum insulin [Laboratory or Test Result]
   879   C0523720:free insulin [Laboratory Procedure]
   807   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   791   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   791   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   791   C1579433:Insulin [Pharmacologic Substance]
   735 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   708 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.97: After 20min at 37C, cells were washed 3times with PBS and fixed with 3% paraformaldehyde in PBS for 20min. 

Phrase: "After 20min"

Phrase: "at 37C,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3times with PBS"

Phrase: "and"

Phrase: "fixed with 3% paraformaldehyde"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 20min."
Processing 00000000.tx.98: Fixed cells were treated with 100mM NH4Cl for 15min, washed with PBS, permeabilized with 0.1% Triton X-100 in PBS for 4min, and blocked by a 20-min incubation with 10% horse serum in PBS. 

Phrase: "Fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 100mM NH4Cl"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 15min,"

Phrase: "washed with PBS,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1548982:Washed [Idea or Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   726 E C0441648:Wash [Activity]

Phrase: "permeabilized with 0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0242759:Triton [Geographic Area]

Phrase: "in PBS"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "for 4min,"

Phrase: "and"

Phrase: "blocked by a 20-min incubation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0028778:Blocked [Pathologic Function]
   753   C0332206:Blocked [Functional Concept]
   753   C0702093:/min [Temporal Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "with 10% horse serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1518416:Serum, Horse [Immunologic Factor]
   827   C0019944:Horse [Mammal]
   827   C0229671:Serum [Body Substance]
   827   C0242616:Horse [Mammal]
   827   C1265527:Horse [Mammal]
   827   C1546774:Serum [Intellectual Product]
   827   C1550100:Serum [Body Substance]

Phrase: "in PBS."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.99: Staining consisted of mouse monoclonal antibody to human insulin (diluted 1:100) (Sigma), mouse monoclonal antibody to rat EEA1 (diluted 1:200) (Transduction Laboratories), and rabbit polyclonal antibody to mouse cathepsin D R291 (diluted 1:100) as the primary reagents, followed by Alexa Fluor 488-conjugated goat anti-mouse (diluted 1:100) (Molecular Probes) and Texas Red-conjugated goat anti-rabbit (diluted 1:400) (Jackson Immunoresearch). 

Phrase: "Staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]

Phrase: "consisted of mouse monoclonal antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0746619:monoclonal [Finding]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "to human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "mouse monoclonal antibody to rat EEA1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: "(Transduction Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rabbit polyclonal antibody to mouse cathepsin D R291"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0369095:antibody d [Immunologic Factor]
   767   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "as the primary reagents,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "followed by Alexa Fluor 488-conjugated goat"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0332283:Followed by [Temporal Concept]
           followed
   778   C3272928:Alexa Fluor [Indicator, Reagent, or Diagnostic Aid]
   748   C0018019:goat [Mammal]
   748   C0235665:FLUOR [Pathologic Function]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1071616:Alexa [Plant]
   748   C1265549:goat [Mammal]
   748   C1510458:Goat [Mammal]
   714 E C1719822:Follow [Intellectual Product]

Phrase: "anti-mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100"

Phrase: ")"

Phrase: "(Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "Texas Red-conjugated goat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0018019:goat [Mammal]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]

Phrase: "anti-rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "400"

Phrase: ")"

Phrase: "(Jackson Immunoresearch"

Phrase: ")."
Processing 00000000.tx.100: Laser-scanning confocal microscopy was done with a Zeiss LSM 510confocal (Axiovert 100M) inverted microscope equipped with a Zeiss X63/1.4 NA oil immersion objective lens (plan-Apochromat). 

Phrase: "Laser-scanning confocal microscopy"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0242841:Microscopy, Confocal, Laser Scanning [Laboratory Procedure]
   923   C0600396:Laser Scanning Microscopy [Laboratory Procedure]
   902   C0600395:Laser Microscopy [Laboratory Procedure]
   861   C0242842:Microscopy, Confocal [Laboratory Procedure]
   812   C0023089:Laser [Manufactured Object]
   812   C0026018:Microscopy [Laboratory Procedure]
   812   C0034606:Scanning [Diagnostic Procedure]
   812   C0441633:Scanning [Diagnostic Procedure]
   812   C0458142:Laser [Phenomenon or Process]
   812   C1023865:Laser [Plant]
   812   C1706315:Laser [Medical Device]
   779 E C2826292:SCAN [Finding]
   741 E C0205288:Microscopic [Qualitative Concept]

Phrase: "was"

Phrase: "done with a Zeiss LSM 510confocal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1272695:Done [Qualitative Concept]
   753   C2746065:Done [Temporal Concept]

Phrase: "(Axiovert 100M"

Phrase: ")"

Phrase: "inverted microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "equipped with a Zeiss X63/1.4 NA oil immersion objective lens"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   736   C0018017:Objective [Intellectual Product]
   736   C0020940:Immersion [Therapeutic or Preventive Procedure]
   736   C0023317:Lens [Body Part, Organ, or Organ Component]
   736   C0023318:Lens [Medical Device]
   736   C0028908:Oil [Lipid]
   736   C0038561:Immersion [Injury or Poisoning]
   736   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   736   C0996842:Lens [Plant]
   736   C1272460:{NA} [Qualitative Concept]
   736   C1278892:Lens [Body Part, Organ, or Organ Component]
   736   C1517288:Oil [Food,Lipid]
   736   C1571702:Objective [Qualitative Concept]
   736   C2827727:Immersion [Functional Concept]

Phrase: "(plan-Apochromat"

Phrase: ")."
Processing 00000000.tx.101: Fluorescent images were acquired with argon (wavelength 488nm) and helium neon (wavelength 543nm) lasers. 

Phrase: "Fluorescent images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired with argon"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0003781:Argon [Element, Ion, or Isotope]
   790   C0439661:Acquired [Temporal Concept]
   790   C1948015:Argon [Eukaryote]
   790   C3245488:acquired [Intellectual Product]
   756 E C1706701:Acquire [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(wavelength 488nm"

Phrase: ")"

Phrase: "and"

Phrase: "helium neon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027608:Neon [Element, Ion, or Isotope]
   861   C1091843:Neon [Eukaryote]

Phrase: "(wavelength 543nm"

Phrase: ")"

Phrase: "lasers."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0023089:Lasers [Manufactured Object]
   966 E C0458142:Laser [Phenomenon or Process]
   966 E C1023865:Laser [Plant]
   966 E C1706315:Laser [Medical Device]
Processing 00000000.tx.102: Simultaneous images corresponding to Alexa Fluor 488and Texas Red fluorescence were obtained using the multi-tracking function of the microscope.  

Phrase: "Simultaneous images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "corresponding to Alexa Fluor 488and Texas Red fluorescence"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0076359:Texas red [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C3272928:Alexa Fluor [Indicator, Reagent, or Diagnostic Aid]
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0039711:Texas [Geographic Area]
   744   C0235665:FLUOR [Pathologic Function]
   744   C0332575:Red [Finding]
   744   C1071616:Alexa [Plant]
   744   C1260956:Red [Qualitative Concept]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the multi-tracking function of the microscope."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]
Processing 00000000.tx.103: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES Catalytic Properties of Endosomal Acidic Insulinase-- As a substrate, radiolabeled HI may lack many structural features of the natural EAI substrate that might be important in directing protease interaction and cleavage. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Catalytic Properties of Endosomal Acidic Insulinase"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0871161:properties [Qualitative Concept]
   753   C1292721:properties [Functional Concept]
   719 E C1882134:Property [Conceptual Entity]
   719 E C2347695:Property [Entity]

Phrase: "-"

Phrase: "-"

Phrase: "As"

Phrase: "a substrate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710236:Substrate [Manufactured Object]

Phrase: "radiolabeled HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "may"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "many structural features of the natural EAI substrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   706   C1521970:Feature [Qualitative Concept]
   706   C1706388:Feature [Conceptual Entity]
   706   C2346469:Feature [Qualitative Concept]
   706   C2348519:Feature [Qualitative Concept]

Phrase: "that"

Phrase: "might"

Phrase: "be"

Phrase: "important in directing protease interaction"

Phrase: "and"

Phrase: "cleavage."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]
Processing 00000000.tx.104: Moreover, the trichloroacetic acid precipitation assay gives only limited information about the enzymatic mechanism of insulin degradation where conditions are far from the initial reaction rate. 

Phrase: "Moreover,"

Phrase: "the trichloroacetic acid precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "gives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "only limited information about the enzymatic mechanism of insulin degradation where"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1533716:Information [Idea or Concept]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "are"

Phrase: "far from the initial reaction rate."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0678608:reaction rate [Temporal Concept]
   753   C0205108:far [Spatial Concept]
   753   C0205265:Initial [Temporal Concept]
   753   C0443286:Reaction [Functional Concept]
   753   C0871208:Rate [Activity]
   753   C1114821:Reaction [Clinical Attribute]
   753   C1279901:Initial [Qualitative Concept]
   753   C1521828:Rate [Quantitative Concept]
   753   C1555582:Initial [Idea or Concept]
   753   C1705685:INITIAL [Functional Concept]
Processing 00000000.tx.105: The most appropriate substrate for assaying EAI activity is native HI, which contains the physiological prerequisites for protease recognition. 

Phrase: "The most appropriate substrate for assaying EAI activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1710236:Substrate [Manufactured Object]

Phrase: "is"

Phrase: "native HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "which"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the physiological prerequisites for protease recognition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679209:prerequisites [Idea or Concept]
Processing 00000000.tx.106: We therefore decided to reevaluate the effect of various protease inhibitors on the insulin-degrading activity contained in endosomes using a highly specific RP HPLC assay (Fig. 1). 

Phrase: "We therefore"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reevaluate"

Phrase: "the effect of various protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the insulin-degrading activity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   913   C1145751:insulin activity [Molecular Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1561536:*Activity [Idea or Concept]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "contained in endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034850:Endosomes [Cell Component]
   790   C0332256:contained [Functional Concept]
   790   C2700400:Contained [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a highly specific RP HPLC assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0005507:Assay [Laboratory Procedure]
   799   C0243073:assay [Qualitative Concept]
   799   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.107: A short time of digestion was always chosen in order to follow the major primary cleavage of HI at residues PheB24-PheB25, which generates the hexapeptide B25-30 (Fig. 1B, middle panel, peak 2) and the remaining N-terminal residues B1-24 connected to the intact A chain A1-21 (A1-21-B1-24; Fig. 1B, middle panel, peak 3) (11). 

Phrase: "A short time of digestion"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C1282927:short [Qualitative Concept]
   760   C1806781:Short [Quantitative Concept]
   760   C2350002:Short [Quantitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "was"

Phrase: "always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "chosen in order to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1705175:Order [Intellectual Product]
   770   C1705176:Order [Qualitative Concept]
   770   C1705177:Order [Classification]
   770   C1705178:Order [Activity]
   770   C1707391:Chosen [Activity]
   770   C1882348:Order [Qualitative Concept]

Phrase: "follow"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "the major primary cleavage of HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "at residues PheB24-PheB25,"

Phrase: "which"

Phrase: "generates"

Phrase: "the hexapeptide B25-30"

Phrase: "(Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "middle panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "peak 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the remaining N-terminal residues B1-24"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   799   C0205088:Terminal [Temporal Concept]
   799   C1527428:Remaining [Qualitative Concept]
   799   C1705314:Terminal [Manufactured Object]
   799   C1705315:Terminal [Spatial Concept]
   766   C1709915:Residue [Conceptual Entity]
   766   C1882936:RESIDUE [Phenomenon or Process]
   716 E C1609982:Residual [Qualitative Concept]

Phrase: "connected to the intact A chain A1-21"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205266:Intact [Qualitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C1524075:Chain [Idea or Concept]
   744   C1554187:Intact [Idea or Concept]
   711   C2986575:Connect [Activity]

Phrase: "(A1-21-B1-24"

Phrase: "; Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "middle panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "peak 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.108: Correct endoproteolytic cleavage of HI at the PheB24-PheB25 peptide bond was confirmed using electron spray ionization-mass spectrometry analysis (results not shown) (11). 

Phrase: "Correct endoproteolytic cleavage of HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "at the PheB24-PheB25 peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "electron spray ionization-mass spectrometry analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0002778:Analysis [Laboratory Procedure]
   799   C0936012:Analysis [Research Activity]
   799   C1524024:analysis [Functional Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.109: Native HI was then digested with ENs at pH 4and 37C for 15min in the presence of protease inhibitors (Fig. 1A). 

Phrase: "Native HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "digested with ENs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C0868946:digested [Physiologic Function]

Phrase: "at pH 4and 37C"

Phrase: "for 15min"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.110: The protease activity was strongly inhibited (>95%) by pepstatin A, an inhibitor of aspartic acid proteases (Fig. 1, A and B, lower panel). 

Phrase: "The protease activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150095:protease activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "strongly"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "("

Phrase: ">95%"

Phrase: ")"

Phrase: "by pepstatin A,"

Phrase: "an inhibitor of aspartic acid proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   767   C3536890:Protease Inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.111: No effect was observed with metallo-, cysteine-, and serine-protease inhibitors (Fig. 1A). 

Phrase: "No effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed with metallo-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "cysteine-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "serine-protease inhibitors"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
  1000   C0036733:Serine Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   901   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   901   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   901   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   867 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1947941:Protease [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.112: From these results it was concluded that the primary cleavages of native HI were due to aspartic acid protease(s). 

Phrase: "From these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "it"

Phrase: "was"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the primary cleavages of native HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0010813:cleavage [Cell Function]
   719   C0596311:Cleavage [Phenomenon or Process]
   719   C1330957:cleavage [Cell Function]

Phrase: "were due to aspartic acid protease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0004015:Aspartic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0678226:Due to [Functional Concept]
           due
   783   C2717969:Aspartic Protease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0001128:Acid [Chemical]
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1947941:Protease [Enzyme]
   753   C3146286:Due [Idea or Concept]

Phrase: "("

Phrase: "s)."
Processing 00000000.tx.113: View larger version (44K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(44K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.114: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.115: Effect of protease inhibitors on endosomal insulin-degrading activity. 

Phrase: "Effect of protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on endosomal insulin-degrading activity."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C1145751:insulin activity [Molecular Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.116: ENs (~1 ng) was incubated with 106 M native HI at 37C for 15min in 50mM citrate-phosphate buffer, pH 4,in the absence or presence of 0.1-5 g/ml pepstatin A (PA), 1% Me2SO (DMSO), 1mM EDTA, 1mM 1,10-phenanthroline, 107 M E64, 107 M CA074, 104 M N-ethylmaleimide, 104 M p-hydroxymercuriphenylsulfonic acid, 104 M iodoacetamide, 1mM phenylmethylsulfonyl fluoride (PMSF), or 1mM benzamidine (panel A). 

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(~1 ng)"

Phrase: "was"

Phrase: "incubated with 106 M native HI"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0626189:M 106 [Organic Chemical,Pharmacologic Substance]
   753   C0018619:HI [Geographic Area]
   753   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   753   C0302891:Native [Functional Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1412082:HI [Gene or Genome]
   753   C1412316:HI [Gene or Genome]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "for 15min"

Phrase: "in 50mM citrate-phosphate buffer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C3256468:citrate buffer [Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 0.1-5 g/ml pepstatin A (PA),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "1% Me2SO"

Phrase: "(DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "1mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1mM 1,"

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "107 M E64,"

Phrase: "107 M CA074,"

Phrase: "104 M N-ethylmaleimide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "104 M p-hydroxymercuriphenylsulfonic acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "104 M iodoacetamide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021973:Iodoacetamide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1mM phenylmethylsulfonyl fluoride (PMSF),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   827   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "1mM benzamidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "(panel A"

Phrase: ")."
Processing 00000000.tx.117: At the end of the incubation, the proteolytic reaction was stopped with acetic acid (15%), and the incubation mixtures were analyzed by RP HPLC as described under "Experimental Procedures." 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation,"

Phrase: "the proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the incubation mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "analyzed by RP HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.118: The rate of HI proteolysis was determined by following the disappearance of the peak area corresponding to the parent peptide. 

Phrase: "The rate of HI proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "determined by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the disappearance of the peak area"

Phrase: "corresponding to the parent peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030551:parent [Family Group]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.119: The results are expressed as HI degraded (%of control) and normalized to that seen in the absence of added compound. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018619:HI [Geographic Area]
   790   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   790   C1412082:HI [Gene or Genome]
   790   C1412316:HI [Gene or Genome]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(%"

Phrase: "of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "normalized to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "seen in the absence of added compound."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0205198:Compound [Qualitative Concept]
   748   C0205397:Seen [Qualitative Concept]
   748   C0332197:absence [Quantitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1706082:Compound [Chemical]
   714 E C0042789:see [Organism Function]
   714 E C1883712:Add [Functional Concept]
   714 E C1947903:See [Activity]
Processing 00000000.tx.120: The results are the meanS.D. of three to five different experiments performed on endosomal fractions prepared from separate liver fractionations. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of three to five different experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed on endosomal fractions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from separate liver fractionations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0443299:Separate [Spatial Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   726   C0016640:fractionation [Laboratory Procedure]
   726   C0524811:fractionation [Therapeutic or Preventive Procedure]
   726   C1521827:Prepare [Functional Concept]
   726   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.121: Panel B shows representative RP HPLC profiles resulting from the incubation of HI with ENs in the presence or absence of 0.1g/ml PA. 

Phrase: "Panel B"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "representative RP HPLC profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "resulting from the incubation of HI"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0018619:HI [Geographic Area]
   753   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   753   C0678226:resulting [Functional Concept]
   753   C1412082:HI [Gene or Genome]
   753   C1412316:HI [Gene or Genome]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "with ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of 0.1g/ml PA."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332197:absence [Quantitative Concept]
   748   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.122: All panels show absorbance profiles at 214nm. 

Phrase: "All panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "absorbance profiles at 214nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1979963:Profile [Laboratory Procedure]
   737   C2003903:Profile [Functional Concept]
Processing 00000000.tx.123: Intact HI had an elution time of 48min. 

Phrase: "Intact HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "had"

Phrase: "an elution time of 48min."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.124: The endosomal proteins alone did not give any detectable peak (results not shown). 

Phrase: "The endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any detectable peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.125: Identification of Aspartic Acid Proteases Associated with Hepatic Endosomes-- Of the intracellular aspartic acid proteases characterized to date in mammalian cells, the most obvious candidates for our observed results are cathepsin D, cathepsin E, or BACE (28, 29). 

Phrase: "Identification of Aspartic Acid Proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "Associated with Hepatic Endosomes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "-"

Phrase: "-"

Phrase: "Of the intracellular aspartic acid proteases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C2717969:Aspartic Acid Proteases [Amino Acid, Peptide, or Protein,Enzyme]
           Aspartic Protease
   812   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Proteases [Enzyme]

Phrase: "characterized to date"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011008:Date [Temporal Concept]
   790   C1880022:Characterized [Activity]
   790   C2348077:Date [Food]

Phrase: "in mammalian cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1512977:Mammalian Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "the most obvious candidates for our observed results"

Phrase: "are"

Phrase: "cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin E,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054867:Cathepsin E [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413812:CATHEPSIN E [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "BACE (28,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412727:BACE [Gene or Genome]

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.126: We were unable to detect cathepsin E in hepatic endosomes by Western blot analysis (results not shown), confirming the little or no detectable expression of the protease previously reported in rat liver parenchyma (29). 

Phrase: "We"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "cathepsin E in hepatic endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0054867:Cathepsin E [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1413812:CATHEPSIN E [Gene or Genome]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by Western blot analysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   901   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   827   C1705493:Western [Spatial Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no detectable expression of the protease previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "reported in rat liver parenchyma"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0736268:Liver parenchyma [Body Part, Organ, or Organ Component]
           LIVER
   806   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C0933845:Parenchyma [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.127: ENs was then evaluated for its content of cathepsin D and BACE by immunoblotting with well characterized polyclonal antibodies (Fig. 2) (5, 16). 

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "evaluated for its content of cathepsin D"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1332805:CATHEPSIN D [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0220825:Evaluated [Functional Concept]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "BACE by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1412727:BACE [Gene or Genome]

Phrase: "with well characterized polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.128: The soluble hypotonic extract from endosomes (ENs) showed intense immunoreactivity for the 45-kDa mature cathepsin D enzyme and the 64-kDa cathepsin D proenzyme. 

Phrase: "The soluble hypotonic extract from endosomes (ENs)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2828366:Extract [Substance]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "intense immunoreactivity for the 45-kDa mature cathepsin D enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0597879:immunoreactivity [Molecular Function]

Phrase: "and"

Phrase: "the 64-kDa cathepsin D proenzyme."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0014436:Proenzyme [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.129: By contrast, using anti-BACE antibodies directed against N- (-BACE N) and C-terminal (-BACE C) BACE peptides (16), BACE immunoreactivity (68-kDa) was restricted to endosomal membranes (ENm) with none detectable in the luminal content (ENs), confirming that BACE is an integral membrane protein (30). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-BACE antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against N- (-BACE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1412727:BACE [Gene or Genome]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "N)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1707271:C-Terminal [Amino Acid Sequence]
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "(-BACE C) BACE peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "BACE immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "(68-kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "was"

Phrase: "restricted to endosomal membranes (ENm)"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   780   C1179907:endosome membrane [Cell Component]
   770   C0025255:Membranes [Tissue]
   770   C0443288:Restricted [Functional Concept]
   737 E C0596901:Membrane [Cell Component]
   737 E C1706182:Membrane [Manufactured Object]

Phrase: "with none detectable"

Phrase: "in the luminal content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "is"

Phrase: "an integral membrane protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0021699:Integral Membrane Protein [Amino Acid, Peptide, or Protein]
   901   C0025252:Membrane Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0025255:Membrane [Tissue]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0443238:Integral [Quantitative Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.130: View larger version (23K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.131: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.132: Association of aspartyl proteases with endosomal fractions. 

Phrase: "Association of aspartyl proteases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with endosomal fractions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.133: Hepatic endosomes were disrupted by hypotonic shock. 

Phrase: "Hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "disrupted by hypotonic shock."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C3661442:Hypotonic Shock [Natural Phenomenon or Process]
   770   C0036974:Shock [Pathologic Function]
   770   C0241938:Hypotonic [Pathologic Function]
   770   C0332454:Disrupted [Qualitative Concept]
Processing 00000000.tx.134: The lysate supernatants (ENs) from the 300,000gav60min centrifugation and their respective membrane pellets (endosomal membranes (ENm)) were prepared, adjusted to the same volume, subjected to SDS-PAGE, transferred to nitrocellulose, and immunoblotted with rabbit polyclonal antisera against N-terminal (N) and C-terminal (C) human BACE peptides (16) or mouse liver CD (5). 

Phrase: "The lysate supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "from the 300,"

Phrase: "000gav60min centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "and"

Phrase: "their respective membrane pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0993610:pellets [Biomedical or Dental Material]
   793 E C0441436:Pellet [Manufactured Object]
   793 E C1998480:Pellet [Quantitative Concept]

Phrase: "(endosomal membranes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   947   C1179907:endosome membrane [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "(ENm"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   947   C1179907:endosome membrane [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: ","

Phrase: "adjusted to the same volume,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0445247:Same [Qualitative Concept]
   760   C0449468:*Volume [Quantitative Concept]
   760   C0456081:Adjusted [Functional Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with rabbit polyclonal antisera"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0034493:Rabbit [Mammal]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "against N-terminal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "(N)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "C-terminal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1707271:C-Terminal [Amino Acid Sequence]
   861   C0205088:Terminal [Temporal Concept]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "(C) human BACE peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C0006558:c peptides [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "(16"

Phrase: ")"

Phrase: "or"

Phrase: "mouse liver CD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C2606224:cathepsin D, mouse [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332805:CATHEPSIN D [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.135: Molecular mass markers are indicated to the left of each panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of each panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.136: The possibility of lysosome contamination of our endosomal fraction has been assessed in Fig. 

Phrase: "The possibility of lysosome contamination of our endosomal fraction"

Phrase: "has"

Phrase: "been"

Phrase: "assessed in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1516048:Assessed [Activity]
Processing 00000000.tx.137: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.138: We compared enzyme distribution in endosomal and lysosomal fractions of two lysosomal enzyme markers, acid phosphatase and N-acetyl--D-glucosaminidase (Fig. 3A). 

Phrase: "We"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "enzyme distribution in endosomal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "lysosomal fractions of two lysosomal enzyme markers,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C1264633:Fraction of [Quantitative Concept]
           Fractions
   714 E C1554103:Fraction [Idea or Concept]

Phrase: "acid phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001128:Acid [Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0202406:Acid [Laboratory Procedure]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017724:Glucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.139: The endosomal fraction revealed no significant enrichment of N-acetyl--D-glucosaminidase (relative specific activity=1.5) and acid phosphatase (relative specific activity=2.2) with the yield of enzymes accounting for <0.2% that of homogenate. 

Phrase: "The endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no significant enrichment of N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017724:Glucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(relative specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1552740:specific [Intellectual Product]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "=1.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "acid phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001128:Acid [Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0202406:Acid [Laboratory Procedure]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "(relative specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1552740:specific [Intellectual Product]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "=2.2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "with the yield"

Phrase: "of enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014442:Enzymes [Enzyme,Organic Chemical]
  1000   C0014445:enzymes [Functional Concept]

Phrase: "accounting for"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   833   C0000938:Accounting [Occupational Activity]
   799 E C1551359:account [Idea or Concept]
   799 E C2741673:Account # [Clinical Attribute]
   799 E C2981730:Account [Classification]

Phrase: "<0.2%"

Phrase: "that of homogenate."
Processing 00000000.tx.140: On the other hand, the L2 lysosomal fraction was more than 60times enriched in lysosomal enzyme markers (Fig. 3A). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the L2 lysosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "more than 60times"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205172:More [Functional Concept]

Phrase: "enriched in lysosomal enzyme markers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0391845:Lysosomal enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0359583:enriched [Food]
   760   C0521450:Lysosomal [Body Location or Region]
   726   C0005516:Marker [Clinical Attribute]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.141: Overall, the enrichment of radiolabeled [125I]TyrA14 human insulin in endosomal fractions at the early time (4min) of endocytosis (relative specific activity=92.46.38) was far greater than that of any of the enzymes assayed (results not shown; Ref. 3). 

Phrase: "Overall,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282416:Overall [Intellectual Product]
  1000   C1561607:Overall [Qualitative Concept]

Phrase: "the enrichment of radiolabeled"

Phrase: "[125I"

Phrase: "]TyrA14 human insulin in endosomal fractions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "at the early time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "(4min"

Phrase: ")"

Phrase: "of endocytosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014139:Endocytosis [Cell Function]
  1000   C2984285:Endocytosis [Functional Concept]

Phrase: "(relative specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0205369:Specific [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1552740:specific [Intellectual Product]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "=92.46.38"

Phrase: ")"

Phrase: "was"

Phrase: "far greater than that of any of the enzymes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   764   C0439093:Greater Than [Quantitative Concept]
   742   C0443228:greater [Quantitative Concept]
   742   C1704243:Greater [Quantitative Concept]
   708 E C0549177:Great [Quantitative Concept]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "; Ref. 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.142: As well, we used the well characterized anti-cathepsin antibodies to assess the distribution of precursor and mature forms of cathepsins in hepatic endosomes (EN) and lysosomes (L2) (Fig. 3B). 

Phrase: "As well,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the well characterized anti-cathepsin antibodies to"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   839   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   822 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the distribution of precursor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "mature forms of cathepsins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "in hepatic endosomes (EN)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(L2) (Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450365:3b [Intellectual Product]
   827   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.143: The 37-kDa procathepsin L and 64-kDa procathepsin D proenzymes were exclusively identified in endosomes, whereas lysosomes showed strong immunoreactivity only for mature cathepsin L (29-and 22-kDa species) and cathepsin D (45-and 31-kDa species). 

Phrase: "The 37-kDa procathepsin L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0084175:procathepsin L [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "64-kDa procathepsin D proenzymes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0014436:Proenzymes [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "exclusively"

Phrase: "identified in endosomes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034850:Endosomes [Cell Component]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "whereas"

Phrase: "lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "strong immunoreactivity only for mature cathepsin L"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597879:immunoreactivity [Molecular Function]

Phrase: "(29-"

Phrase: "and"

Phrase: "22-kDa species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(45-"

Phrase: "and"

Phrase: "31-kDa species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.144: The distinct distribution of procathepsin L to endosomes and mature 29-kDa single-chain and 22-kDa heavy-chain cathepsin L to lysosomes attests to the lack of contamination of our endosomal fraction by lysosomes (Fig. 3B). 

Phrase: "The distinct distribution of procathepsin L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "to endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "mature 29-kDa single-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0337112:Chain [Manufactured Object]
   804   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "22-kDa heavy-chain cathepsin L to lysosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332807:CATHEPSIN L [Gene or Genome]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "attests to the lack of contamination of our endosomal fraction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C1264633:Fraction of [Quantitative Concept]
           Fraction
   739   C0259846:contamination [Human-caused Phenomenon or Process]
   739   C0332268:lack [Qualitative Concept]
   739   C1554103:Fraction [Idea or Concept]
   739   C1881659:CONTAMINATION [Event]
   739   C2349974:Contamination [Idea or Concept]

Phrase: "by lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.145: These data essentially agree with previously published studies (5, 21). 

Phrase: "These data essentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "agree with previously published studies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0034037:Published [Occupational Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1704324:Published [Intellectual Product]
   760   C3641827:Agree [Intellectual Product]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.146: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.147: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.148: Distribution of lysosomal enzymes in endosomal and lysosomal fractions from rat liver. 

Phrase: "Distribution of lysosomal enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "and"

Phrase: "lysosomal fractions from rat liver."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.149: Endosomal (EN) and lysosomal (L2) fractions were isolated from control rats. 

Phrase: "Endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "(EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "lysosomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0521450:Lysosomal [Body Location or Region]
   928 E C0024369:Lysosome [Cell Component]
   928 E C2984253:Lysosome [Functional Concept]

Phrase: "(L2) fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated from control rats."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
Processing 00000000.tx.150: Panel A, acid phosphatase and N-acetyl--D-glucosaminidase activities were determined, and results are expressed as relative specific activity, i.e. specific activity found in the subcellular fraction/specific activity measured in the homogenate. 

Phrase: "Panel A,"

Phrase: "acid phosphatase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001128:Acid [Chemical]
   861   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0202406:Acid [Laboratory Procedure]
   861   C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441655:Activities [Activity]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined"

Phrase: ","

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as relative specific activity,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0080103:Relative [Family Group]
   760   C0205177:Activity [Functional Concept]
   760   C0205345:Relative [Qualitative Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1547039:*Relative [Quantitative Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "i.e. specific activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0205177:Activity [Functional Concept]
   812   C0205369:Specific [Qualitative Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1552740:specific [Intellectual Product]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "found in the subcellular fraction/specific activity"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   778   C0038528:Subcellular Fraction [Cell Component]
   748   C0150312:Found [Quantitative Concept]
   748   C0205177:Activity [Functional Concept]
   748   C0205369:Specific [Qualitative Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1264633:Fraction [Quantitative Concept]
   748   C1552740:specific [Intellectual Product]
   748   C1554103:Fraction [Idea or Concept]
   748   C1561536:*Activity [Idea or Concept]
   738   C0439161:Fractional activity [Quantitative Concept]
   714 E C0243095:Find [Finding]

Phrase: "measured in the homogenate."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.151: Recoveries (%of the constituent present in the homogenate) of lysosomal marker enzymes in endosomal fraction were 0.17%0.01acid phosphatase and 0.113%0.01N-acetyl--D-glucosaminidase. 

Phrase: "Recoveries"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0237820:recoveries [Activity]
   966 E C1555688:recovery [Idea or Concept]
   966 E C2004454:Recovery [Organism Function]

Phrase: "(%"

Phrase: "of the constituent present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]

Phrase: "in the homogenate"

Phrase: ")"

Phrase: "of lysosomal marker enzymes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0391845:Lysosomal enzymes [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzymes [Enzyme,Organic Chemical]
   827   C0014445:enzymes [Functional Concept]

Phrase: "in endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "0.17%0.01acid phosphatase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1149880:phosphatase [Molecular Function]

Phrase: "and"

Phrase: "0.113%0.01N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017724:Glucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.152: The results are the meanS.D. of three to six separate experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of three to six separate experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.153: Panel B, endosomal (EN) and lysosomal (L2) fractions were subjected to SDS-PAGE on a 12% acrylamide-resolving gel for the anti-CL immunoblot and 8% acrylamide-resolving gel for the anti-CD immunoblot, transferred to nitrocellulose, and immunoblotted with polyclonal antisera against mouse liver CD or rat cathepsin L (CL). 

Phrase: "Panel B,"

Phrase: "endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "(EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "and"

Phrase: "lysosomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0521450:Lysosomal [Body Location or Region]
   928 E C0024369:Lysosome [Cell Component]
   928 E C2984253:Lysosome [Functional Concept]

Phrase: "(L2) fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "on a 12% acrylamide-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel for the anti-CL immunoblot"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "8% acrylamide-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel for the anti-CD immunoblot,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1382104:Gel [Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with polyclonal antisera"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "against mouse liver CD or rat cathepsin L (CL)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   864   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
   864   C1332807:CATHEPSIN L [Gene or Genome]
Processing 00000000.tx.154: Each lane contained 80g of endosomal protein or 5g of lysosomal protein. 

Phrase: "Each lane contained 80g of endosomal protein"

Phrase: "or"

Phrase: "5g of lysosomal protein."
Processing 00000000.tx.155: Molecular mass markers are indicated to the left of the panels. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of the panels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.156: The arrows indicate the mobility of immunoreactive proforms and mature forms of cathepsins L and D. 

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the mobility of immunoreactive proforms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "and"

Phrase: "mature forms of cathepsins L"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   781   C0022828:form l [Bacterium]
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.157: Identification of Endosomal Acidic Insulinase as Cathepsin D-- The aspartic acid proteolytic activity associated with soluble endosomal proteins that generates the major primary cleavage PheB24-PheB25 after digestion of native HI was further purified on a TSK-GEL G3000 HPLC column (Fig. 4). 

Phrase: "Identification of Endosomal Acidic Insulinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "as Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "-"

Phrase: "-"

Phrase: "The aspartic acid proteolytic activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C0597304:Proteolytic [Molecular Function]
   812   C1561536:*Activity [Idea or Concept]
   812   C1947941:proteolytic [Enzyme]

Phrase: "associated with soluble endosomal proteins"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1749467:soluble [Cell Component]
   760   C1948047:Soluble [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "that"

Phrase: "generates"

Phrase: "the major primary cleavage PheB24-PheB25 after digestion of native HI"

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "purified on a TSK-GEL G3000 HPLC column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0008562:HPLC [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1382104:Gel [Substance]
   744   C1706132:Column [Idea or Concept]
   744   C1823517:TSK [Gene or Genome]
   744   C1998793:Purified [Functional Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.158: Fractions eluted from the gel-filtration HPLC column were characterized for their insulinase activity at pH 4using native HI followed by RP HPLC (Fig. 4A). 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "eluted from the gel-filtration HPLC column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0008559:Gel Filtration [Laboratory Procedure]
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0016107:filtration [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1382104:Gel [Substance]
   748   C1706132:Column [Idea or Concept]

Phrase: "were"

Phrase: "characterized for their insulinase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C1150184:insulinase activity [Molecular Function]
   760   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1415875:INSULINASE [Gene or Genome]
   760   C1561536:*Activity [Idea or Concept]
   760   C1880022:Characterized [Activity]

Phrase: "at pH 4using native HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0018619:HI [Geographic Area]
   812   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   812   C1412082:HI [Gene or Genome]
   812   C1412316:HI [Gene or Genome]

Phrase: "followed by RP HPLC (Fig. 4A"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0332283:Followed by [Temporal Concept]
           followed
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C0349966:Fig [Food]
   748   C0450373:4a [Intellectual Product]
   748   C1337208:FIG [Food]
   748   C1553636:4a [Medical Device]
   748   C1555029:Reverse [Idea or Concept]
   714 E C1719822:Follow [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.159: In addition, fractions 13-25 were assayed for their content of cathepsin D by Western blotting using anti-cathepsin D antibody (Fig. 4B). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "fractions 13-25"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "assayed for their content of cathepsin D"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1332805:CATHEPSIN D [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-cathepsin D antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   902   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.160: The peak of acidic insulinase activity (fraction 20) coincided with elution of two cathepsin D immunoreactive polypeptides of 45kDa (major peptide; fractions 19-21) and 31kDa (minor peptide; fractions 20-21). 

Phrase: "The peak of acidic insulinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0444505:Peak [Quantitative Concept]

Phrase: "(fraction 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "coincided with elution of two cathepsin D immunoreactive polypeptides of 45kDa"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1332805:CATHEPSIN D [Gene or Genome]
   738   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0205448:Two [Quantitative Concept]
   738   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]
   738   C1441565:Elution [Laboratory Procedure]

Phrase: "(major peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "; fractions 19-21"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "31kDa"

Phrase: "(minor peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "; fractions 20-21"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.161: The elution of the inactive 64-kDa cathepsin D proenzyme (fractions 16-18) was clearly separated from the mature active enzyme (Fig. 4B). 

Phrase: "The elution of the inactive 64-kDa cathepsin D proenzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1441565:Elution [Laboratory Procedure]

Phrase: "(fractions 16-18"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "clearly"

Phrase: "separated from the mature active enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0205177:Active [Functional Concept]
   753   C0205286:Mature [Temporal Concept]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: View larger version (29K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(29K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.163: 4.  

Phrase: "4."
Processing 00000000.tx.164: Characterization of endosomal acidic insulinase activity by gel-filtration HPLC. 

Phrase: "Characterization of endosomal acidic insulinase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "by gel-filtration HPLC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008562:HPLC [Laboratory Procedure]
   734   C0008559:Gel Filtration [Laboratory Procedure]
Processing 00000000.tx.165: ENs (230g) was applied to a TSK-GEL G3000 HPLC column. 

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(230g"

Phrase: ")"

Phrase: "was"

Phrase: "applied to a TSK-GEL G3000 HPLC column."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   744   C0008562:HPLC [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0185125:Applied [Health Care Activity]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1382104:Gel [Substance]
   744   C1706132:Column [Idea or Concept]
   744   C1823517:TSK [Gene or Genome]
   711 E C1632850:Apply [Functional Concept]
   711 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.166: Panel A shows the absorbance profile at 214nm. 

Phrase: "Panel A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the absorbance profile at 214nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1979963:Profile [Laboratory Procedure]
   760   C2003903:Profile [Functional Concept]
Processing 00000000.tx.167: The eluted fractions were also tested for their ability to degrade 5105 M HI at 37C and pH 4and analyzed using RP HPLC. 

Phrase: "The eluted fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "also"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "5105 M HI at 37C"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "pH 4and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RP HPLC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]
Processing 00000000.tx.168: In panel B, fractions 13-25 were evaluated for their content of cathepsin D by immunoblotting with polyclonal anti-mouse cathepsin D antibody R291. 

Phrase: "In panel B,"

Phrase: "fractions 13-25"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "evaluated for their content of cathepsin D"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1332805:CATHEPSIN D [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0220825:Evaluated [Functional Concept]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with polyclonal anti-mouse cathepsin D antibody R291."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   710   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   701   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.169: Molecular mass markers are indicated to the left of panel B. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of panel B."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.170: To determine whether other endosomal proteases in addition to aspartic acid proteases may participate in the primary cleavage of the insulin B chain at the PheB24-PheB25 peptide bond, ENs was incubated with pepstatin A-agarose at pH 7,and the absorbed proteins were precipitated by centrifugation (Fig. 5). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "other endosomal proteases in addition to aspartic acid proteases"

Phrase: "may"

Phrase: "participate in the primary cleavage of the insulin B chain"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   782   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   739   C0010813:cleavage [Cell Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205225:Primary [Qualitative Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0439631:Primary [Therapeutic or Preventive Procedure]
   739   C0596311:Cleavage [Phenomenon or Process]
   739   C1330957:cleavage [Cell Function]
   739   C1524075:Chain [Idea or Concept]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "at the PheB24-PheB25 peptide bond,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "incubated with pepstatin A-agarose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036681:Agarose [Carbohydrate]
   760   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at pH 7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "the absorbed proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "precipitated by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.171: Analysis of the bead supernatant showed that depletion of pepstatin A-binding proteins prevented proteolysis of native HI as measured at pH 4and 15or 30min of incubation (Fig. 5A). 

Phrase: "Analysis of the bead supernatant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that depletion of pepstatin A-binding proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333668:Depletion [Functional Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "proteolysis of native HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "as"

Phrase: "measured at pH 4and 15or 30min of incubation"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0020283:[pH] [Quantitative Concept]
   744   C0444706:Measured [Qualitative Concept]
   744   C0450407:ph+ [Finding]
   744   C0450408:ph++ [Finding]
   744   C0450409:ph+++ [Finding]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.172: To test whether pepstatin A-agarose bound nonspecifically to other endosomal proteins, we determined the protein concentration of the endosomal fractions before and after the pepstatin A-agarose precipitation step (Fig. 5B), and we could not detect any significant change in protein concentration. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "pepstatin A-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]

Phrase: "bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "nonspecifically to other endosomal proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "determined"

Phrase: "the protein concentration of the endosomal fractions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0427716:Protein concentration [Laboratory Procedure]
   778   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0086045:Concentration [Mental Process]
   748   C1446561:Concentration [Quantitative Concept]

Phrase: "before"

Phrase: "and after the pepstatin A-agarose precipitation step"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0032931:Precipitation [Natural Phenomenon or Process]
   744   C0032932:Precipitation [Molecular Function]
   744   C0036681:Agarose [Carbohydrate]
   744   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1261552:Step [Conceptual Entity]
   744   C1515981:And [Idea or Concept]
   744   C1642401:% precipitation [Quantitative Concept]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C2584299:Precipitation [Natural Phenomenon or Process]
   744   C2825408:Step [Manufactured Object]

Phrase: "(Fig. 5B"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any significant change in protein concentration."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]
Processing 00000000.tx.173: To gain more information regarding the specificity of the insulinase-pepstatin A interaction, the HPLC fraction from the TSK-GEL G3000 column with the highest acidic insulinase activity (fraction 20, see Fig. 4A) was incubated with pepstatin A-agarose beads (Fig. 5C). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gain"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1517378:Gain [Quantitative Concept]
   944 E C0205217:Increased [Quantitative Concept]
   944 E C0439661:Acquired [Temporal Concept]
   944 E C0442805:Increase [Functional Concept]
   944 E C0442808:Increasing [Functional Concept]
   944 E C1301820:Obtain [Functional Concept]
   944 E C1706701:Acquire [Activity]
   944 E C3245488:acquired [Intellectual Product]

Phrase: "more information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "regarding"

Phrase: "the specificity of the insulinase-pepstatin A interaction,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0037791:Specificity [Quantitative Concept]
   744   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1415875:INSULINASE [Gene or Genome]
   744   C1511884:Specificity [Quantitative Concept]
   744   C1704675:Interaction [Functional Concept]

Phrase: "the HPLC fraction from the TSK-GEL G3000 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1264633:Fraction [Quantitative Concept]
   742   C1554103:Fraction [Idea or Concept]

Phrase: "with the highest acidic insulinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(fraction 20,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "was"

Phrase: "incubated with pepstatin A-agarose beads"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0036681:Agarose [Carbohydrate]
   753   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0991566:Beads [Biomedical or Dental Material]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C2346972:Bead [Spatial Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.174: The bead precipitate was then subjected to SDS-PAGE and Western blotting using anti-mouse cathepsin D antibody (Fig. 5C, PA-ag pellet), revealing the presence of the two active forms of cathepsin D at 45and 31kDa. 

Phrase: "The bead precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-mouse cathepsin D antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C2606224:cathepsin D, mouse [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 5C,"

Phrase: "PA-ag pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0441436:Pellet [Manufactured Object]
   812   C0993610:Pellet [Biomedical or Dental Material]
   812   C1998480:Pellet [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "revealing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:revealing [Qualitative Concept]

Phrase: "the presence of the two active forms of cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "at 45and 31kDa."
Processing 00000000.tx.175: Hence, the EAI activity present in ENs likely corresponds to an active form of cathepsin D. 

Phrase: "Hence,"

Phrase: "the EAI activity present in ENs likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0150312:Present [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]

Phrase: "corresponds to an active form of cathepsin D."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332805:CATHEPSIN D [Gene or Genome]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0205177:Active [Functional Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]
Processing 00000000.tx.176: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.177: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.178: Affinity purification of a soluble endosomal pepstatin A-sensitive protease. 

Phrase: "Affinity purification of a soluble endosomal pepstatin A-sensitive protease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0008551:affinity purification [Laboratory Procedure]
   739   C0243114:purification [Functional Concept]
   739   C1998793:Purification [Functional Concept]
Processing 00000000.tx.179: Panel A, ENs was incubated for 15h at 4C with pepstatin A-agarose in 20mM citrate-phosphate buffer, pH 7.

Phrase: "Panel A,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "incubated for 15h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "with pepstatin A-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Agarose [Carbohydrate]

Phrase: "in 20mM citrate-phosphate buffer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C3256468:citrate buffer [Pharmacologic Substance]
   861   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.180: After centrifugation at 20,000gav for 5min, the resultant supernatant was tested for its ability to degrade 106 M HI in 300mM citrate-phosphate buffer, pH 4,for 15or 30min of incubation at 37C (PA-ag supernatant). 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 20,"

Phrase: "000gav for 5min,"

Phrase: "the resultant supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "tested for its ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "106 M HI in 300mM citrate-phosphate buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0018619:HI [Geographic Area]
   744   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   744   C1412082:HI [Gene or Genome]
   744   C1412316:HI [Gene or Genome]

Phrase: "pH 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "for 15or 30min"

Phrase: "of incubation"

Phrase: "at 37C"

Phrase: "(PA-ag supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1550101:Supernatant [Body Substance]

Phrase: ")."
Processing 00000000.tx.181: The amount of protein recovered in the supernatant (PA-ag supernatant) as well as in the starting material (ENs) is presented in panel B.Panel C, the fraction eluted from the gel-filtration HPLC column that contained insulin-degrading activity with the highest specific activity (fraction 20; see Fig. 4A) was incubated with pepstatin A-agarose beads using the same procedure as described for panel A. 

Phrase: "The amount of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "recovered in the supernatant"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0521108:recovered [Qualitative Concept]
   770   C1550101:Supernatant [Body Substance]
   737 E C2004454:recover [Organism Function]

Phrase: "(PA-ag supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "as well as in the starting material"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205170:Well [Qualitative Concept]
   748   C0520510:Material [Substance]
   748   C3146287:Well [Manufactured Object]
   714   C0439659:Start [Temporal Concept]

Phrase: "(ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "is"

Phrase: "presented in panel B.Panel C,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0441833:Panel [Idea or Concept]
   753   C0449450:Presented [Idea or Concept]
   753   C1999270:Panel [Intellectual Product]
   753   C3537156:Panel [Manufactured Object]
   719 E C0150312:Present [Quantitative Concept]

Phrase: "the fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "eluted from the gel-filtration HPLC column"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0008559:Gel Filtration [Laboratory Procedure]
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0016107:filtration [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1382104:Gel [Substance]
   748   C1706132:Column [Idea or Concept]

Phrase: "that contained insulin-degrading activity with the highest specific activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   757   C1145751:insulin activity [Molecular Function]
   741   C0020459:high insulin [Disease or Syndrome]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0205177:Activity [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1561536:*Activity [Idea or Concept]
   739   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(fraction 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: "was"

Phrase: "incubated with pepstatin A-agarose beads"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0036681:Agarose [Carbohydrate]
   753   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0991566:Beads [Biomedical or Dental Material]
   753   C1439852:Incubated [Laboratory Procedure]
   719 E C2346972:Bead [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "as"

Phrase: "described for panel A."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441833:Panel [Idea or Concept]
   770   C1552738:described [Idea or Concept]
   770   C1999270:Panel [Intellectual Product]
   770   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.182: Proteins associated with the pellet (lane PA-ag pellet) were eluted from the pepstatin A-agarose beads under denaturing conditions by suspending the beads in Laemmli buffer and heating at 100C for 5min. 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "associated with the pellet"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0441436:Pellet [Manufactured Object]
   770   C0993610:Pellet [Biomedical or Dental Material]
   770   C1998480:Pellet [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(lane PA-ag pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0441436:Pellet [Manufactured Object]
   804   C0993610:Pellet [Biomedical or Dental Material]
   804   C1998480:Pellet [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "eluted from the pepstatin A-agarose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036681:Agarose [Carbohydrate]
   753   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "beads under denaturing conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C2346972:Bead [Spatial Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "by suspending"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038959:Suspending [Biomedical or Dental Material]
  1000   C1705537:suspending [Functional Concept]

Phrase: "the beads in Laemmli buffer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0991566:Beads [Biomedical or Dental Material]
   726 E C2346972:Bead [Spatial Concept]

Phrase: "and"

Phrase: "heating at 100C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0018851:Heating [Environmental Effect of Humans]

Phrase: "for 5min."
Processing 00000000.tx.183: The samples were then subjected to SDS-PAGE, transferred to nitrocellulose, and immunoblotted with anti-mouse cathepsin D antibody R291. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with anti-mouse cathepsin D antibody R291."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   800   C2606224:cathepsin D, mouse [Amino Acid, Peptide, or Protein,Enzyme]
   793   C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   770   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332805:CATHEPSIN D [Gene or Genome]
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0369095:antibody d [Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   711   C0020985:Immunoblot [Laboratory Procedure]
Processing 00000000.tx.184: The parent soluble endosomal fraction is also shown (lane ENs). 

Phrase: "The parent soluble endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "is"

Phrase: "also"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "(lane ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: ")."
Processing 00000000.tx.185: Molecular mass markers are indicated to the left of panel C. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of panel C."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C2951798:Left C [Body Location or Region]
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.186: As further evidence, we used well characterized polyclonal antibodies to mature cathepsin D and its proform (5) to deplete cathepsin D from ENs (Fig. 6). 

Phrase: "As further evidence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "well characterized polyclonal antibodies to mature cathepsin D"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0369095:antibodies d [Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   737   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "its proform"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "cathepsin D from ENs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.187: Quantitative immunoprecipitation of cathepsin D using antibodies directed against the mouse and human enzyme removed greater than 90% of endosomal HI-degrading activity from ENs based on the PheB24-PheB25 peptide bond cleavage assay at acidic pH (Fig. 6, A and B). 

Phrase: "Quantitative immunoprecipitation of cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mouse [Mammal]
   770   C0025929:mouse [Mammal]
   770   C0026809:Mouse [Mammal]
   737   C0439851:Direct [Qualitative Concept]
   737   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "human enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "greater than 90% of endosomal HI-degrading activity"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439093:Greater Than [Quantitative Concept]
   744   C0443228:greater [Quantitative Concept]
   744   C1704243:Greater [Quantitative Concept]
   711 E C0549177:Great [Quantitative Concept]

Phrase: "from ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "based on the PheB24-PheB25 peptide bond cleavage assay"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   764   C0678595:peptide bond [Natural Phenomenon or Process]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0010813:cleavage [Cell Function]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   742   C0243073:assay [Qualitative Concept]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]

Phrase: "at acidic pH (Fig. 6,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0001128:Acidic [Chemical]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0349966:Fig [Food]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
   812   C1337208:FIG [Food]
   741 E C0202406:Acid [Laboratory Procedure]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.188: Immunodepletion of ENs with antibodies to cathepsins L and B and insulin-degrading enzyme failed to remove the insulinase activity as measured at pH 4(Fig. 

Phrase: "Immunodepletion of ENs"

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to cathepsins L"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1332807:CATHEPSIN L [Gene or Genome]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the insulinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150184:insulinase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "as"

Phrase: "measured at pH 4"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C2678549:PH-4 [Gene or Genome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.189: 6A). 

Phrase: "6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553638:6a [Medical Device]

Phrase: ")."
Processing 00000000.tx.190: View larger version (36K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.191: 6.  

Phrase: "6."
Processing 00000000.tx.192: Effect of immunodepletion of endosomal proteases on endosomal insulin-degrading activity. 

Phrase: "Effect of immunodepletion of endosomal proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on endosomal insulin-degrading activity."
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   875   C1145751:insulin activity [Molecular Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1561536:*Activity [Idea or Concept]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.193: Panel A, ENs were immunodepleted of active insulin-degrading enzyme (-IDE), cathepsin L (-CL), cathepsin B (-CB), or cathepsin D (-CD) using monoclonal (insulin-degrading enzyme) or polyclonal antibodies (cathepsin L, cathepsin B, and CD) coated to protein G-Sepharose. 

Phrase: "Panel A,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "immunodepleted of active insulin-degrading enzyme (-IDE),"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Active [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "cathepsin L (-CL),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332807:CATHEPSIN L [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin B (-CB),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "cathepsin D (-CD)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "(insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(cathepsin L,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332807:CATHEPSIN L [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "coated to protein G-Sepharose."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0060916:protein g [Amino Acid, Peptide, or Protein]
   797 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   781   C1423498:coat-protein [Gene or Genome]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0439267:g% [Quantitative Concept]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.194: After centrifugation, the resultant supernatants were tested for their ability to degrade native HI at pH 4and analyzed by RP HPLC. 

Phrase: "After centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "native HI at pH 4and"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]

Phrase: "analyzed by RP HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.195: The results were normalized to that seen in the absence of antibody and are the meanS.D. of four experiments. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "normalized to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "seen in the absence of antibody"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205397:Seen [Qualitative Concept]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of four experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.196: Panel B, ENs were immunodepleted of active cathepsin D using polyclonal antibodies directed against mouse and human cathepsin D, and the resultant supernatants were tested for their ability to degrade 5105 M HI in 50mM citrate-phosphate buffer, pH 4,after 20min incubation at 37C. 

Phrase: "Panel B,"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "immunodepleted of active cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1332805:CATHEPSIN D [Gene or Genome]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Active [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against mouse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025914:Mouse [Mammal]
   790   C0025929:mouse [Mammal]
   790   C0026809:Mouse [Mammal]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "human cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "5105 M HI in 50mM citrate-phosphate buffer,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0018619:HI [Geographic Area]
   744   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   744   C1412082:HI [Gene or Genome]
   744   C1412316:HI [Gene or Genome]

Phrase: "pH 4,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "after"

Phrase: "20min incubation at 37C."
Processing 00000000.tx.197: The proteolytic reaction was stopped with acetic acid (15%), and the samples were analyzed by RP HPLC. 

Phrase: "The proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by RP HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.198: All panels show absorbance profiles at 214nm. 

Phrase: "All panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "absorbance profiles at 214nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1979963:Profile [Laboratory Procedure]
   737   C2003903:Profile [Functional Concept]
Processing 00000000.tx.199: Digestion of Insulin Peptides with Cathepsin D-- To determine whether cathepsin D is capable of cleaving HI at the same primary sites as those observed with ENs (11), HI was subjected to in vitro digestion with bovine cathepsin D at pH 4.

Phrase: "Digestion of Insulin Peptides"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "with Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "capable of cleaving HI"

Phrase: "at the same primary sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0449695:primary sites [Spatial Concept]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "as those"

Phrase: "observed with ENs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C1441672:Observed [Functional Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "was"

Phrase: "subjected to in vitro digestion"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0012238:Digestion [Organism Function]
   760   C2349986:Digestion [Research Activity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "with bovine cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "at pH 4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.200: The digestion products were separated by RP HPLC, and the resulting chromatogram is shown in Fig. 

Phrase: "The digestion products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "separated by RP HPLC,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0086972:Separated [Finding]
   760   C0205390:Phase [Temporal Concept]
   760   C0443299:separated [Spatial Concept]
   760   C0687118:Separated [Functional Concept]
   760   C1555029:Reverse [Idea or Concept]

Phrase: "and"

Phrase: "the resulting chromatogram"

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.201: 7 (lower panel, HI+CD). 

Phrase: "7"

Phrase: "(lower panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "HI+CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.202: RP HPLC analysis revealed four proteolytic products (peaks 1-4) with retention times identical to those seen with ENs (upper panel, HI+ENs) (11). 

Phrase: "RP HPLC analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C2986798:Phase Analysis [Occupational Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "four proteolytic products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "(peaks 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0444505:peaks [Quantitative Concept]

Phrase: ")"

Phrase: "with retention times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:times [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1632851:Times [Quantitative Concept]
   861   C1753315:retention [Cell Function]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "identical to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "seen with ENs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0034850:Endosomes [Cell Component]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "(upper panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "HI+ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.203: Each of the major HPLC peaks for HI plus CD was analyzed using mass spectrometry to determine the molecular masses of the peptide products. 

Phrase: "Each of the major HPLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205164:Major [Qualitative Concept]
   760   C1457900:Each [Quantitative Concept]

Phrase: "peaks for HI plus CD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1332805:CATHEPSIN D [Gene or Genome]
   753   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0018619:HI [Geographic Area]
   753   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   753   C0332287:Plus [Qualitative Concept]
   753   C0444505:Peak [Quantitative Concept]
   753   C1412082:HI [Gene or Genome]
   753   C1412316:HI [Gene or Genome]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mass spectrometry to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "determine"

Phrase: "the molecular masses of the peptide products."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   714   C0577559:Mass [Finding]
   714   C1306372:*Mass [Quantitative Concept]
Processing 00000000.tx.204: Table I lists the peptide peaks (HPLC pools), their retention times, theoretical and experimental molecular masses, and structures. 

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "lists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0745732:List [Conceptual Entity]
  1000   C3272378:LIST [Intellectual Product]

Phrase: "the peptide peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "(HPLC pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0337051:pools [Geographic Area]
   827 E C1509144:pool [Clinical Attribute]
   827 E C2349200:Pool [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "their retention times,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:times [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1632851:Times [Quantitative Concept]
   861   C1753315:retention [Cell Function]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "theoretical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871935:Theoretical [Idea or Concept]

Phrase: "and"

Phrase: "experimental molecular masses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]

Phrase: "and"

Phrase: "structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.205: Peak 2corresponded to a mixture of the hexapeptide B25-30 (755.5Da) and pentapeptide B26-30 (608.2Da). 

Phrase: "Peak 2corresponded to a mixture of the hexapeptide B25-30"

Phrase: "(755.5Da"

Phrase: ")"

Phrase: "and"

Phrase: "pentapeptide B26-30"

Phrase: "(608.2Da"

Phrase: ")."
Processing 00000000.tx.206: Peak 4was a mixture of the remaining N-terminal residues B1-24 and B1-25 connected to the intact A-chain A1-21 (A1-21-B1-24, 5087Da, and A1-21-B1-25, 5216Da). 

Phrase: "Peak 4was"

Phrase: "a mixture of the remaining N-terminal residues B1-24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "B1-25"

Phrase: "connected to the intact A-chain A1-21"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0205266:Intact [Qualitative Concept]
   744   C0337112:Chain [Manufactured Object]
   744   C1524075:Chain [Idea or Concept]
   744   C1554187:Intact [Idea or Concept]
   711   C2986575:Connect [Activity]

Phrase: "(A1-21-B1-24,"

Phrase: "5087Da,"

Phrase: "and"

Phrase: "A1-21-B1-25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0450347:21/25 [Quantitative Concept]

Phrase: "5216Da"

Phrase: ")."
Processing 00000000.tx.207: Peak 3(5069Da) was the same as the A1-21-B1-24 peptide with an internal peptide bond cleaved. 

Phrase: "Peak 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(5069Da"

Phrase: ")"

Phrase: "was"

Phrase: "the same as the A1-21-B1-24 peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C1278655:SAME AS [Classification]
   742   C0445247:Same [Qualitative Concept]

Phrase: "with an internal peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0678595:peptide bond [Natural Phenomenon or Process]
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "cleaved."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]
Processing 00000000.tx.208: The HPLC pool 1contained the B27-30 peptide (445.2Da), thereby indicating the removal of the TyrB26 residue from peptide 2a. 

Phrase: "The HPLC pool 1contained"

Phrase: "the B27-30 peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(445.2Da"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "indicating"

Phrase: "the removal of the TyrB26 residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015252:Removal [Therapeutic or Preventive Procedure]
   753   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from peptide 2a."
Processing 00000000.tx.209: The full-length HI substrate (peptide 4c; 5806Da) coeluted with products 4a and b with a retention time of 48min. 

Phrase: "The full-length HI substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710236:Substrate [Manufactured Object]

Phrase: "(peptide 4c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "; 5806Da"

Phrase: ")"

Phrase: "coeluted with products 4a"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0450373:4a [Intellectual Product]
   770   C1514468:Products [Entity]
   770   C1553636:4a [Medical Device]
   737 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "b with a retention time of 48min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.210: Thus, HI was similarly cleaved by cathepsin D (Table I) and ENs (11) at the two primary sites, PheB24-PheB25 and PheB25-TyrB26, both located in the C terminus of the B chain. 

Phrase: "Thus,"

Phrase: "HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "was"

Phrase: "similarly"

Phrase: "cleaved by cathepsin D"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "(Table I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(11"

Phrase: ")"

Phrase: "at the two primary sites,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0449695:primary sites [Spatial Concept]
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]

Phrase: "PheB24-PheB25"

Phrase: "and"

Phrase: "PheB25-TyrB26,"

Phrase: "both"

Phrase: "located in the C terminus of the B chain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0337112:Chain [Manufactured Object]
   742   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.211: Digestion with human cathepsin D (not shown) gave identical results to that of bovine cathepsin D, indicating that the cleavage specificity of this enzyme is conserved across species. 

Phrase: "Digestion with human cathepsin D"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0012238:Digestion [Organism Function]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "identical results to that of bovine cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "indicating"

Phrase: "that"

Phrase: "the cleavage specificity of this enzyme"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0678612:enzyme specificity [Natural Phenomenon or Process]
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "is"

Phrase: "conserved across species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.212: View larger version (20K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.213: 7.  

Phrase: "7."
Processing 00000000.tx.214: HPLC profiles of native human insulin digested in vitro with a soluble endosomal extract or cathepsin D.HI (5105 M) was treated in vitro with ENs or 0.025units/ml cathepsin D in 0.1M citrate-phosphate buffer, pH 4.

Phrase: "HPLC profiles of native human insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1979963:Profile [Laboratory Procedure]
   719   C2003903:Profile [Functional Concept]

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "in vitro with a soluble endosomal extract"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0021135:In Vitro [Intellectual Product]
   778   C1533691:in vitro [Qualitative Concept]
           vitro
   778   C2827718:In Vitro [Functional Concept]

Phrase: "or"

Phrase: "cathepsin D.HI (5105"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332805:CATHEPSIN D [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0018619:HI [Geographic Area]
   812   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   812   C1412082:HI [Gene or Genome]
   812   C1412316:HI [Gene or Genome]

Phrase: "M)"

Phrase: "was"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "in vitro with ENs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "or"

Phrase: "0.025units/ml cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439446:mL/d [Quantitative Concept]
   840   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1332805:CATHEPSIN D [Gene or Genome]
   804   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in 0.1M citrate-phosphate buffer,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C3256468:citrate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.215: After 15min (HI+ENs) or 60min (HI+CD) at 37C, the proteolytic reaction was stopped by adding acetic acid (15%), and the hydrolysis products were immediately analyzed by RP HPLC. 

Phrase: "After 15min"

Phrase: "(HI+ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "or"

Phrase: "60min"

Phrase: "(HI+CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "at 37C,"

Phrase: "the proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by adding acetic acid"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0000985:Acetic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   760   C1272691:stopped [Qualitative Concept]
   726   C1883712:Add [Functional Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]
   704 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the hydrolysis products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "analyzed by RP HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.216: The major degradation products, pools 1-4, were collected from the elution profile HI+CD as indicated. 

Phrase: "The major degradation products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "pools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "1-4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "were"

Phrase: "collected from the elution profile HI+CD"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   770   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332805:CATHEPSIN D [Gene or Genome]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0018619:HI [Geographic Area]
   744   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   744   C1412082:HI [Gene or Genome]
   744   C1412316:HI [Gene or Genome]
   744   C1441565:Elution [Laboratory Procedure]
   744   C1516695:Collected [Idea or Concept]
   744   C1516698:Collected [Functional Concept]
   744   C1979963:Profile [Laboratory Procedure]
   744   C2003903:Profile [Functional Concept]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.217: These pools were subjected to mass spectrometry analyses (see Table I).  

Phrase: "These pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0337051:pools [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]
   966 E C2349200:Pool [Functional Concept]

Phrase: "were"

Phrase: "subjected to mass spectrometry analyses (see Table I)."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C1306372:*Mass [Quantitative Concept]
   760   C3152252:Mass [Quantitative Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0681850:Subject [Group]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.218: View this table: [in this window] [in a new window]  Table I Masses and assigned structures of the cleavage products generated from human insulin by cathepsin D Selected HPLC pools (see Fig. 7) generated by bovine cathepsin D were analyzed by HPLC coupled with electron spray ionization-mass spectrometry. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table I Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]
   793   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "assigned structures of the cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "generated from human insulin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0086418:Human [Human]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C3146294:Generated [Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "by cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "Selected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707391:Select [Activity]

Phrase: "HPLC pools"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0337051:pools [Geographic Area]
   827 E C1509144:pool [Clinical Attribute]
   827 E C2349200:Pool [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "generated by bovine cathepsin D"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1332805:CATHEPSIN D [Gene or Genome]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0007452:Bovine [Mammal]
   760   C1140701:bovine [Mammal]
   760   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "analyzed by HPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "coupled with electron spray ionization-mass spectrometry."
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   778   C0037813:Mass Spectrometry [Laboratory Procedure]
   774   C1551075:electron mass [Quantitative Concept]
   748   C0013852:Electron [Quantitative Concept]
   748   C0436196:Spectrometry [Laboratory Procedure]
   748   C0577559:Mass [Finding]
   748   C0596801:Ionization [Phenomenon or Process]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1704413:{Spray} [Quantitative Concept]
   748   C1948027:Coupled [Functional Concept]
   748   C2003858:Spray [Functional Concept]
   748   C3152252:Mass [Quantitative Concept]
   748   C3463986:Electron [Bird]
   714 E C0010222:couple [Family Group]
Processing 00000000.tx.219: Average molecular masses are used for calculations. 

Phrase: "Average molecular masses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   793   C0577559:Mass [Finding]
   793   C1306372:*Mass [Quantitative Concept]

Phrase: "are"

Phrase: "used for calculations."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1441506:Calculation [Activity]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.220: HPLC pools 2and 4are heterogeneous. 

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "pools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "2and 4are"

Phrase: "heterogeneous."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneous [Qualitative Concept]
Processing 00000000.tx.221: HPLC pools 1and 2are the carboxyl end of the B chain. 

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "pools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "1and 2are"

Phrase: "the carboxyl end of the B chain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0444930:End [Spatial Concept]
   748   C2746065:End [Temporal Concept]
Processing 00000000.tx.222: HPLC pools 3,4a, and 4b are portions of the amino end of the B chain still connected by disulfide bonds to intact A chain. 

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "pools"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0337051:Pool [Geographic Area]
  1000   C1509144:pool [Clinical Attribute]
  1000   C2349200:Pool [Functional Concept]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4a,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450373:4a [Intellectual Product]
  1000   C1553636:4a [Medical Device]

Phrase: "and"

Phrase: "4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450375:4b [Intellectual Product]

Phrase: "are"

Phrase: "portions of the amino end of the B chain still"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C0449719:Portion [Spatial Concept]

Phrase: "connected by disulfide bonds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1511997:Disulfide Bond [Amino Acid Sequence]
   770   C0012771:disulfide [Chemical Viewed Structurally]
   737   C2986575:Connect [Activity]

Phrase: "to intact A chain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.223: HPLC pool 4c is intact human insulin. 

Phrase: "HPLC pool 4c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450376:4c [Intellectual Product]

Phrase: "is"

Phrase: "intact human insulin."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.224: We have previously shown that the insulin B chain represents a high affinity substrate for EAI (11). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a high affinity substrate for EAI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710236:Substrate [Manufactured Object]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.225: Using RP HPLC analysis of digestions performed under initial rate conditions, we have compared the rate of hydrolysis of intact HI and the individual insulin A and B chains by ENs or pure cathepsin D (Fig. 8). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RP HPLC analysis of digestions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2986798:Phase Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "performed under initial rate conditions,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C0205265:Initial [Temporal Concept]
   760   C0871208:Rate [Activity]
   760   C0884358:Performed [Functional Concept]
   760   C1279901:Initial [Qualitative Concept]
   760   C1521828:Rate [Quantitative Concept]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "we"

Phrase: "have"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the rate of hydrolysis of intact HI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "the individual insulin A"

Phrase: "and"

Phrase: "B chains by ENs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0337112:chains [Manufactured Object]
   770   C1524075:Chains [Idea or Concept]

Phrase: "or"

Phrase: "pure cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.226: As previously reported (11), ENs degraded insulin B chain more efficiently than for intact HI, whereas the rate of hydrolysis of insulin A chain was lower than that of HI (Fig. 8A). 

Phrase: "As"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "ENs degraded insulin B chain more efficiently than"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0034850:Endosomes [Cell Component]
   744   C0337112:Chain [Manufactured Object]
   744   C1524075:Chain [Idea or Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "for intact HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "whereas"

Phrase: "the rate of hydrolysis of insulin A chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "lower than that of HI (Fig. 8A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: ")."
Processing 00000000.tx.227: Pure cathepsin D was found to degrade insulin peptides in a manner similar to ENs (i.e. insulin B chain>HI>insulin A-chain, Fig. 8B). 

Phrase: "Pure cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "degrade"

Phrase: "insulin peptides in a manner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "similar to ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "(i.e. insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   884   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0337112:Chain [Manufactured Object]
   804   C1524075:Chain [Idea or Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ">HI>insulin A-chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.228: These results support the hypothesis that EAI and endosomal cathepsin D are the same enzyme. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that EAI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "and"

Phrase: "endosomal cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "the same enzyme."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.229: View larger version (31K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.230: 8.  

Phrase: "8."
Processing 00000000.tx.231: Proteolysis of native human insulin, insulin A-chain, and insulin B chain by ENs or cathepsin D.Native HI, insulin A chain and insulin B chain were incubated in vitro with ENs (panel A) or 0.025units/ml cathepsin D (panel B) in 0.1M citrate-phosphate buffer, pH 4.

Phrase: "Proteolysis of native human insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "insulin A-chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin B chain by ENs"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0337112:Chain [Manufactured Object]
   760   C1524075:Chain [Idea or Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "cathepsin D.Native HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0018619:HI [Geographic Area]
   812   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   812   C1412082:HI [Gene or Genome]
   812   C1412316:HI [Gene or Genome]

Phrase: "insulin A chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021642:Insulin A Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "in vitro with ENs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "A)"

Phrase: "or"

Phrase: "0.025units/ml cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0439446:mL/d [Quantitative Concept]
   840   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1332805:CATHEPSIN D [Gene or Genome]
   804   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "B) in 0.1M citrate-phosphate buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347469:/B [Quantitative Concept]

Phrase: "pH 4."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.232: After 5-120 min at 37C, the proteolytic reaction was stopped by adding acetic acid (15%), and the incubation mixture was analyzed by RP HPLC. 

Phrase: "After 5-120 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "at 37C,"

Phrase: "the proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by adding acetic acid"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0000985:Acetic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   760   C1272691:stopped [Qualitative Concept]
   726   C1883712:Add [Functional Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]
   704 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the incubation mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "analyzed by RP HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.233: The rate of hydrolysis of each peptide was determined by following the disappearance of the peak area, corresponding to the parent peptide. 

Phrase: "The rate of hydrolysis of each peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "determined by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the disappearance of the peak area,"

Phrase: "corresponding to the parent peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030551:parent [Family Group]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.234: The results are the meanS.D. of three different experiments performed on endosomal fractions prepared from separate liver fractionations. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the meanS.D."

Phrase: "of three different experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed on endosomal fractions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1264633:Fractions [Quantitative Concept]
   737 E C1554103:Fraction [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from separate liver fractionations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0443299:Separate [Spatial Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   726   C0016640:fractionation [Laboratory Procedure]
   726   C0524811:fractionation [Therapeutic or Preventive Procedure]
   726   C1521827:Prepare [Functional Concept]
   726   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.235: Intracellular Colocalization of Human Insulin with Cathepsin D-- To strengthen the physiological relevance of our observations obtained with cell-free endosomes, we studied the cellular localization of internalized HI and cathepsin D in intact hepatocytes by confocal microscopy coupled to immunostaining (Fig. 9). 

Phrase: "Intracellular Colocalization of Human Insulin"

Phrase: "with Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "--"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "strengthen"

Phrase: "the physiological relevance of our observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevance [Qualitative Concept]

Phrase: "obtained with cell-free endosomes,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C1183428:cell free [Cell]
   760   C0007634:Cell [Cell]
   760   C0034850:Endosomes [Cell Component]
   760   C0332296:free [Functional Concept]
   760   C1269647:Cell [Cell]
   760   C1301820:Obtained [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1880497:Free [Qualitative Concept]
   760   C1948049:Cell [Spatial Concept]
   760   C1996904:Free [Qualitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the cellular localization of internalized HI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1660642:cellular localisation [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "cathepsin D in intact hepatocytes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1332805:CATHEPSIN D [Gene or Genome]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "by confocal microscopy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "coupled to immunostaining"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1948027:Coupled [Functional Concept]
   756 E C0010222:couple [Family Group]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.236: Hepatocytes were incubated with 2106 M HI for 20min, when most of the internalized ligand would be located in the endosomes (3), and the subcellular localization of both HI and cathepsin D were revealed by indirect immunofluorescence (Fig. 9A). 

Phrase: "Hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "incubated with 2106 M HI"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 20min,"

Phrase: "when"

Phrase: "most of the internalized ligand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0023688:Ligand [Chemical]
   760   C0205393:Most [Quantitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "located in the endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034850:Endosomes [Cell Component]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the subcellular localization of both HI"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "revealed by indirect immunofluorescence"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0282646:Indirect Immunofluorescence [Laboratory Procedure]
   770   C0016318:Immunofluorescence [Laboratory Procedure]
   770   C0079603:Immunofluorescence [Laboratory Procedure]
   770   C0439852:Indirect [Qualitative Concept]
   770   C0443289:Revealed [Qualitative Concept]
   715 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.237: Antibody to HI (in green) demonstrated a highly punctate staining pattern reminiscent of vesicular compartments. 

Phrase: "Antibody to HI ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "in green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "demonstrated"

Phrase: "a highly punctate staining pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449774:Pattern [Spatial Concept]

Phrase: "reminiscent of vesicular compartments."
Processing 00000000.tx.238: Costaining with antibody directed against mature and precursor cathepsin D enzyme (in red) revealed a partial colocalization (in yellow) with the intracellular protease. 

Phrase: "Costaining with antibody"

Phrase: "directed against mature"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205286:Mature [Temporal Concept]
   756   C0439851:Direct [Qualitative Concept]
   756   C1947931:Direct [Qualitative Concept]
   718 E C0449989:Maturity [Qualitative Concept]
   718 E C0700597:Maturity [Temporal Concept]

Phrase: "and"

Phrase: "precursor cathepsin D enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "("

Phrase: "in red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a partial colocalization"

Phrase: "("

Phrase: "in yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")"

Phrase: "with the intracellular protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]
Processing 00000000.tx.239: HI co-localization did not overlap completely with intracellular cathepsin D, although the extent of signal overlap was quite significant (Fig. 9A). 

Phrase: "HI co-localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0475264:Localisation [Functional Concept]
   827   C1744691:localisation [Biologic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "overlap"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185027:overlap [Therapeutic or Preventive Procedure]
  1000   C1948020:Overlap [Conceptual Entity]

Phrase: "completely with intracellular cathepsin D,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1332805:CATHEPSIN D [Gene or Genome]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C0205197:Completely [Qualitative Concept]

Phrase: "although"

Phrase: "the extent of signal overlap"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "quite significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.240: View larger version (49K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.241: 9.  

Phrase: "9."
Processing 00000000.tx.242: Partial colocalization of internalized insulin and cathepsin D in hepatocytes. 

Phrase: "Partial colocalization of internalized insulin"

Phrase: "and"

Phrase: "cathepsin D in hepatocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.243: Hepatocytes were treated with 2106 M HI for 20min, fixed with paraformaldehyde, and permeabilized with Triton X-100 before staining. 

Phrase: "Hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "treated with 2106 M HI"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0018619:HI [Geographic Area]
   760   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1412082:HI [Gene or Genome]
   760   C1412316:HI [Gene or Genome]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "for 20min,"

Phrase: "fixed with paraformaldehyde,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "permeabilized with Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   862   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   806   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   760   C0242759:Triton [Geographic Area]

Phrase: "before staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
Processing 00000000.tx.244: Panel A, HI is shown in green, cathepsin D is shown in red, and merged images on the far right indicate the extent of colocalization (yellow). 

Phrase: "Panel A,"

Phrase: "HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "is"

Phrase: "shown in green,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332583:Green [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "shown in red,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332575:Red [Finding]
   790   C1260956:Red [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "merged images on the far right"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1704254:Image [Intellectual Product]
   719   C1704922:Image [Entity]
   719   C3542466:Image [Intellectual Product]

Phrase: "indicate"

Phrase: "the extent of colocalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "(yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.245: Anti-HI antibody gave a typical endosomal vesicular pattern that colocalized partially with intracellular cathepsin D.Scale bar, 7.6m. 

Phrase: "Anti-HI antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a typical endosomal vesicular"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205378:Vesicular [Qualitative Concept]
   755 E C0333262:VESICLES [Acquired Abnormality]
   755 E C1622418:vesicle [Cell Component]

Phrase: "pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "that"

Phrase: "colocalized"

Phrase: "partially with intracellular cathepsin D.Scale bar,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   778   C1332805:CATHEPSIN D [Gene or Genome]
   748   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0175659:Scale [Medical Device]
   748   C0175996:intracellular [Cell Component]
   748   C0178719:Intracellular [Spatial Concept]
   748   C0349674:Scale [Intellectual Product]
   748   C1947916:Scale [Activity]
   748   C3536777:Scale [Manufactured Object]

Phrase: "7.6m."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3171719:6M [Quantitative Concept]
Processing 00000000.tx.246: Two cells with a typical fluorescent staining pattern are presented. 

Phrase: "Two cells with a typical fluorescent staining pattern"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "presented."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.247: Panel B, cathepsin D is shown in red, EEA1 is shown in green, and the merged image on the far right indicates the extent of colocalization (yellow). 

Phrase: "Panel B,"

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "shown in red,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332575:Red [Finding]
   790   C1260956:Red [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "EEA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414266:EEA1 [Gene or Genome]

Phrase: "is"

Phrase: "shown in green,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332583:Green [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "the merged image on the far right"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1704254:Image [Intellectual Product]
   748   C1704922:Image [Entity]
   748   C3542466:Image [Intellectual Product]

Phrase: "indicates"

Phrase: "the extent of colocalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "(yellow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221205:Yellow [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.248: Scale bar, 8.5m. 

Phrase: "Scale bar,"

Phrase: "8.5m."
Processing 00000000.tx.249: Fluorescent images were captured at two emission wavelengths (488and 543nm). 

Phrase: "Fluorescent images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured at two emission wavelengths"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205448:Two [Quantitative Concept]
   760   C0233929:Emission [Body Substance]
   760   C0449819:wavelengths [Quantitative Concept]
   760   C2349995:Emission [Substance]

Phrase: "(488and 543nm"

Phrase: ")."
Processing 00000000.tx.250: The localization of cathepsin D in endocytic vesicles was next examined by double-staining immunofluorescence with the early endosome marker EEA1 (Fig. 9B). 

Phrase: "The localization of cathepsin D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in endocytic vesicles"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0887883:Endocytic Vesicles [Cell Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "was"

Phrase: "next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined by double-staining immunofluorescence"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   760   C0016318:Immunofluorescence [Laboratory Procedure]
   760   C0079603:Immunofluorescence [Laboratory Procedure]
   760   C0205173:Double [Functional Concept]
   760   C0332128:Examined [Finding]
   760   C0487602:Staining [Laboratory Procedure]
   760   C1704680:Staining [Finding]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   745   C0183489:Immunofluorescent stain [Indicator, Reagent, or Diagnostic Aid]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   704 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "with the early endosome marker EEA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1414266:EEA1 [Gene or Genome]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.251: A partial immunoreactivity of cathepsin D was observed in the early endocytic vesicles identified by the presence of EEA1. 

Phrase: "A partial immunoreactivity of cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "observed in the early endocytic vesicles"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0887883:Endocytic Vesicles [Cell Component]
   753   C0333262:VESICLES [Acquired Abnormality]
   753   C1279919:Early [Temporal Concept]
   753   C1441672:Observed [Functional Concept]
   719 E C1622418:vesicle [Cell Component]

Phrase: "identified by the presence of EEA1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205396:Identified [Qualitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1414266:EEA1 [Gene or Genome]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
Processing 00000000.tx.252: These results confirm a minor but genuine endosomal location for the lysosomal aspartic acid protease. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "a minor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026193:Minor [Population Group]
  1000   C0205165:Minor [Qualitative Concept]

Phrase: "but"

Phrase: "genuine endosomal location for the lysosomal aspartic acid protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0450429:Location [Spatial Concept]
   742   C1515974:Location [Body Location or Region]
Processing 00000000.tx.253: Moreover, the previous biochemical and morphological demonstrations that internalized insulin in hepatocytes accumulated into endocytic components clearly distinguishable from lysosomes (reviewed in Ref. 31) combined with the biochemical (this study; Refs. 5 and 32) and morphological (this study; Ref. 33) demonstrations of the presence of cathepsin D within hepatic endosomes suggest that the partial colocalization of internalized insulin and cathepsin D observed in Fig. 

Phrase: "Moreover,"

Phrase: "the previous biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "morphological demonstrations"

Phrase: "that internalized insulin in hepatocytes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "accumulated into endocytic components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "clearly distinguishable from lysosomes"

Phrase: "("

Phrase: "reviewed in Ref. 31"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0282443:reviewed [Intellectual Product]
   770   C0450355:31 [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")"

Phrase: "combined with the biochemical"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205195:Combined [Qualitative Concept]
   770   C0205474:Biochemical [Functional Concept]
   737 E C0336789:Combine [Manufactured Object]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "; Refs. 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "32"

Phrase: ")"

Phrase: "and"

Phrase: "morphological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0543482:morphological [Spatial Concept]
   928 E C0332437:Morphology [Qualitative Concept]
   928 E C0700329:Morphology, NOS [Finding]
   928 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "; Ref. 33"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "demonstrations of the presence of cathepsin D"

Phrase: "within hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the partial colocalization of internalized insulin"

Phrase: "and"

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "observed in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.254: 9A occurred most probably within endocytic vesicles. 

Phrase: "9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "most probably within endocytic vesicles."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0887883:Endocytic Vesicles [Cell Component]
   760   C0205393:Most [Quantitative Concept]
   760   C0333262:VESICLES [Acquired Abnormality]
   760   C0750492:Probably [Idea or Concept]
   726 E C1622418:vesicle [Cell Component]
Processing 00000000.tx.255: Effect of Pepstatin A on the Fate of Insulin Receptor within Hepatic Endosomes in Vivo-- The level of insulin receptor internalization and the tyrosine phosphorylation state of the internalized insulin receptor could potentially be affected by pepstatin A, which affects endosomal proteolysis of HI. 

Phrase: "Effect of Pepstatin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the Fate"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1539479:FATE [Gene or Genome]
   928 E C1302234:Fatal [Qualitative Concept]
   928 E C1705232:Fatal [Finding]

Phrase: "of Insulin Receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "within Hepatic Endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "in Vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "-"

Phrase: "-"

Phrase: "The level of insulin receptor internalization"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0202098:Insulin level [Laboratory Procedure]
   783   C0428405:insulin level [Laboratory or Test Result]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "the tyrosine phosphorylation state of the internalized insulin receptor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1519726:Tyrosine Phosphorylation [Molecular Function]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]

Phrase: "could"

Phrase: "potentially"

Phrase: "be"

Phrase: "affected by pepstatin A,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "which"

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "endosomal proteolysis of HI."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]
Processing 00000000.tx.256: Therefore, the effect of pepstatin A on endosomal insulin receptor signal transduction was next examined (Fig. 10). 

Phrase: "Therefore,"

Phrase: "the effect of pepstatin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on endosomal insulin receptor signal transduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   911   C3270432:endosomal signal transduction [Cell Function]
   840   C0037083:Signal Transduction [Cell Function]
   804   C1160185:transduction [Organism Function]
   804   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.257: Animals were administered an intraperitoneal injection of either 12.5% Me2SO, 0.15M NaCl or 2mg of pepstatin A diluted in 12.5% Me2SO, 0.15M NaCl 1h before native HI administration, and animals were sacrificed 2-60 min after HI administration. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "an intraperitoneal injection of either 12.5% Me2SO,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C0442120:Intraperitoneal [Spatial Concept]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "0.15M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "or"

Phrase: "2mg of pepstatin A"

Phrase: "diluted in 12.5% Me2SO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "0.15M NaCl 1h before native HI administration,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1442450:1H [Temporal Concept]

Phrase: "and"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "sacrificed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0681205:Sacrifice [Idea or Concept]

Phrase: "2-60 min after HI administration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0702093:/min [Temporal Concept]
Processing 00000000.tx.258: Hepatic endosomes were prepared, and the amount of internalized insulin receptor and its phosphotyrosine content was determined by Western blot analyses. 

Phrase: "Hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the amount of internalized insulin receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "its phosphotyrosine content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined by Western blot analyses."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   828   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C1705493:Western [Spatial Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]
Processing 00000000.tx.259: A time-dependent increase in insulin receptor content was observed in endosomal fractions isolated 2-30 min after administration of a single receptor-saturating dose of HI (15g/100 g of body weight) as described previously (3) (Fig. 10, lower panel). 

Phrase: "A time-dependent increase in insulin receptor content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0020459:INSULIN INCREASE [Disease or Syndrome]
   744   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed in endosomal fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1264633:Fractions [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "2-30 min after administration of a single receptor-saturating dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0456693:/30 min [Temporal Concept]
   756   C1442458:30 min [Temporal Concept]
   738   C0702093:/min [Temporal Concept]

Phrase: "of HI (15g/100 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "of body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "(Fig. 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.260: No difference in the time nor extent of receptor internalization was observed after pepstatin A treatment. 

Phrase: "No difference in the time"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1442103:Time Difference [Temporal Concept]
   797   C1547049:*Time Difference [Quantitative Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "nor"

Phrase: "extent of receptor internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "was"

Phrase: "observed after pepstatin A treatment."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0039798:treatment [Functional Concept]
   760   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1441672:Observed [Functional Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.261: In contrast, a difference was observed for tyrosine phosphorylation of the insulin receptor -subunit. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "observed for tyrosine phosphorylation of the insulin receptor -subunit."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   764   C1334133:INSULIN RECEPTOR [Gene or Genome]
   764   C1519726:Tyrosine Phosphorylation [Molecular Function]
   762   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0031715:Phosphorylation [Molecular Function]
   742   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1158886:Phosphorylation [Molecular Function]
   742   C1441672:Observed [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.262: Insulin administration led to a brief burst (2min) of tyrosine autophosphorylation of the insulin receptor, and pepstatin A treatment could extend this time to 5min (Fig. 10, upper panel). 

Phrase: "Insulin administration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0199782:insulin administration [Therapeutic or Preventive Procedure]
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "led to a brief burst"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   760   C0439818:burst [Qualitative Concept]
   760   C1282927:brief [Qualitative Concept]
   760   C1708698:LED [Manufactured Object]
   760   C1879313:Brief [Temporal Concept]
   760   C1881705:BURST [Phenomenon or Process]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C1522538:Lead [Functional Concept]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "(2min"

Phrase: ")"

Phrase: "of tyrosine autophosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3271785:tyrosine autophosphorylation [Molecular Function]
   861   C0813988:autophosphorylation [Molecular Function]

Phrase: "of the insulin receptor,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "pepstatin A treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "this time to 5min"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "(Fig. 10,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.263: View larger version (65K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(65K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.264: 10.  

Phrase: "10."
Processing 00000000.tx.265: Effect of pepstatin A treatment on the internalization of tyrosine-phosphorylated insulin receptor after administration of human insulin in vivo. 

Phrase: "Effect of pepstatin A treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "of tyrosine-phosphorylated insulin receptor"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   902   C0255618:tyrosine receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C1334133:INSULIN RECEPTOR [Gene or Genome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "after administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001554:Administration [Occupational Activity]
  1000   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "of human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.266: Rats were injected with native HI (15g/100 g of body weight) having first received an intraperitoneal injection of either 12.5% Me2SO, 0.15M NaCl or 2mg of pepstatin A in 12.5% Me2SO, 0.15M NaCl 1h before ligand administration. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "injected with native HI (15g/100 g of body weight"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0005910:Body Weight [Organism Attribute]
           weight
   760   C1305866:body weight [Diagnostic Procedure]
           weight
   739   C0018619:HI [Geographic Area]
   739   C0043100:Weight [Quantitative Concept]
   739   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   739   C0242821:body [Human]
   739   C0302891:Native [Functional Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C0460148:Body [Anatomical Structure]
   739   C1268086:Body [Anatomical Structure]
   739   C1412082:HI [Gene or Genome]
   739   C1412316:HI [Gene or Genome]
   739   C1705104:Weight [Idea or Concept]
   706   C1720154:Inject [Functional Concept]

Phrase: ")"

Phrase: "having"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "an intraperitoneal injection of either 12.5% Me2SO,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021493:Intraperitoneal injection [Therapeutic or Preventive Procedure]
   744   C0021485:injection [Therapeutic or Preventive Procedure]
   744   C0442120:Intraperitoneal [Spatial Concept]
   744   C1272883:Injection [Biomedical or Dental Material]
   744   C1533685:Injection [Therapeutic or Preventive Procedure]
   744   C1828121:Injection [Functional Concept]

Phrase: "0.15M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "or"

Phrase: "2mg of pepstatin A"

Phrase: "in 12.5% Me2SO,"

Phrase: "0.15M NaCl 1h before ligand administration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1442450:1H [Temporal Concept]
Processing 00000000.tx.267: Endosomal fractions were isolated at the indicated times and evaluated by Western blotting for their content of insulin receptor using polyclonal antibody to the insulin receptor -subunit (Anti-IR) and for their immunoreactivity to monoclonal antibody against phosphotyrosine (Anti-PY). 

Phrase: "Endosomal fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated at the indicated times"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0040223:times [Temporal Concept]
   760   C0205409:Isolated [Functional Concept]
   760   C1444656:Indicated [Finding]
   760   C1548221:Isolated [Idea or Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]
   726 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "evaluated by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0220825:Evaluated [Functional Concept]
   770   C1705493:Western [Spatial Concept]

Phrase: "for their content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "of insulin receptor"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
  1000   C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal antibody to the insulin receptor -subunit (Anti-IR)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0443876:Insulin receptor antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   778   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0021644:Insulin antibody [Immunologic Factor]
   774   C0034805:antibody receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and for their immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0597879:immunoreactivity [Molecular Function]
   770   C1515981:And [Idea or Concept]

Phrase: "to monoclonal antibody against phosphotyrosine (Anti-PY)."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   840   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C0070948:Phosphotyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0746619:monoclonal [Finding]
   804   C1883351:To [Qualitative Concept]
Processing 00000000.tx.268: Each lane contained 60g of endosomal protein. 

Phrase: "Each lane contained 60g of endosomal protein."
Processing 00000000.tx.269: The arrows indicate the mobility of the -subunit of the insulin receptor (94kDa). 

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the mobility of the -subunit of the insulin receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0425245:Mobility [Finding]
   742   C0449580:Mobility [Qualitative Concept]

Phrase: "(94kDa"

Phrase: ")."
Processing 00000000.tx.270: Molecular mass markers are indicated to the left of the panels.  

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of the panels."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.271: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES The soluble aspartic acid protease cathepsin D has been identified as the insulin-degrading activity responsible for the primary cleavages of internalized insulin within hepatic endosomes. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The soluble aspartic acid protease cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   885   C0949755:ASPARTIC ACID D [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1332805:CATHEPSIN D [Gene or Genome]
   799   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "identified as the insulin-degrading activity"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   783   C1145751:insulin activity [Molecular Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Activity [Functional Concept]
   753   C0205396:Identified [Qualitative Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "responsible for the primary cleavages of internalized insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "within hepatic endosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.272: In this study, we sought to characterize the proteolytic function of endosomal cathepsin D toward the insulin substrate through a series of biochemical and morphological investigations. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the proteolytic function of endosomal cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "toward the insulin substrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710236:Substrate [Manufactured Object]

Phrase: "through a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "morphological investigations."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261322:Investigations [Health Care Activity]
   827 E C1552578:investigation [Idea or Concept]
   777 E C1517586:Investigational [Qualitative Concept]
   777 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.273: Using similar approaches, we have previously reported that hepatic endosomes contain the cysteine protease cathepsin B, that processes internalized glucagon (5), epidermal growth factor (7), and IGF-I (8). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "similar approaches,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the cysteine protease cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332804:CATHEPSIN B [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "internalized"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.274: Identically, we have recently shown that CA074-methyl ester, a cathepsin B inhibitor, prevented endosomal processing of internalized IGF-I in MCF-7 and H-59 tumor cells (8). 

Phrase: "Identically,"

Phrase: "we"

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that CA074-methyl ester,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: "a cathepsin B inhibitor,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1999216:Inhibitor [Qualitative Concept]
   734   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332804:CATHEPSIN B [Gene or Genome]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "endosomal processing of internalized IGF-I"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]

Phrase: "in MCF-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0008015:MCF [Immunologic Factor]

Phrase: "and"

Phrase: "H-59 tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   861   C0431085:Tumor cells [Cell]
   827 E C0597032:Tumor Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.275: Consistent with our previous studies, we concluded in this present work that the EAI activity was likely the aspartic acid protease cathepsin D, as indicated by the following observations. 

Phrase: "Consistent with our previous studies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "we"

Phrase: "concluded in this present"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   737   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "that"

Phrase: "the EAI activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "the aspartic acid protease cathepsin D,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   911   C0949755:ASPARTIC ACID D [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1332805:CATHEPSIN D [Gene or Genome]
   804   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "as"

Phrase: "indicated by the following observations."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0302523:observations [Research Activity]
   760   C0700325:observations [Health Care Activity]
   760   C1444656:Indicated [Finding]
   760   C3244290:observations [Functional Concept]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1964257:Observation [Diagnostic Procedure]
Processing 00000000.tx.276: (a) The inhibitor profile and the pH optimum of the endosomal proteolytic activity were similar to those of cathepsin D; 

Phrase: "(a)"

Phrase: "The inhibitor profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "and"

Phrase: "the pH optimum of the endosomal proteolytic activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2698651:Optimum [Qualitative Concept]

Phrase: "were"

Phrase: "similar to those of cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.277: (b) immunodepletion of cathepsin D from ENs led to a loss of EAI activity; 

Phrase: "(b) immunodepletion of cathepsin D"

Phrase: "from ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "led to a loss of EAI activity"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   764   C1150184:insulinase activity [Molecular Function]
   742   C0001128:Acidic [Chemical]
   742   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1415875:INSULINASE [Gene or Genome]
   742   C1517945:Loss [Quantitative Concept]
   742   C1561536:*Activity [Idea or Concept]
   742   C1708698:LED [Manufactured Object]
   708 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   708 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   708 E C1522538:Lead [Functional Concept]
   708 E C2348269:Lead [Element, Ion, or Isotope]
   708 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.278: (c) the EAI activity was specifically absorbed to pepstatin A-agarose; 

Phrase: "(c)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "the EAI activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "specifically"

Phrase: "absorbed"

Phrase: "to pepstatin A-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: ";"
Processing 00000000.tx.279: (d) Western blot experiments demonstrated the presence of the 45-kDa active form of cathepsin D as well as its 64-kDa inactive precursor in the endosomal lumen; 

Phrase: "("

Phrase: "d)"

Phrase: "Western blot experiments"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   734   C0949466:Western Blot [Laboratory Procedure]

Phrase: "demonstrated"

Phrase: "the presence of the 45-kDa active form of cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "as well as"

Phrase: "its 64-kDa inactive precursor in the endosomal lumen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709634:Precursor [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.280: (e) using confocal immunofluorescent microscopy, internalization of HI into rat hepatocytes led to partial colocalization of internalized insulin with cathepsin D and cathepsin D with the early endocytic marker EEA1; 

Phrase: "(e)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "confocal immunofluorescent microscopy,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0242842:Microscopy, Confocal [Laboratory Procedure]
   865   C0079604:Immunofluorescence Microscopy [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   755 E C0205288:Microscopic [Qualitative Concept]

Phrase: "internalization of HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0871786:internalization [Mental Process]

Phrase: "into rat hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "led to partial colocalization of internalized insulin"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0728938:Partial [Quantitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550516:partial [Idea or Concept]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1708698:LED [Manufactured Object]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C1522538:Lead [Functional Concept]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "with cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cathepsin D with the early endocytic marker EEA1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1332805:CATHEPSIN D [Gene or Genome]
   744   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.281: and (f) pure cathepsin D produced a cleavage pattern for HI that was similar to that generated using the endosomal proteolytic activity. 

Phrase: "and ("

Phrase: "f) pure cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332805:CATHEPSIN D [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "produced"

Phrase: "a cleavage pattern for HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "that"

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the endosomal proteolytic activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C0597304:Proteolytic [Molecular Function]
   827   C1561536:*Activity [Idea or Concept]
   827   C1947941:proteolytic [Enzyme]
Processing 00000000.tx.282: That the presence of active cathepsin D within hepatic endosomes was due to lysosomal contamination of our endosomal fraction is highly unlikely. 

Phrase: "That"

Phrase: "the presence of active cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "within hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "was due to lysosomal contamination of our endosomal fraction"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   764   C0678226:Due to [Functional Concept]
           due
   762   C1264633:Fraction of [Quantitative Concept]
           Fraction
   742   C0043194:WAS [Disease or Syndrome]
   742   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0259846:contamination [Human-caused Phenomenon or Process]
   742   C0521450:Lysosomal [Body Location or Region]
   742   C1421478:WAS [Gene or Genome]
   742   C1554103:Fraction [Idea or Concept]
   742   C1881659:CONTAMINATION [Event]
   742   C2349974:Contamination [Idea or Concept]
   742   C3146286:Due [Idea or Concept]

Phrase: "is"

Phrase: "highly unlikely."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]
Processing 00000000.tx.283: Thus, the modest content of N-acetyl--D-glucosaminidase and acid phosphatase in our endosomal fraction points to minimal contamination by lysosomes and confirms our earlier observations (21). 

Phrase: "Thus,"

Phrase: "the modest content of N-acetyl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017724:Glucosaminidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "acid phosphatase in our endosomal fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0001109:Acid Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0001128:Acid [Chemical]
   753   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0202406:Acid [Laboratory Procedure]
   753   C1149880:phosphatase [Molecular Function]

Phrase: "points to minimal contamination"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0259846:contamination [Human-caused Phenomenon or Process]
   770   C0547040:Minimal [Qualitative Concept]
   770   C1524031:MINIMAL [Qualitative Concept]
   770   C1552961:Point [Quantitative Concept]
   770   C1881659:CONTAMINATION [Event]
   770   C2347617:point [Quantitative Concept]
   770   C2349974:Contamination [Idea or Concept]
   770   C2945599:Minimal [Qualitative Concept]

Phrase: "by lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "and"

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "our earlier observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.284: Moreover, mature lysosomal cathepsin L was undetectable in our endosomal fraction although its inactive precursor was easily identified. 

Phrase: "Moreover,"

Phrase: "mature lysosomal cathepsin L"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0054871:Cathepsin L [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332807:CATHEPSIN L [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "undetectable in our endosomal fraction"

Phrase: "although"

Phrase: "its inactive precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709634:Precursor [Idea or Concept]

Phrase: "was"

Phrase: "easily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332219:Easily [Qualitative Concept]

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.285: Finally, immunofluorescence studies performed on rat hepatocytes revealed that the endosomal marker protein EEA1 was present in some cathepsin D-positive structures, suggesting a genuine endosomal localization for the cathepsin D enzyme. 

Phrase: "Finally,"

Phrase: "immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "performed on rat hepatocytes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0227525:Hepatocytes [Cell]
   770   C0884358:Performed [Functional Concept]
   737 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the endosomal marker protein EEA1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1414266:EEA1 [Gene or Genome]

Phrase: "was"

Phrase: "present in some cathepsin D-positive structures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a genuine endosomal localization for the cathepsin D enzyme."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0475264:Localisation [Functional Concept]
   742   C1744691:localisation [Biologic Function]
   729   C1819354:endosome localisation [Biologic Function]
Processing 00000000.tx.286: These data conform well to previous biochemical (5, 32) and morphological evidence (33) that active cathepsin D was selectively retained within hepatic endosomes. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "conform"

Phrase: "well to previous biochemical"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205156:Previous [Temporal Concept]
   770   C0205170:Well [Qualitative Concept]
   770   C0205474:Biochemical [Functional Concept]
   770   C1552607:previous [Temporal Concept]
   770   C3146287:Well [Manufactured Object]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "32"

Phrase: ")"

Phrase: "and"

Phrase: "morphological evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "(33"

Phrase: ")"

Phrase: "that active cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "selectively"

Phrase: "retained within hepatic endosomes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C0333118:Retained [Functional Concept]
Processing 00000000.tx.287: Although the radiolabeled peptide [125I-TyrA14]HI can be used to assay insulin degradation at the endosomal locus (2-4), caution should be used when interpreting this cleavage activity as the true EAI activity (11). 

Phrase: "Although"

Phrase: "the radiolabeled peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "[125I-TyrA14"

Phrase: "]HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "insulin degradation at the endosomal locus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3547574:insulin degradation [Molecular Function]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "(2-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "caution"

Phrase: "should"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "when"

Phrase: "interpreting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285553:interpreting [Functional Concept]

Phrase: "this cleavage activity as the true EAI activity"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.288: First, radioactive HI might not display all the primary, secondary, and tertiary structural elements of the natural peptide substrate (34). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "radioactive HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0018619:HI [Geographic Area]
   861   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   861   C1412082:HI [Gene or Genome]
   861   C1412316:HI [Gene or Genome]

Phrase: "might"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "all the primary, secondary,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027627:secondary [Neoplastic Process]
   861   C0175668:Secondary [Temporal Concept]
   861   C0205436:Secondary [Quantitative Concept]

Phrase: "and"

Phrase: "tertiary structural elements of the natural peptide substrate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0013879:Elements [Element, Ion, or Isotope]
   711 E C1705248:Element [Conceptual Entity]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.289: Thus, the radioactive iodine on the molecule might mask the substrate recognition site and the sites of cleavage for the endosomal proteolytic system. 

Phrase: "Thus,"

Phrase: "the radioactive iodine on the molecule"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1441129:Radioactive Iodine [Element, Ion, or Isotope,Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0021966:Iodine- [Inorganic Chemical]
   753   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0034553:radioactive [Natural Phenomenon or Process]
   753   C0885449:iodine [Pharmacologic Substance]
   753   C2348268:Iodine [Element, Ion, or Isotope]
           Molecular Iodine

Phrase: "might"

Phrase: "mask"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024861:Mask [Medical Device]
  1000   C1538279:MASK [Gene or Genome]
  1000   C1845191:MASK [Gene or Genome]

Phrase: "the substrate recognition site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205145:Site [Spatial Concept]
   827   C0524637:Recognition [Mental Process]
   827   C1515974:Site [Body Location or Region]
   827   C1710236:Substrate [Manufactured Object]
   827   C2825164:Site [Spatial Concept]

Phrase: "and"

Phrase: "the sites of cleavage"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   816   C2945843:Site of [Qualitative Concept]
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "for the endosomal proteolytic system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.290: Secondly, although a trichloroacetic acid precipitation assay has been developed for the degradation analysis of radioactive insulin (2-4, 11), the limitation of this type of assay is that it greatly underestimates actual degradation and measures the proteolytic activities under conditions far from the initial rate of the reaction. 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "although"

Phrase: "a trichloroacetic acid precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "developed for the degradation analysis of radioactive insulin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   767   C3547574:insulin degradation [Molecular Function]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0034553:radioactive [Natural Phenomenon or Process]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "(2-4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "11"

Phrase: ")"

Phrase: ","

Phrase: "the limitation of this type of assay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449295:Limitation [Functional Concept]

Phrase: "is"

Phrase: "that"

Phrase: "it greatly"

Phrase: "underestimates"

Phrase: "actual degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "and"

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "the proteolytic activities under conditions far"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0441655:Activities [Activity]
   753   C0597304:Proteolytic [Molecular Function]
   753   C1947941:proteolytic [Enzyme]
   750   C1292728:Condition activity [Functional Concept]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "from the initial rate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205265:Initial [Temporal Concept]
   861   C0871208:Rate [Activity]
   861   C1279901:Initial [Qualitative Concept]
   861   C1521828:Rate [Quantitative Concept]
   861   C1555582:Initial [Idea or Concept]
   861   C1705685:INITIAL [Functional Concept]

Phrase: "of the reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.291: In a complex system where intermediate cleavage products can be further processed, it is difficult to obtain any meaningful information on the enzyme of interest. 

Phrase: "In a complex system where intermediate cleavage products"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0010813:cleavage [Cell Function]
   799   C0596311:Cleavage [Phenomenon or Process]
   799   C1330957:cleavage [Cell Function]
   799   C1514468:Products [Entity]
   766 E C1704444:Product [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "any meaningful information on the enzyme of interest."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1533716:Information [Idea or Concept]
Processing 00000000.tx.292: The trichloroacetic acid precipitation assay is, therefore, inherently unsuitable to screening for a specific protease in endosomal lysates, where many other proteases with a broad substrate specificity are likely to be present (5, 7). 

Phrase: "The trichloroacetic acid precipitation assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: ","

Phrase: "therefore,"

Phrase: "inherently unsuitable to screening"

Phrase: "for a specific protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "in endosomal lysates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "where"

Phrase: "many other proteases with a broad substrate specificity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C1947941:Proteases [Enzyme]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "present"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.293: Thus, we have developed an RP HPLC assay based on measurement of the initial degradation step of native HI by endosomal lysates, with the subsequent identification of the early insulin intermediates. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "have"

Phrase: "developed"

Phrase: "an RP HPLC assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "based on measurement of the initial degradation step of native HI"
Meta Candidates (Total=21; Excluded=3; Pruned=0; Remaining=18)
   738   C0018619:HI [Geographic Area]
   738   C0205265:Initial [Temporal Concept]
   738   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
   738   C0242485:Measurement [Functional Concept]
   738   C0243125:degradation [Functional Concept]
   738   C0302891:Native [Functional Concept]
   738   C0699900:Degradation [Organism Function]
   738   C1261552:Step [Conceptual Entity]
   738   C1279901:Initial [Qualitative Concept]
   738   C1412082:HI [Gene or Genome]
   738   C1412316:HI [Gene or Genome]
   738   C1527178:Based [Functional Concept]
   738   C1555582:Initial [Idea or Concept]
   738   C1704379:Step [Functional Concept]
   738   C1705117:Step [Quantitative Concept]
   738   C1705685:INITIAL [Functional Concept]
   738   C1705938:Based [Idea or Concept]
   738   C2825408:Step [Manufactured Object]
   704 E C0002055:base [Inorganic Chemical]
   704 E C0178499:Base [Chemical Viewed Functionally]
   704 E C1880279:Base [Biomedical or Dental Material]

Phrase: "by endosomal lysates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1881488:Lysate [Physical Object]

Phrase: "with the subsequent identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020792:Identification [Mental Process]
   861   C0205396:Identification [Qualitative Concept]

Phrase: "of the early insulin intermediates."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]
Processing 00000000.tx.294: The improved specificity of this method allowed for the rigorous screening of EAI activity. 

Phrase: "The improved specificity of this method"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037791:Specificity [Quantitative Concept]
   753   C1511884:Specificity [Quantitative Concept]

Phrase: "allowed for the rigorous screening of EAI activity."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   760   C1150184:insulinase activity [Molecular Function]
   739   C0001128:Acidic [Chemical]
   739   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0205177:Activity [Functional Concept]
   739   C0220908:Screening [Health Care Activity]
   739   C0220909:screening [Functional Concept]
   739   C0439167:% activity [Quantitative Concept]
   739   C0441655:Activity [Activity]
   739   C0683607:allowed [Social Behavior]
   739   C1415875:INSULINASE [Gene or Genome]
   739   C1561536:*Activity [Idea or Concept]
   739   C1698960:screening [Intellectual Product]
   739   C1710031:Screening [Diagnostic Procedure]
   739   C1710477:SCREENING [Research Activity]
Processing 00000000.tx.295: However, we cannot exclude that very late cleavages of small insulin intermediates observed within hepatic endosomes (11) may be produced by other endosomal endo- and/or exopeptidases such as cathepsin B (5, 7), insulin-degrading enzyme (35), or other as yet unidentified endosomal proteolytic activities. 

Phrase: "However,"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "that very late cleavages of small insulin intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C0010813:cleavage [Cell Function]
   711   C0596311:Cleavage [Phenomenon or Process]
   711   C1330957:cleavage [Cell Function]

Phrase: "observed within hepatic endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C1441672:Observed [Functional Concept]

Phrase: "(11"

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "produced by other endosomal endo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0014175:Endo [Disease or Syndrome]
   760   C1427293:ENDO [Gene or Genome]

Phrase: "and/or"

Phrase: "exopeptidases such as cathepsin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0117059:Exopeptidases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(35"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "other as yet unidentified endosomal proteolytic activities."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   757   C2712604:Other activity [Daily or Recreational Activity]
   748   C0205394:Other [Qualitative Concept]
   748   C0205427:Unidentified [Qualitative Concept]
   748   C0441655:Activities [Activity]
   748   C0597304:Proteolytic [Molecular Function]
   748   C1947941:proteolytic [Enzyme]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.296: Despite the limitations of the trichloroacetic acid precipitation assay, an accurate examination of the early proteolytic cleavages generated in vivo has been possible with the use of monoiodinated insulin isomers combined with RP HPLC and radiosequencing procedures (35-38). 

Phrase: "Despite the limitations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449295:limitations [Functional Concept]

Phrase: "of the trichloroacetic acid precipitation assay,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "an accurate examination of the early proteolytic cleavages"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "has"

Phrase: "been"

Phrase: "possible with the use of monoiodinated insulin isomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332149:Possible [Qualitative Concept]
   744   C1705910:Possible [Qualitative Concept]
   744   C2362652:Possible [Qualitative Concept]

Phrase: "combined with RP HPLC"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205195:Combined [Qualitative Concept]
   760   C0205390:Phase [Temporal Concept]
   760   C1555029:Reverse [Idea or Concept]
   726 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "radiosequencing procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "(35-38"

Phrase: ")."
Processing 00000000.tx.297: Using this approach, endosome-associated degradation products extracted at an early time of insulin endocytosis displayed intact A chain and cleavages in the B chain at B24-B25, B23-B24, B16-B17, and B14-B15 bonds (35-38). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "this approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "endosome-associated degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "extracted at an early time of insulin endocytosis"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   744   C0014139:Endocytosis [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0040223:Time [Temporal Concept]
   744   C0185115:Extracted [Therapeutic or Preventive Procedure]
   744   C1279919:Early [Temporal Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C2984285:Endocytosis [Functional Concept]
   744   C3541383:Time [Temporal Concept]
   744   C3541890:EXTRACTED [Finding]
   711 E C2828366:Extract [Substance]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "intact A chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "cleavages in the B chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0010813:cleavage [Cell Function]
   726   C0596311:Cleavage [Phenomenon or Process]
   726   C1330957:cleavage [Cell Function]

Phrase: "at B24-B25,"

Phrase: "B23-B24,"

Phrase: "B16-B17,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1414132:B17 [Gene or Genome]
   861   C1417638:B17 [Gene or Genome]

Phrase: "and"

Phrase: "B14-B15 bonds"

Phrase: "(35-38"

Phrase: ")."
Processing 00000000.tx.298: Structural and kinetic analyses of in vivo intermediates isolated from the intraendosomal compartment have allowed the determination of an ordered sequence involving an initial cleavage in the B chain at 24-25, which produces des(hexapeptide)insulin (38). 

Phrase: "Structural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structural [Spatial Concept]

Phrase: "and"

Phrase: "kinetic analyses of in vivo intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "isolated from the intraendosomal compartment"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0205409:Isolated [Functional Concept]
   760   C1185625:Compartment [Body Space or Junction]
   760   C1548221:Isolated [Idea or Concept]
   760   C2986730:Compartment [Spatial Concept]
   726 E C0370215:Isolate [Substance]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "have"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "the determination of an ordered sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0917791:Sequence Determination [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1148554:determination [Laboratory Procedure]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "an initial cleavage in the B chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "at 24-25,"

Phrase: "which"

Phrase: "produces"

Phrase: "des(hexapeptide"

Phrase: ")"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.299: This process has been supported by our in vitro study characterizing endosomal proteolysis of native HI using a soluble endosomal extract from rat liver parenchyma (11). 

Phrase: "This process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "has"

Phrase: "been"

Phrase: "supported by our in vitro study"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0681828:in vitro study [Research Activity]
           study vitro
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0557651:Study [Manufactured Object]
   753   C1521721:Supported [Conceptual Entity]
   753   C2603343:Study [Research Activity]
   719 E C0183683:Support [Medical Device]

Phrase: "characterizing"

Phrase: "endosomal proteolysis of native HI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597304:Proteolysis [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a soluble endosomal extract from rat liver parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0023899:Liver Extract [Organic Chemical,Pharmacologic Substance]
   744   C2828366:Extract [Substance]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.300: This study showed initial B24-B25 cleavage with the parallel production of des(hexapeptide)-HI and the C-terminal B chain hexapeptide (B25-30) (11). 

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "initial B24-B25 cleavage with the parallel production of des(hexapeptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C0010813:cleavage [Cell Function]
   738   C0596311:Cleavage [Phenomenon or Process]
   738   C1330957:cleavage [Cell Function]

Phrase: ")-"

Phrase: "HI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "and"

Phrase: "the C-terminal B chain hexapeptide"

Phrase: "(B25-30"

Phrase: ")"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.301: Therefore, we elected to pursue the in vitro characterization of EAI using the most sensitive assay for insulin degradation by following the primary in vivo cleavage between PheB24 and PheB25 residues. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "elected"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "pursue"

Phrase: "the in vitro characterization of EAI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880022:Characterization [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the most sensitive assay for insulin degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005507:Assay [Laboratory Procedure]
   748   C0243073:assay [Qualitative Concept]
   748   C0332324:Sensitive [Functional Concept]
   748   C1510438:Assay [Laboratory Procedure]
   748   C1550474:sensitive [Idea or Concept]

Phrase: "by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the primary in vivo cleavage between PheB24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "PheB25 residues."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]
Processing 00000000.tx.302: The two primary end products of HI that are generated using cell-free endosomes (this study; Ref. 11) and pure cathepsin D (this study) result from proteolytic cleavages occurring at residues PheB24-PheB25 (major pathway) and PheB25-TyrB26 (minor pathway), two sites that fit the specificity pattern for sites cleaved by cathepsin D (39). 

Phrase: "The two primary end products of HI"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0444930:End [Spatial Concept]
   748   C1514468:Products [Entity]
   748   C2746065:End [Temporal Concept]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell-free endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034850:Endosomes [Cell Component]
   734   C1183428:cell free [Cell]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "; Ref. 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "pure cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "this study) result from proteolytic cleavages"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0683954:result study [Finding]
   753   C0557651:Study [Manufactured Object]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2603343:Study [Research Activity]
   753   C2825142:Result [Finding]

Phrase: "occurring at residues PheB24-PheB25"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   726   C1709305:Occur [Activity]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]
   726   C2745955:OCCUR [Temporal Concept]

Phrase: "(major pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: ")"

Phrase: "and"

Phrase: "PheB25-TyrB26"

Phrase: "(minor pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "two sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "the specificity pattern for sites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "cleaved by cathepsin D"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.303: Sequences readily cleaved by cathepsin D contain apolar or hydrophobic residues situated on both sides of the cleavage site, with the Phe-Phe bond strongly favored and, in most cases, a hydrophobic residue in position P1 (39). 

Phrase: "Sequences"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004793:Sequence [Nucleotide Sequence]
  1000   C0162326:Sequence [Nucleotide Sequence]
  1000   C0162327:Sequence [Nucleotide Sequence]
  1000   C1519249:Sequence [Functional Concept]

Phrase: "readily"

Phrase: "cleaved by cathepsin D"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0205242:Cleaved [Spatial Concept]
   770   C0333853:Cleaved [Cell]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "apolar"

Phrase: "or"

Phrase: "hydrophobic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "situated on both sides of the cleavage site,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   767   C2945843:Site of [Qualitative Concept]
   744   C0010813:cleavage [Cell Function]
   744   C0205145:Site [Spatial Concept]
   744   C0596311:Cleavage [Phenomenon or Process]
   744   C1330957:cleavage [Cell Function]
   744   C1515974:Site [Body Location or Region]
   744   C2825164:Site [Spatial Concept]
   711   C0441987:Side [Spatial Concept]

Phrase: "with the Phe-Phe"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070662:Phe-Phe [Amino Acid, Peptide, or Protein]

Phrase: "bond"

Phrase: "strongly"

Phrase: "favored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: ","

Phrase: "in most cases,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "a hydrophobic residue in position P1 (39"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1709915:Residue [Conceptual Entity]
   748   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.304: Thus, the sites in HI that were cleaved to produce the two primary end products A1-21-B1-24 and A1-21-B1-25 satisfy all the requirements for a cathepsin D cleavage site. 

Phrase: "Thus,"

Phrase: "the sites in HI"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "that"

Phrase: "were"

Phrase: "cleaved"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205242:Cleaved [Spatial Concept]
  1000   C0333853:Cleaved [Cell]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "produce"

Phrase: "the two primary end products A1-21-B1-24"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   793   C0205225:Primary [Qualitative Concept]
   793   C0205448:Two [Quantitative Concept]
   793   C0439631:Primary [Therapeutic or Preventive Procedure]
   793   C0444930:End [Spatial Concept]
   793   C1514468:Products [Entity]
   793   C2746065:End [Temporal Concept]
   760 E C1704444:Product [Quantitative Concept]
   737 E C0205088:Terminal [Temporal Concept]
   737 E C1705314:Terminal [Manufactured Object]
   737 E C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "A1-21-B1-25"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   875   C0450347:21/25 [Quantitative Concept]

Phrase: "satisfy"

Phrase: "all the requirements for a cathepsin D cleavage site."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1514873:Requirement [Functional Concept]
Processing 00000000.tx.305: Accordingly, characterization of the residues in positions P1 and P'1, determined with synthetic substrates (39), explains the highly specific primary cleavages obtained using natural and physiological substrates by cathepsin D.

Phrase: "Accordingly,"

Phrase: "characterization of the residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "in positions P1"

Phrase: "and"

Phrase: "P'1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "determined with synthetic substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883254:synthetic [Activity]
   737   C1710236:Substrate [Manufactured Object]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "explains"

Phrase: "the highly specific primary cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   779   C0010813:cleavage [Cell Function]
   779   C0596311:Cleavage [Phenomenon or Process]
   779   C1330957:cleavage [Cell Function]

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "natural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205296:Natural [Functional Concept]

Phrase: "and"

Phrase: "physiological substrates by cathepsin D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.306: Thus, cathepsin D appears to mediate the selective cleavage of parathyroid hormone at the Phe34-Val35 peptide bond (6), human invariant chain at the Leu174-Phe175 peptide bond (40), the A1 protein from myelin at the Phe42-Phe43 peptide bond (41), -1,4-N-acetylgalactosaminyltransferase at the Leu23-Tyr24 peptide bond (42), and -amyloid precursor protein at various hydrophobic peptide bonds such as between the Phe93 and Phe94 residues (43). 

Phrase: "Thus,"

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the selective cleavage of parathyroid hormone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "at the Phe34-Val35 peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "human invariant chain at the Leu174-Phe175 peptide bond"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0063356:invariant chain [Amino Acid, Peptide, or Protein]
   764   C1413237:INVARIANT CHAIN [Gene or Genome]
   742   C0337112:Chain [Manufactured Object]
   742   C1524075:Chain [Idea or Concept]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "the A1 protein from myelin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0026972:Myelin protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at the Phe42-Phe43 peptide bond"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(41"

Phrase: ")"

Phrase: ", -"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-N-acetylgalactosaminyltransferase at the Leu23-Tyr24 peptide bond"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0544511:Acetyl galactosaminyl transferase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "amyloid precursor protein at various hydrophobic peptide bonds"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   800   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   800   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   770   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0011560:Amyloid [Pathologic Function]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1709634:Precursor [Idea or Concept]

Phrase: "such as"

Phrase: "between the Phe93"

Phrase: "and"

Phrase: "Phe94 residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.307: Finally, kallistatin, a serpin that specifically inhibits human tissue kallikrein, was recently demonstrated to be cleaved at the Phe-Phe bond in its reactive site loop by cathepsin D (44). 

Phrase: "Finally,"

Phrase: "kallistatin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0076727:kallistatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418550:KALLISTATIN [Gene or Genome]

Phrase: "a serpin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036764:Serpin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "that specifically"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "human tissue kallikrein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0076726:Tissue Kallikrein [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1416669:KALLIKREIN, TISSUE [Gene or Genome]
   827   C0022478:Kallikrein [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   734   C0440744:Human tissue [Tissue]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "cleaved at the Phe-Phe bond"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0070662:Phe-Phe [Amino Acid, Peptide, or Protein]
   753   C0031453:Phe [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0205242:Cleaved [Spatial Concept]
   753   C0333853:Cleaved [Cell]

Phrase: "in its reactive site loop"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0005456:reactive site [Receptor]
   901   C0205681:Reactive Site [Functional Concept]
   827   C0205145:Site [Spatial Concept]
   827   C0205332:Reactive [Qualitative Concept]
   827   C0419518:Loop [Medical Device]
   827   C0445022:Loop [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "by cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.308: Studies on the structural requirements for HI/EAI binding have also identified a highly specific molecular interaction at the C-terminal B22-B30 region of the insulin B chain, a region that contains the aromatic locus PheB24-PheB25-TyrB26 (11). 

Phrase: "Studies on the structural requirements"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "for HI/EAI binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "have"

Phrase: "also"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "a highly specific molecular interaction at the C-terminal B22-B30 region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1167622:Molecular Interaction [Molecular Function]
   736   C1704675:Interaction [Functional Concept]

Phrase: "of the insulin B chain,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "that"

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the aromatic locus PheB24-PheB25-TyrB26"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.309: Thus, the hydrophobic PheB24-PheB25-TyrB26 tripeptide might also dictate HI binding to cathepsin D.

Phrase: "Thus,"

Phrase: "the hydrophobic PheB24-PheB25-TyrB26 tripeptide"

Phrase: "might"

Phrase: "also"

Phrase: "dictate"

Phrase: "HI binding to cathepsin D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.310: Unexpectedly, binding (11) and cleavage (8) of the insulin-related IGF-I polypeptide by EAI activity and aspartic acid proteases were not detected upon incubation of this growth factor with hepatic ENs and tumor cell lysates. 

Phrase: "Unexpectedly,"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "(11"

Phrase: ")"

Phrase: "and"

Phrase: "cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "(8"

Phrase: ")"

Phrase: "of the insulin-related IGF-I polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "by EAI activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150184:insulinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "aspartic acid proteases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2717969:Aspartic Acid Proteases [Amino Acid, Peptide, or Protein,Enzyme]
           Aspartic Protease
   827   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Proteases [Enzyme]
   734   C0004015:Aspartic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detected upon incubation of this growth factor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1521761:Factor [Functional Concept]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2827422:Factor [Conceptual Entity]
   748   C2911660:Growth [Activity]

Phrase: "with hepatic ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "tumor cell lysates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1881488:Cell Lysate [Physical Object]
           Lysate
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]
Processing 00000000.tx.311: One explanation might be the difference in primary sequence between positions B24-B26 (Phe-Phe-Tyr) of the insulin B chain and the corresponding positions 23-25 (Phe-Tyr-Phe) of IGF-I, which displays a simple inversion of the insulin Phe-Tyr sequence and lacks the unique Phe-Phe bond (45). 

Phrase: "One explanation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0681841:Explanation [Intellectual Product]

Phrase: "might"

Phrase: "be"

Phrase: "the difference in primary sequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "between positions B24-B26"

Phrase: "(Phe-Phe-Tyr"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041484:TYR [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0041485:TYR [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C1421250:TYR [Gene or Genome]
   734   C0070662:Phe-Phe [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "of the insulin B chain"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C3179172:Insulin B Chain [Amino Acid, Peptide, or Protein,Hormone]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0337112:Chain [Manufactured Object]
   827   C1524075:Chain [Idea or Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "the corresponding positions 23-25"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0450348:23 [Quantitative Concept]
   812   C0733755:positions [Spatial Concept]
   729 E C0240795:POSITIONAL [Finding]

Phrase: "(Phe-Tyr-Phe) of IGF-I,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0070662:Phe-Phe [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a simple inversion of the insulin Phe-Tyr sequence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C2718060:Sequence Inversion [Cell or Molecular Dysfunction]
   742   C0021943:Inversion [Cell or Molecular Dysfunction]
   742   C0021945:Inversion [Anatomical Abnormality]
   742   C1705687:Inversion [Cell or Molecular Dysfunction]
   742   C2349984:Inversion [Spatial Concept]

Phrase: "and"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the unique Phe-Phe bond"

Phrase: "(45"

Phrase: ")."
Processing 00000000.tx.312: The present studies indicate that internalized insulin is a physiological substrate for the endosomal protease cathepsin D.

Phrase: "The present studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that internalized insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a physiological substrate for the endosomal protease cathepsin D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1710236:Substrate [Manufactured Object]
Processing 00000000.tx.313: Cathepsin D has been identified in endosomes of rabbit alveolar macrophages by biosynthetic studies and affinity chromatography purification (46), in hepatic endosomes by Western blotting (5, 32) and immunocytochemistry (33), in multivesicular endosomes of macrophages (47) and B-lymphoblastoid cells (48) by immunocytochemistry, and in the late endosomal Rab7-containing compartment by flow cytometric sorting (49). 

Phrase: "Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "identified in endosomes of rabbit alveolar macrophages"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0085236:Macrophages, Alveolar [Cell]
   748   C0024432:Macrophages [Cell]
   748   C0034493:Rabbit [Mammal]
   748   C0034850:Endosomes [Cell Component]
   748   C0205396:Identified [Qualitative Concept]
   748   C1440080:Alveolar [Body Part, Organ, or Organ Component]
   748   C1546706:Macrophages [Intellectual Product]
   748   C1550043:Identified [Finding]
   748   C1550652:Macrophages [Body Substance]
   748   C1551388:Identified [Functional Concept]

Phrase: "by biosynthetic studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "affinity chromatography purification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0008551:affinity purification [Laboratory Procedure]
           Chromatography, Affinity
   827   C0243114:purification [Functional Concept]
   827   C1998793:Purification [Functional Concept]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "in hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "by Western blotting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   983 E C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "32"

Phrase: ")"

Phrase: "and"

Phrase: "immunocytochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "in multivesicular endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0230825:multivesicular endosome [Cell Component]
   861   C0034850:Endosomes [Cell Component]

Phrase: "of macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "(47"

Phrase: ")"

Phrase: "and"

Phrase: "B-lymphoblastoid cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(48"

Phrase: ")"

Phrase: "by immunocytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242349:Immunocytochemistry [Laboratory Procedure]

Phrase: "and in the late endosomal Rab7-containing compartment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0205087:Late [Temporal Concept]
   744   C0332256:Containing [Functional Concept]
   744   C1185625:Compartment [Body Space or Junction]
   744   C1515981:And [Idea or Concept]
   744   C1826758:RAB7 [Gene or Genome]
   744   C2700400:Containing [Activity]
   744   C2986730:Compartment [Spatial Concept]
   735   C1166848:late endosome [Cell Component]

Phrase: "by flow cytometric sorting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0237886:Sorting [Mental Process]
   827   C0700314:sorting [Cell Function]
   827   C1947906:Sorting [Activity]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.314: Consistent with previous studies on the subcellular distribution and molecular species of cathepsins in liver parenchyma (5, 32) and other studies on the biogenesis of cathepsin D (46, 49, 50), the cathepsin D species identified in endosomes consisted of both the inactive precursor and active mature forms. 

Phrase: "Consistent with previous studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "on the subcellular distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0520511:distribution [Idea or Concept]
   861   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "molecular species of cathepsins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705920:Species [Conceptual Entity]

Phrase: "in liver parenchyma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0736268:Liver parenchyma [Body Part, Organ, or Organ Component]
   861   C0933845:Parenchyma [Body Part, Organ, or Organ Component]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "32"

Phrase: ")"

Phrase: "and"

Phrase: "other studies on the biogenesis of cathepsin D"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0947630:studies [Laboratory Procedure]
   711 E C0557651:Study [Manufactured Object]
   711 E C2603343:Study [Research Activity]

Phrase: "(46,"

Phrase: "49,"

Phrase: "50"

Phrase: ")"

Phrase: ","

Phrase: "the cathepsin D species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1705920:Species [Conceptual Entity]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "identified in endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034850:Endosomes [Cell Component]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]

Phrase: "consisted of both"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "the inactive precursor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709634:Precursor [Idea or Concept]

Phrase: "and"

Phrase: "active mature forms."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]
Processing 00000000.tx.315: These data suggest that significant processing of lysosomal hydrolases may occur within endosomes (46). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that significant processing of lysosomal hydrolases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]

Phrase: "may"

Phrase: "occur within endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034850:Endosomes [Cell Component]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.316: The molecular mechanisms responsible for targeting and retaining cathepsin D and its proform in endosomes are not clear. 

Phrase: "The molecular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for targeting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "and"

Phrase: "retaining cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "its proform in endosomes"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.317: Morphological and biochemical analyses, which focused on the localization and targeting of the cation-independent mannose 6-phosphate receptor (CI-MPR) in stable BHK cell lines and one of its ligands, cathepsin D, have shown that a significant fraction of CI-MPR and cathepsin D traffic from the trans-Golgi network to late endosomes/lysosomes via early endosomes (51). 

Phrase: "Morphological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0543482:morphological [Spatial Concept]
   928 E C0332437:Morphology [Qualitative Concept]
   928 E C0700329:Morphology, NOS [Finding]
   928 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "biochemical analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "which"

Phrase: "focused on the localization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205234:Focused [Spatial Concept]
   770   C0475264:Localisation [Functional Concept]
   770   C1285542:focused [Functional Concept]
   770   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "targeting of the cation-independent mannose 6-phosphate receptor (CI-MPR)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   742   C1521840:Targeting [Functional Concept]
   716   C1334090:MANNOSE 6-PHOSPHATE RECEPTOR, CATION-INDEPENDENT [Gene or Genome]
   716   C1334189:Cation-Independent Mannose-6 Phosphate Receptor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Receptor]
   708 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "in stable BHK cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598091:stable cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "one of its ligands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "a significant fraction of CI-MPR"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1264633:Fraction of [Quantitative Concept]
           Fraction
   739   C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "cathepsin D traffic from the trans-Golgi network"

Phrase: "to late endosomes/lysosomes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0024369:Lysosomes [Cell Component]
   793 E C2984253:Lysosome [Functional Concept]
   743 E C0521450:Lysosomal [Body Location or Region]
   717   C1166848:late endosome [Cell Component]

Phrase: "via early endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0887883:Early endosome [Cell Component]
   861   C0034850:Endosomes [Cell Component]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.318: Alternatively, mannose 6-phosphate receptor-independent membrane association of cathepsin D has been reported within acidic endosomes in macrophages (46), in HepG2 cells (50), in human B-lymphocytes (52), and in NIH 3T3 mouse fibroblasts (53). 

Phrase: "Alternatively,"

Phrase: "mannose 6-phosphate receptor-independent membrane association of cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "has"

Phrase: "been"

Phrase: "reported within acidic endosomes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0001128:Acidic [Chemical]
   770   C0034850:Endosomes [Cell Component]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "in macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "(46"

Phrase: ")"

Phrase: ","

Phrase: "in HepG2 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2717940:HepG2 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(50"

Phrase: ")"

Phrase: ","

Phrase: "in human B-lymphocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0004561:B-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]

Phrase: "(52"

Phrase: ")"

Phrase: ","

Phrase: "and in NIH 3T3 mouse fibroblasts"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1257739:NIH/3T3 [Cell]
   783   C1513843:NIH Mouse [Mammal]
   773   C1522260:Mouse Fibroblast [Cell]
   753   C0016030:Fibroblasts [Cell]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C0027468:NIH [Health Care Related Organization]
   753   C1515981:And [Idea or Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.319: In the present study, we provide also the first evidence for endosomal compartmentalization of the recently identified -secretase protein BACE in hepatocytes. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "also"

Phrase: "the first evidence for endosomal compartmentalization of the recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "identified -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "secretase protein BACE in hepatocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1412727:BACE [Gene or Genome]
Processing 00000000.tx.320: By immunoblot analysis, we confirmed earlier biochemical and immunofluorescence studies that had localized BACE to endosomes, one of several intracellular sites where amyloid is thought to be produced (28). 

Phrase: "By immunoblot analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "earlier biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "that"

Phrase: "had"

Phrase: "localized BACE to endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1412727:BACE [Gene or Genome]

Phrase: "one of several intracellular sites where amyloid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "produced"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.321: The accumulation of BACE in the endosomal system appears to be governed largely by a cytoplasmic dileucine motif (16). 

Phrase: "The accumulation of BACE"

Phrase: "in the endosomal system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "governed"

Phrase: "largely by a cytoplasmic dileucine motif"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010834:Cytoplasmic [Cell Component]
   753   C0521449:Cytoplasmic [Body Location or Region]
   753   C1514562:Motif [Amino Acid Sequence]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.322: Although the evidence is quite compelling that BACE is the -secretase in Alzheimer's disease (16, 28, 30), it has not been established whether other soluble or membrane-bound proteins, related or not to -amyloid precursor protein, are subject to endosomal cleavage by BACE. 

Phrase: "Although"

Phrase: "the evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "is"

Phrase: "quite"

Phrase: "compelling"

Phrase: "that BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "is"

Phrase: "the -secretase in Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0171484:secretase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(16,"

Phrase: "28,"

Phrase: "30"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "whether"

Phrase: "other soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "or"

Phrase: "membrane-bound proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "or"

Phrase: "not to -amyloid precursor protein,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   884   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   853   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0011560:Amyloid [Pathologic Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1709634:Precursor [Idea or Concept]

Phrase: "are subject to endosomal cleavage"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C0681850:Subject [Group]
   760   C1330957:cleavage [Cell Function]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1551058:Are [Quantitative Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]

Phrase: "by BACE."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]
Processing 00000000.tx.323: The previously reported transmembrane property of BACE (30), confirmed by us in this study, provides evidence against a role for BACE in the proteolysis of free insulin within the endosomal lumen. 

Phrase: "The previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "transmembrane property of BACE (30"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0871161:Property [Qualitative Concept]
   760   C1882134:Property [Conceptual Entity]
   760   C2347695:Property [Entity]

Phrase: ")"

Phrase: ","

Phrase: "confirmed by us"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence against a role"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "for BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "in the proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "of free insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0523720:free insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "within the endosomal lumen."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   964   C1179919:endosome lumen [Cell Component]
   861   C0524461:Lumen [Body Space or Junction]
   861   C1282864:Lumen [Body Space or Junction]
   861   C1301906:Lumen [Qualitative Concept]
   861   C1551056:Lumen [Quantitative Concept]
   789 E C0524462:Luminal [Spatial Concept]
Processing 00000000.tx.324: However, the type-I integral membrane protein BACE may be a good candidate protease for the endosomal degradation of membrane-associated peptides. 

Phrase: "However,"

Phrase: "the type-I integral membrane protein BACE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1412727:BACE [Gene or Genome]

Phrase: "may"

Phrase: "be"

Phrase: "a good candidate protease for the endosomal degradation of membrane-associated peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   736   C1947941:Protease [Enzyme]
Processing 00000000.tx.325: Our present work combined with our previous studies that provided the first evidence for endosomal compartmentalization of cathepsin B in hepatocytes (5, 7) is in total agreement with other studies suggesting that 20-40% of newly synthesized lysosomal hydrolases can be detected in early endosomes (54). 

Phrase: "Our present work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043227:Work [Occupational Activity]

Phrase: "combined with our previous studies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205156:Previous [Temporal Concept]
   760   C0205195:Combined [Qualitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1552607:previous [Temporal Concept]
   726 E C0336789:Combine [Manufactured Object]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the first evidence for endosomal compartmentalization of cathepsin B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0227525:Hepatocytes [Cell]
   966 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: ")"

Phrase: "is in total agreement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C0680240:Agreement [Social Behavior]

Phrase: "with other studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 20-40% of newly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439509:/40 [Temporal Concept]
   760   C0750546:newly [Idea or Concept]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "lysosomal hydrolases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020289:Hydrolases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "can"

Phrase: "be"

Phrase: "detected in early endosomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   816   C0887883:Early endosome [Cell Component]
   770   C0034850:Endosomes [Cell Component]
   770   C0442726:Detected [Finding]
   770   C1279919:Early [Temporal Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.326: Recently, cell fractionation studies performed on stable BHK cell lines reveal cathepsin D comigration with Rab5 and EEA1, established markers of early endosomes, as well as the sensitivity of cathepsin D to horseradish peroxidase/diaminobenzidine-mediated cross-linking of endosomal proteins (51). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "cell fractionation studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0007593:Cell Fractionation [Laboratory Procedure]

Phrase: "performed on stable BHK cell lines"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   804   C0598091:stable cell line [Cell]
   790   C0007600:Cell lines [Cell]
   753   C0007634:Cell [Cell]
   753   C0205132:lines [Spatial Concept]
   753   C0205360:Stable [Qualitative Concept]
   753   C0884358:Performed [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1547311:Stable [Intellectual Product]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719 E C1550648:Line [Substance]
   719 E C1552960:Line [Quantitative Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "cathepsin D comigration with Rab5"

Phrase: "and"

Phrase: "EEA1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414266:EEA1 [Gene or Genome]

Phrase: "established markers of early endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0005516:Marker [Clinical Attribute]

Phrase: "as well as"

Phrase: "the sensitivity of cathepsin D"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to horseradish peroxidase/diaminobenzidine-mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0086597:mediated [Social Behavior]
   812   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "cross-linking of endosomal proteins"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   764   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.327: Our immunofluorescence studies confirm that a small amount of cathepsin D can be detected in early endocytic EEA1-positive vesicles. 

Phrase: "Our immunofluorescence studies"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "a small amount of cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "detected in early endocytic EEA1-positive vesicles."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   774   C0887883:Endocytic Vesicles [Cell Component]
   748   C0333262:VESICLES [Acquired Abnormality]
   748   C0439178:% Positive [Quantitative Concept]
   748   C0442726:Detected [Finding]
   748   C1279919:Early [Temporal Concept]
   748   C1414266:EEA1 [Gene or Genome]
   748   C1446409:Positive [Qualitative Concept]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1514241:Positive [Finding]
   748   C2825490:Positive [Qualitative Concept]
   714 E C1622418:vesicle [Cell Component]
Processing 00000000.tx.328: In the study of Press et al. 

Phrase: "In the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of Press et al."
Processing 00000000.tx.329: (51), the potential significance of cathepsin D delivery to early endosomes is discussed in light of its involvement in cellular growth control and differentiation. 

Phrase: "(51"

Phrase: ")"

Phrase: ","

Phrase: "the potential significance of cathepsin D delivery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237881:Significance [Quantitative Concept]
   748   C0750502:Significance [Idea or Concept]

Phrase: "to early endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0887883:Early endosome [Cell Component]
   861   C0034850:Endosomes [Cell Component]

Phrase: "is"

Phrase: "discussed in light of its involvement"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C1306462:Light [Functional Concept]
   753   C1314939:Involvement [Functional Concept]
   753   C1881376:Light [Qualitative Concept]

Phrase: "in cellular growth control"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   901   C0007595:Cellular Growth [Cell Function]
   827   C0007634:Cellular [Cell]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0178539:Cellular [Functional Concept]
   827   C0220844:growth [Physiologic Function]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C2911660:Growth [Activity]
   827   C3274648:Control [Qualitative Concept]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.330: Indeed, increased extracellular levels of various cathepsins, especially cathepsins D and B, have been correlated to metastasis and a number of human tumors (55). 

Phrase: "Indeed,"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "extracellular levels of various cathepsins,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "especially cathepsins D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "correlated to metastasis"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   822   C0036525:Metastatic to [Functional Concept]
       E   Metastatic
   790   C0027627:Metastasis [Neoplastic Process]
   790   C1707520:Correlated [Qualitative Concept]
   790   C2939420:metastasis [Neoplastic Process]
   718 E C1522484:metastatic [Quantitative Concept]

Phrase: "and"

Phrase: "a number of human tumors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0475450:Number of tumors [Quantitative Concept]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.331: Thus, endosomal cathepsin D may modulate the amount of these molecules delivered to the cell surface versus the amount transported toward lysosomes (51). 

Phrase: "Thus,"

Phrase: "endosomal cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the amount of these molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "delivered to the cell surface"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705822:Delivered [Activity]
   760   C1948049:Cell [Spatial Concept]
   726 E C0308779:DELIVER [Organic Chemical,Pharmacologic Substance]
   726 E C1874964:DELIVER [Pharmacologic Substance]

Phrase: "versus"

Phrase: "the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "transported toward lysosomes"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   799   C1156063:lysosomal transport [Cell Function]
   790   C0024369:Lysosomes [Cell Component]
   756   C0005528:Transport, NOS [Cell Function]
   756   C1317949:Transport [Manufactured Object]
   756 E C2984253:Lysosome [Functional Concept]
   756   C3495449:transport [Medical Device]
   706 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.332: Even cell death was recently shown to be influenced by endosomal/lysosomal cathepsin D in a study showing its involvement in cell apoptosis induced by oxidative stress (56). 

Phrase: "Even cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "influenced by endosomal/lysosomal cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1332805:CATHEPSIN D [Gene or Genome]
   753   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0521450:Lysosomal [Body Location or Region]

Phrase: "in a study showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1547282:Show [Intellectual Product]

Phrase: "its involvement in cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by oxidative stress"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0205263:Induced [Functional Concept]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.333: Our studies provide important clues regarding another function of endosomal cathepsin D related to the proteolysis of internalized ligands, with the subsequent regulation of intracellular receptor signaling and trafficking at the endosomal locus (1, 3, 5). 

Phrase: "Our studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "important clues"

Phrase: "regarding"

Phrase: "another function of endosomal cathepsin D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "related to the proteolysis of internalized ligands,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0023688:Ligands [Chemical]
   748   C0439849:Related [Qualitative Concept]
   748   C0445223:Related [Finding]
   748   C0597304:Proteolysis [Molecular Function]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "with the subsequent regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "of intracellular receptor signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514762:Receptor Signaling [Molecular Function]
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "trafficking at the endosomal locus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0599896:trafficking [Cell Function]
   760   C1708726:Locus [Gene or Genome]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.334: Cathepsin D induces the proteolytic cleavage of several other polypeptide hormones, proteins, and plant toxins within endocytic vesicles. 

Phrase: "Cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the proteolytic cleavage of several"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0010813:cleavage [Cell Function]
   760   C0596311:Cleavage [Phenomenon or Process]
   760   C1330957:cleavage [Cell Function]

Phrase: "other polypeptide hormones,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0312439:Polypeptide Hormones [Amino Acid, Peptide, or Protein,Hormone]
   861   C0019932:Hormones [Hormone]
   777 E C0458083:Hormonal [Qualitative Concept]

Phrase: "proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "plant toxins within endocytic vesicles."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0032086:plant toxins [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]
   760   C0032098:Plant [Plant]
   760   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]
Processing 00000000.tx.335: Thus, we have previously reported that internalized glucagon is partially processed within hepatic endosomes by the endopeptidase activity of cathepsin D (5). 

Phrase: "Thus,"

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that internalized glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "partially"

Phrase: "processed within hepatic endosomes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C1522240:Processed [Phenomenon or Process]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "by the endopeptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150171:endopeptidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.336: Also, proteolysis of mannose-bovine serum albumin and parathyroid hormone-(1-84), with the subsequent release of the bioactive peptide parathyroid hormone-(1-34), was primarily mediated by cathepsin D within macrophage endosomes (6). 

Phrase: "Also,"

Phrase: "proteolysis of mannose-bovine serum albumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "and"

Phrase: "parathyroid hormone-"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0030520:Parathyroid Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1882913:PARATHYROID HORMONE [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C3536885:Parathyroid Hormone [Pharmacologic Substance]
   861   C0019932:Hormone [Hormone]
   861   C0030518:Parathyroid, NOS [Body Part, Organ, or Organ Component]
   789 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(1-84"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "with the subsequent release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of the bioactive peptide parathyroid hormone-"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   875   C0597192:peptide hormone [Amino Acid, Peptide, or Protein,Hormone]
   875   C1149477:peptide hormone [Molecular Function]
   861   C0030520:Parathyroid Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1882913:PARATHYROID HORMONE [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C3536885:Parathyroid Hormone [Pharmacologic Substance]
   812   C0019932:Hormone [Hormone]
   812   C0030518:Parathyroid, NOS [Body Part, Organ, or Organ Component]
   741 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(1-34"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "primarily"

Phrase: "mediated by cathepsin D"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "within macrophage endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.337: The participation of cathepsin D in the endosomal processing, membrane translocation, and cytotoxicity of ricin A chain has also been demonstrated (10). 

Phrase: "The participation of cathepsin D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0679823:Participation [Functional Concept]

Phrase: "in the endosomal processing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "membrane translocation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040715:Translocation [Cell or Molecular Dysfunction]
   861   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "cytotoxicity of ricin A chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.338: Studies have also suggested the potential role of cathepsin D in conjunction with cathepsins S and L in degrading the invariant chain and endocytosed antigens within antigen-presenting cells (57). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the potential role of cathepsin D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in conjunction with cathepsins S"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0054874:cathepsin S [Amino Acid, Peptide, or Protein,Enzyme]
   983   C1413821:CATHEPSIN S [Gene or Genome]

Phrase: "and"

Phrase: "L in degrading"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439394:l's [Quantitative Concept]
   790   C1706495:L- [Intellectual Product]
   790   C3642217:/L [Quantitative Concept]

Phrase: "the invariant chain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0063356:invariant chain [Amino Acid, Peptide, or Protein]
  1000   C1413237:INVARIANT CHAIN [Gene or Genome]
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "endocytosed antigens within antigen-presenting cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   809   C0003315:Antigen-Presenting Cells [Cell]
   753   C0003320:Antigens [Immunologic Factor]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.339: Finally, some properties associated with cathepsin D favor its putative role in the amyloidogenic processing of -amyloid precursor protein within the endo-lysosomal compartment (43, 58). 

Phrase: "Finally,"

Phrase: "some properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]

Phrase: "associated with cathepsin D"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1332805:CATHEPSIN D [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "its putative role in the amyloidogenic processing of -amyloid precursor protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "within the endo-lysosomal compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185625:Compartment [Body Space or Junction]
   827   C2986730:Compartment [Spatial Concept]

Phrase: "(43,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.340: In this study, we have shown that in vivo administration of pepstatin A, a compound that inhibits endosomal degradation of insulin in vitro, was without apparent effect on the level of insulin receptors present in endosomes but induced a more prolonged tyrosine autophosphorylation of the insulin receptor -subunit. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that in vivo administration of pepstatin A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "a compound"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205198:Compound [Qualitative Concept]
  1000   C1706082:Compound [Chemical]

Phrase: "that"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "endosomal degradation of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C3547574:insulin degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "was without apparent effect"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0750489:apparent [Idea or Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C1421478:WAS [Gene or Genome]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of insulin receptors"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0034818:Receptors, Insulin [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   966 E C1334133:INSULIN RECEPTOR [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "present in endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034850:Endosomes [Cell Component]
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "but"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a more prolonged tyrosine autophosphorylation of the insulin receptor -subunit."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C3271785:tyrosine autophosphorylation [Molecular Function]
   739   C0813988:autophosphorylation [Molecular Function]
Processing 00000000.tx.341: The concentration of pepstatin A required to demonstrate this same phenomenon in vitro was in the order of 1g/ml and induced a complete inhibitory effect. 

Phrase: "The concentration of pepstatin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "this same phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "was in the order of 1g/ml"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0043194:WAS [Disease or Syndrome]
   748   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C1421478:WAS [Gene or Genome]
   748   C1705175:Order [Intellectual Product]
   748   C1705176:Order [Qualitative Concept]
   748   C1705177:Order [Classification]
   748   C1705178:Order [Activity]
   748   C1882348:Order [Qualitative Concept]

Phrase: "and"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a complete inhibitory effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.342: The modest effect of pepstatin A observed in vivo probably reflects its low degree of cell and organelle penetrance (59, 60) and also its inability to affect the dissociation of internalized insulin from its endosomal receptor, which attenuates any further ligand-driven receptor re-phosphorylation (3). 

Phrase: "The modest effect of pepstatin A observed in vivo probably"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C1515655:In Vivo [Spatial Concept]
           vivo
   739   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0750492:Probably [Idea or Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C1441672:Observed [Functional Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "its low degree of cell"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "and"

Phrase: "organelle penetrance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0524899:Penetrance [Quantitative Concept]

Phrase: "(59,"

Phrase: "60"

Phrase: ")"

Phrase: "and"

Phrase: "also"

Phrase: "its inability to"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the dissociation of internalized insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from its endosomal receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "which"

Phrase: "attenuates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuate [Activity]

Phrase: "any further ligand-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "driven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013126:Drive [Mental Process]

Phrase: "receptor re-phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
   827   C2986904:RE [Idea or Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.343: Moreover, after intravenous administration in rats, pepstatin A is rapidly cleared from the blood by the kidneys (61), confirming that it requires very high concentrations to be effective in vivo (60). 

Phrase: "Moreover,"

Phrase: "after"

Phrase: "intravenous administration in rats,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0013125:intravenous administration [Spatial Concept]
   833   C0021440:intravenous administration [Therapeutic or Preventive Procedure]
   770   C0001554:Administration [Occupational Activity]
   770   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "pepstatin A"

Phrase: "is"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "cleared from the blood"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0229664:Blood [Body Substance]
   770   C0521097:cleared [Functional Concept]
   737 E C2963144:Clear [Qualitative Concept]

Phrase: "by the kidneys"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0022646:Kidneys [Body Part, Organ, or Organ Component]
  1000   C0227665:kidneys [Body Part, Organ, or Organ Component]
   966 E C1278978:Kidney [Body Part, Organ, or Organ Component]
   966 E C1514845:KIDNEY [Tissue]
   900 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(61"

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "requires"

Phrase: "very high concentrations to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0086045:Concentrations [Mental Process]
   779 E C1446561:Concentration [Quantitative Concept]
   729 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "be"

Phrase: "effective in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.344: Consequently, because cells are rather impermeable to pepstatin A, it was necessary to treat rats with high concentrations (>1 mg) in the presence of Me2SO to obtain effective intracellular concentrations. 

Phrase: "Consequently,"

Phrase: "because"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "rather impermeable to pepstatin A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "it"

Phrase: "was"

Phrase: "necessary to"

Phrase: "treat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292734:TREAT [Functional Concept]
  1000   C1522326:Treat [Functional Concept]

Phrase: "rats with high concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]

Phrase: "("

Phrase: ">1 mg) in the presence of Me2SO to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439269:mg% [Quantitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "effective intracellular concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.345: The development of specific and potent inhibitors of CD activity will greatly advance the elucidation of the function of the endosomal proteolysis of internalized insulin. 

Phrase: "The development of specific"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "and"

Phrase: "potent inhibitors of CD activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "will"

Phrase: "greatly"

Phrase: "advance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725066:Advance [Medical Device]

Phrase: "the elucidation of the function of the endosomal proteolysis of internalized insulin."
Processing 00000000.tx.346: Some studies point out that the defects in the metabolism of intracellular insulin observed in non-insulin-dependent diabetes mellitus could be localized within the endosomal apparatus and are caused mainly by a defective acidification of its interior (62, 63). 

Phrase: "Some studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "point"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552961:Point [Quantitative Concept]
  1000   C2347617:point [Quantitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "that"

Phrase: "the defects in the metabolism of intracellular insulin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0243067:defects [Functional Concept]
   711 E C1457869:Defect [Functional Concept]
   711 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "observed in non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   897   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   897   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   853   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   778   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1518422:Non [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "localized within the endosomal apparatus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243111:apparatus [Manufactured Object]
   760   C0392752:Localized [Spatial Concept]
   760   C1947951:Apparatus [Anatomical Structure]

Phrase: "and"

Phrase: "are"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "mainly by a defective acidification of its interior"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332452:Defective [Functional Concept]
   744   C1522821:acidification [Cell Function]
   744   C2987513:Acidification [Phenomenon or Process]

Phrase: "(62,"

Phrase: "63"

Phrase: ")."
Processing 00000000.tx.347: Studies are under way to determine whether the pathological decrease in endosomal proteolysis of insulin observed in non-insulin-dependent diabetes mellitus may also be caused by alterations in the endosomal targeting or activity of the pepstatin A-sensitive CD activity.  

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "under way to"

Phrase: "determine"

Phrase: "whether"

Phrase: "the pathological decrease in endosomal proteolysis of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "observed in non-insulin-dependent diabetes mellitus"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   897   C0011860:Diabetes Mellitus, Non-Insulin-Dependent [Disease or Syndrome]
           Non-Insulin Dependent Diabetes
   897   C2697407:DIABETES MELLITUS, NONINSULIN-DEPENDENT [Gene or Genome]
   853   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   778   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1518422:Non [Functional Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "caused by alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0015127:cause [Functional Concept]
   756   C1515926:Alteration [Idea or Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "in the endosomal targeting"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1521840:Targeting [Functional Concept]
   827 E C2986546:TARGET [Diagnostic Procedure]

Phrase: "or"

Phrase: "activity of the pepstatin A-sensitive CD activity."
Processing 00000000.tx.348: ACKNOWLEDGEMENTS We thank Pamela H.

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Pamela H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.349: Cameron (McGill University, Montreal, Quebec, Canada) for reviewing the manuscript. 

Phrase: "Cameron"

Phrase: "(McGill University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Montreal,"

Phrase: "Quebec,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034390:Quebec [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "for reviewing"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0282443:reviewing [Intellectual Product]
  1000   C1704362:Reviewing [Qualitative Concept]
   966 E C1552617:Review [Idea or Concept]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.350: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.351: R.A.Roth (Stanford University, Stanford, CA), Dr. 

Phrase: "R.A.Roth"

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA),"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.352: J.S.Mort (Shriners Hospital for Crippled Children, Montreal, Quebec, Canada), Dr. 

Phrase: "J.S.Mort (Shriners Hospital for Crippled Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0020017:Children's hospital [Health Care Related Organization]
   744   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   744   C1510665:Hospital [Qualitative Concept]

Phrase: "Montreal,"

Phrase: "Quebec,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034390:Quebec [Geographic Area]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.353: R.W.Doms (University of Pennsylvania, Philadelphia, PA) for kind gifts of anti-insulin-degrading enzyme, -cathepsins, and -BACE antibodies, respectively. 

Phrase: "R.W.Doms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C3539821:DOM [Gene or Genome]

Phrase: "(University of Pennsylvania,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030853:Pennsylvania [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Philadelphia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031525:Philadelphia [Geographic Area]

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for kind gifts"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1136188:Gifts [Entity]
   777 E C0423899:Gifted [Finding]

Phrase: "of anti-insulin-degrading enzyme, -"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "cathepsins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "BACE antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "respectively."
Processing 00000000.tx.354: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.355: F.Daniel and P.Perron (U327 INSERM, Paris, France) for assistance in the preparation of primary hepatocytes. 

Phrase: "F.Daniel"

Phrase: "and"

Phrase: "P.Perron"

Phrase: "(U327 INSERM,"

Phrase: "Paris,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030561:Paris [Geographic Area]
  1000   C0331677:Paris [Plant]
  1000   C1824032:PARIS [Gene or Genome]
   966 E C1824369:PARI [Gene or Genome]

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "for assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018896:Assistance [Social Behavior]

Phrase: "in the preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]

Phrase: "of primary hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.356: We thank Dr. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.357: V.

Phrase: "V."
Processing 00000000.tx.358: Nicolas (IFR 75INSERM, Facult de Pharmacie, Chtenay-Malabry, France) for assistance in confocal microscopy.  

Phrase: "Nicolas"

Phrase: "(IFR 75INSERM,"

Phrase: "Facult de Pharmacie,"

Phrase: "Chtenay-Malabry,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "for assistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018896:Assistance [Social Behavior]

Phrase: "in confocal microscopy."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0242842:Microscopy, Confocal [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
Processing 00000000.tx.359: FOOTNOTES * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.360: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.361: Section 1734solely to indicate this fact.  

Phrase: "Section 1734solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.362: To whom correspondence should be addressed: INSERM U510, Facult de Pharmacie Paris XI, 5rue Jean-Baptiste Clment, 92296Chtenay-Malabry, France. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "INSERM U510,"

Phrase: "Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "5rue Jean-Baptiste Clment,"

Phrase: "92296Chtenay-Malabry,"

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.363: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.364: 33.1.46835843; 

Phrase: "33.1.46835843"

Phrase: ";"
Processing 00000000.tx.365: Fax: 33.1.46835844; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "33.1.46835844"

Phrase: ";"
Processing 00000000.tx.366: E-mail: francois.authier@cep.u-psud.fr. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "francois.authier@cep.u-psud.fr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C2348513:Fr. [Conceptual Entity]
   799   C3538902:FR [Gene or Genome]
Processing 00000000.tx.367: Published, JBC Papers in Press, January 4,2002,DOI 10.1074/jbc.M110188200  ABBREVIATIONS The abbreviations used are: IGF-I, insulin-like growth factor I; 

Phrase: "Published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ","

Phrase: "JBC Papers in Press,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0030351:Papers [Manufactured Object]
   737 E C1547566:Paper [Idea or Concept]

Phrase: "January 4,"

Phrase: "2002,"

Phrase: "DOI 10.1074/jbc.M110188200  ABBREVIATIONS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0000723:Abbreviations [Intellectual Product]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "IGF-I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:IGF I [Gene or Genome]
   861   C0021966:I- [Inorganic Chemical]
   861   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "insulin-like growth factor I"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
  1000   C0021665:Insulin-Like Growth Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1334089:INSULIN-LIKE GROWTH FACTOR I [Gene or Genome]
   937   C0037657:Insulin-like growth factor [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   937   C1753359:insulin-like growth factor [Molecular Function]
   870   C3180941:Iletin I [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   840   C0016006:Factor I [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0018270:'growth' NOS [Organism Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0021966:I- [Inorganic Chemical]
   804   C0220844:growth [Physiologic Function]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1521761:Factor [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1621966:Growth [Organ or Tissue Function]
   804   C2827422:Factor [Conceptual Entity]
   804   C2911660:Growth [Activity]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.368: BACE, -site amyloid precursor protein-cleaving enzyme; 

Phrase: "BACE, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412727:BACE [Gene or Genome]

Phrase: "site amyloid precursor protein-"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   923   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   875   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1709634:Precursor [Idea or Concept]

Phrase: "cleaving"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: ";"
Processing 00000000.tx.369: EAI, endosomal acidic insulinase; 

Phrase: "EAI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: "endosomal acidic insulinase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021669:Insulinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415875:INSULINASE [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.370: EEA1, early endosome antigen 1; 

Phrase: "EEA1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414266:EEA1 [Gene or Genome]

Phrase: "early endosome antigen 1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0298073:early endosome antigen 1 [Amino Acid, Peptide, or Protein,Receptor]
  1000   C1414266:EARLY ENDOSOME ANTIGEN 1 [Gene or Genome]
   861   C0887883:Early endosome [Cell Component]
   812   C0003320:Antigen [Immunologic Factor]
   812   C0034850:Endosome [Cell Component]
   812   C1279919:Early [Temporal Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: ";"
Processing 00000000.tx.371: ENs, soluble endosomal extract; 

Phrase: "ENs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "soluble endosomal extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828366:Extract [Substance]

Phrase: ";"
Processing 00000000.tx.372: HI, human insulin; 

Phrase: "HI,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0018619:HI [Geographic Area]
  1000   C0239849:HI [Congenital Abnormality,Disease or Syndrome]
  1000   C1412082:HI [Gene or Genome]
  1000   C1412316:HI [Gene or Genome]

Phrase: "human insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.373: RP HPLC, reverse-phase high pressure liquid chromatography; 

Phrase: "RP HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "reverse-phase high pressure liquid chromatography"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   913   C2717789:Reverse-Phase Liquid Chromatography [Laboratory Procedure]
   904   C0597410:Chromatography, Reverse-Phase [Laboratory Procedure]
   901   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   827   C0008565:Liquid Chromatography [Laboratory Procedure]
   799   C0008550:Chromatography [Laboratory Procedure]
   799   C0033095:Pressure [Phenomenon or Process]
   799   C0205250:High [Qualitative Concept]
   799   C0302908:Liquid [Substance]
   799   C0460139:Pressure [Finding]
   799   C1299351:High [Qualitative Concept]
   799   C1304698:Liquid [Finding]
   799   C1306345:Pressure [Functional Concept]
   799   C1546699:Liquid NOS [Intellectual Product]
   799   C1561501:Liquid NOS [Substance]
   799   C2700149:HIGH [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.374: CD, cathepsin D; 

Phrase: "CD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.375: PBS, phosphate-buffered saline.  

Phrase: "PBS,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.376: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.377: Authier, F., Posner, B. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.378: I., and Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.379: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.380: (1996) FEBS Lett. 

Phrase: "(1996"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.381: 389, 55-60[CrossRef][Medline] [OrderarticleviaInfotrieve] 2. 

Phrase: "389,"

Phrase: "55-60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.382: Authier, F., Rachubinski, R. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rachubinski,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.383: A., Posner, B. 

Phrase: "A.,"

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.384: I., and Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.385: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.386: (1994) J. 

Phrase: "(1994"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.387: Biol. 

Phrase: "Biol."
Processing 00000000.tx.388: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.389: 269, 3010-3016[Abstract/Free FullText] 3. 

Phrase: "269,"

Phrase: "3010-3016"

Phrase: "[Abstract/Free FullText"

Phrase: "] 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.390: Authier, F., Di, Guglielmo, G. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "Guglielmo,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.391: M., Danielsen, G. 

Phrase: "M."

Phrase: ","

Phrase: "Danielsen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.392: M., and Bergeron, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.393: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.394: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.395: J. 

Phrase: "J."
Processing 00000000.tx.396: 332, 421-430[Medline] [OrderarticleviaInfotrieve] 4. 

Phrase: "332,"

Phrase: "421-430"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 4."
Processing 00000000.tx.397: Desbuquois, B., Janicot, M., and Dupuis, A. 

Phrase: "Desbuquois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Janicot,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Dupuis,"

Phrase: "A."
Processing 00000000.tx.398: (1990) Eur. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.399: J.

Phrase: "J."
Processing 00000000.tx.400: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.401: 193, 501-512[Abstract] 5. 

Phrase: "193,"

Phrase: "501-512"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.402: Authier, F., Mort, J. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mort,"

Phrase: "J."
Processing 00000000.tx.403: S., Bell, A. 

Phrase: "S."

Phrase: ","

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "A."
Processing 00000000.tx.404: W., Posner, B. 

Phrase: "W., Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.405: I., and Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.406: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.407: (1995) J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.408: Biol. 

Phrase: "Biol."
Processing 00000000.tx.409: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.410: 270, 15798-15807[Abstract/Free FullText] 6. 

Phrase: "270,"

Phrase: "15798-15807"

Phrase: "[Abstract/Free FullText"

Phrase: "] 6."
Processing 00000000.tx.411: Diment, S., Martin, K. 

Phrase: "Diment,"

Phrase: "S."

Phrase: ","

Phrase: "Martin,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.412: J., and Stahl, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Stahl,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.413: D. 

Phrase: "D."
Processing 00000000.tx.414: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.415: Biol. 

Phrase: "Biol."
Processing 00000000.tx.416: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.417: 264, 13403-13406[Abstract/Free FullText] 7. 

Phrase: "264,"

Phrase: "13403-13406"

Phrase: "[Abstract/Free FullText"

Phrase: "] 7."
Processing 00000000.tx.418: Authier, F., Mtioui, M., Bell, A. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Mtioui,"

Phrase: "M."

Phrase: ","

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "A."
Processing 00000000.tx.419: W., and Mort, J. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Mort,"

Phrase: "J."
Processing 00000000.tx.420: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.421: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.422: Biol. 

Phrase: "Biol."
Processing 00000000.tx.423: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.424: 274, 33723-33731[Abstract/Free FullText] 8. 

Phrase: "274,"

Phrase: "33723-33731"

Phrase: "[Abstract/Free FullText"

Phrase: "] 8."
Processing 00000000.tx.425: Navab, R., Chevet, E., Authier, F., Di, Guglielmo, G. 

Phrase: "Navab,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Chevet,"

Phrase: "E.,"

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "Guglielmo,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.426: M., Bergeron, J. 

Phrase: "M."

Phrase: ","

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.427: J.M., and Brodt, P. 

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Brodt,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.428: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.429: Biol. 

Phrase: "Biol."
Processing 00000000.tx.430: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.431: 276, 13644-13649[Abstract/Free FullText] 9. 

Phrase: "276,"

Phrase: "13644-13649"

Phrase: "[Abstract/Free FullText"

Phrase: "] 9."
Processing 00000000.tx.432: Chapman, H. 

Phrase: "Chapman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.433: A. 

Phrase: "A."
Processing 00000000.tx.434: (1998) Curr. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Curr."
Processing 00000000.tx.435: Opin. 

Phrase: "Opin."
Processing 00000000.tx.436: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.437: 10, 93-102[CrossRef][Medline] [OrderarticleviaInfotrieve] 10. 

Phrase: "10,"

Phrase: "93-102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 10."
Processing 00000000.tx.438: Blum, J. 

Phrase: "Blum,"

Phrase: "J."
Processing 00000000.tx.439: S., Fiani, M. 

Phrase: "S."

Phrase: ","

Phrase: "Fiani,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: L., and Stahl, P. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Stahl,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.441: D. 

Phrase: "D."
Processing 00000000.tx.442: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.443: Biol. 

Phrase: "Biol."
Processing 00000000.tx.444: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.445: 266, 22091-22095[Abstract/Free FullText] 11. 

Phrase: "266,"

Phrase: "22091-22095"

Phrase: "[Abstract/Free FullText"

Phrase: "] 11."
Processing 00000000.tx.446: Authier, F., Danielsen, G. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Danielsen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.447: M., Kouach, M., Briand, G., and Chauvet, G. 

Phrase: "M."

Phrase: ","

Phrase: "Kouach,"

Phrase: "M."

Phrase: ","

Phrase: "Briand,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Chauvet,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.448: (2001) Endocrinology 142, 276-289[Abstract/Free FullText] 12. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Endocrinology 142,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "276-289"

Phrase: "[Abstract/Free FullText"

Phrase: "] 12."
Processing 00000000.tx.449: Mort, J. 

Phrase: "Mort,"

Phrase: "J."
Processing 00000000.tx.450: S., Poole, A. 

Phrase: "S."

Phrase: ","

Phrase: "Poole,"

Phrase: "A."
Processing 00000000.tx.451: R., and Decker, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Decker,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.452: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.453: (1981) J. 

Phrase: "(1981"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.454: Histochem. 

Phrase: "Histochem."
Processing 00000000.tx.455: Cytochem. 

Phrase: "Cytochem."
Processing 00000000.tx.456: 29, 649-657[Abstract] 13. 

Phrase: "29,"

Phrase: "649-657"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 13."
Processing 00000000.tx.457: Mort, J. 

Phrase: "Mort,"

Phrase: "J."
Processing 00000000.tx.458: S., Recklies, A. 

Phrase: "S."

Phrase: ","

Phrase: "Recklies,"

Phrase: "A."
Processing 00000000.tx.459: D., and Poole, A. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Poole,"

Phrase: "A."
Processing 00000000.tx.460: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.461: (1984) Arthritis Rheum. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Arthritis Rheum."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035431:Rheum [Plant]
Processing 00000000.tx.462: 27, 509-515[Medline] [OrderarticleviaInfotrieve] 14. 

Phrase: "27,"

Phrase: "509-515"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 14."
Processing 00000000.tx.463: Rowan, A. 

Phrase: "Rowan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0330667:Rowan [Plant]

Phrase: "A."
Processing 00000000.tx.464: D., Mason, P., Mach, L., and Mort, J. 

Phrase: "D."

Phrase: ","

Phrase: "Mason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331857:Mason [Health Care Related Organization]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mach,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0667830:MACH [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332667:MACH [Gene or Genome]
  1000   C1705065:MACH [Gene or Genome]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Mort,"

Phrase: "J."
Processing 00000000.tx.465: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.466: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.467: Biol. 

Phrase: "Biol."
Processing 00000000.tx.468: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.469: 267, 15993-15999[Abstract/Free FullText] 15. 

Phrase: "267,"

Phrase: "15993-15999"

Phrase: "[Abstract/Free FullText"

Phrase: "] 15."
Processing 00000000.tx.470: Hughes, C. 

Phrase: "Hughes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551730:Hughes [Population Group]

Phrase: "C."
Processing 00000000.tx.471: E., Caterson, B., White, R. 

Phrase: "E.,"

Phrase: "Caterson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.472: J., Roughley, P. 

Phrase: "J.,"

Phrase: "Roughley,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.473: J., and Mort, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Mort,"

Phrase: "J."
Processing 00000000.tx.474: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.475: (1992) J. 

Phrase: "(1992"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.476: Biol. 

Phrase: "Biol."
Processing 00000000.tx.477: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.478: 267, 16011-16014[Abstract/Free FullText] 16. 

Phrase: "267,"

Phrase: "16011-16014"

Phrase: "[Abstract/Free FullText"

Phrase: "] 16."
Processing 00000000.tx.479: Huse, J. 

Phrase: "Huse,"

Phrase: "J."
Processing 00000000.tx.480: T., Pijak, D. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Pijak,"

Phrase: "D."
Processing 00000000.tx.481: S., Leslie, G. 

Phrase: "S."

Phrase: ","

Phrase: "Leslie,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.482: J., Lee, V. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.483: M.Y., and Doms, R. 

Phrase: "M."

Phrase: "Y.,"

Phrase: "and"

Phrase: "Doms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3539821:DOM [Gene or Genome]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.484: W. 

Phrase: "W."
Processing 00000000.tx.485: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.486: Biol. 

Phrase: "Biol."
Processing 00000000.tx.487: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.488: 275, 33729-33737[Abstract/Free FullText] 17. 

Phrase: "275,"

Phrase: "33729-33737"

Phrase: "[Abstract/Free FullText"

Phrase: "] 17."
Processing 00000000.tx.489: Shii, K., and Roth, R. 

Phrase: "Shii,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Roth,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.490: A. 

Phrase: "A."
Processing 00000000.tx.491: (1986) Proc. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.492: Natl. 

Phrase: "Natl."
Processing 00000000.tx.493: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.494: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.495: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.496: 83, 4147-4151[Abstract] 18. 

Phrase: "83,"

Phrase: "4147-4151"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 18."
Processing 00000000.tx.497: Lowry, O. 

Phrase: "Lowry,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.498: H., Rosebrough, N. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rosebrough,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.499: J., Farr, A. 

Phrase: "J.,"

Phrase: "Farr,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441583:Farr [Laboratory Procedure]

Phrase: "A."
Processing 00000000.tx.500: L., and Randall, R. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Randall,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.501: J. 

Phrase: "J."
Processing 00000000.tx.502: (1951) J. 

Phrase: "(1951"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.503: Biol. 

Phrase: "Biol."
Processing 00000000.tx.504: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.505: 193, 265-275[Free FullText] 19. 

Phrase: "193,"

Phrase: "265-275"

Phrase: "[Free FullText"

Phrase: "] 19."
Processing 00000000.tx.506: Touster, O., Aronson, N. 

Phrase: "Touster,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Aronson,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.507: N., Dulaney, J. 

Phrase: "N., Dulaney,"

Phrase: "J."
Processing 00000000.tx.508: T., and Hendrickson, H. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Hendrickson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.509: (1970) J. 

Phrase: "(1970"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.510: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.511: 47, 604-618[Abstract/Free FullText] 20. 

Phrase: "47,"

Phrase: "604-618"

Phrase: "[Abstract/Free FullText"

Phrase: "] 20."
Processing 00000000.tx.512: Trouet, A. 

Phrase: "Trouet,"

Phrase: "A."
Processing 00000000.tx.513: (1974) Methods Enzymol. 

Phrase: "(1974"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.514: 31, 323-329[Medline] [OrderarticleviaInfotrieve] 21. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "323-329"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 21."
Processing 00000000.tx.515: Authier, F., Janicot, M., Lederer, F., and Desbuquois, B. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Janicot,"

Phrase: "M."

Phrase: ","

Phrase: "Lederer,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Desbuquois,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.516: (1990) Biochem. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.517: J. 

Phrase: "J."
Processing 00000000.tx.518: 272, 703-712[Medline] [OrderarticleviaInfotrieve] 22. 

Phrase: "272,"

Phrase: "703-712"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 22."
Processing 00000000.tx.519: Authier, F., and Desbuquois, B. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Desbuquois,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.520: (1991) Biochem. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.521: J. 

Phrase: "J."
Processing 00000000.tx.522: 280, 211-218[Medline] [OrderarticleviaInfotrieve] 23. 

Phrase: "280,"

Phrase: "211-218"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.523: Authier, F., Desbuquois, B., and De Galle, B. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "De Galle,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.524: (1992) Endocrinology 131, 447-457[Abstract] 24. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Endocrinology 131,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "447-457"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 24."
Processing 00000000.tx.525: Wattiaux, R., Wattiaux-de Coninck, S., Ronveaux-Dupal, M. 

Phrase: "Wattiaux,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wattiaux-de Coninck,"

Phrase: "S."

Phrase: ","

Phrase: "Ronveaux-Dupal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.526: F., and Dubois, F. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Dubois,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.527: (1978) J. 

Phrase: "(1978"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.528: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.529: 78, 349-368[Abstract] 25. 

Phrase: "78,"

Phrase: "349-368"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 25."
Processing 00000000.tx.530: Authier, F., Bergeron, J. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.531: J.M., Ou, W.-J., Rachubinski, R. 

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Ou,"

Phrase: "W.-J.,"

Phrase: "Rachubinski,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: A., Posner, B. 

Phrase: "A.,"

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.533: I., and Walton, P. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Walton,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.534: A. 

Phrase: "A."
Processing 00000000.tx.535: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.536: Natl. 

Phrase: "Natl."
Processing 00000000.tx.537: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.538: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.539: U.S.A. 

Phrase: "U.S.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0041703:U.S.A. [Geographic Area]
           U S
Processing 00000000.tx.540: 92, 3859-3863[Abstract/Free FullText] 26. 

Phrase: "92,"

Phrase: "3859-3863"

Phrase: "[Abstract/Free FullText"

Phrase: "] 26."
Processing 00000000.tx.541: Seglen, P. 

Phrase: "Seglen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.542: O., Gordon, P. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Gordon,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.543: B., and Poli, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Poli,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032400:poli [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0071360:poli [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1418734:POLI [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.544: (1980) Biochim. 

Phrase: "(1980"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.545: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.546: Acta 630, 103-118[Medline] [OrderarticleviaInfotrieve] 27. 

Phrase: "Acta 630,"

Phrase: "103-118"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 27."
Processing 00000000.tx.547: Balavoine, S., Feldmann, G., and Lardeux, B. 

Phrase: "Balavoine,"

Phrase: "S."

Phrase: ","

Phrase: "Feldmann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Lardeux,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.548: (1990) Eur. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Eur."
Processing 00000000.tx.549: J.

Phrase: "J."
Processing 00000000.tx.550: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.551: 189, 617-623[Abstract] 28. 

Phrase: "189,"

Phrase: "617-623"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 28."
Processing 00000000.tx.552: Nunan, J., and Small, D. 

Phrase: "Nunan,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Small, D."
Processing 00000000.tx.553: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.554: (2000) FEBS Lett. 

Phrase: "(2000"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.555: 483, 6-10[CrossRef][Medline] [OrderarticleviaInfotrieve] 29. 

Phrase: "483,"

Phrase: "6-10"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 29."
Processing 00000000.tx.556: Yamamoto, K. 

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.557: (1999) in Proteases: New Perspective (Turk, V., ed) , pp. 

Phrase: "(1999"

Phrase: ")"

Phrase: "in Proteases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Proteases [Enzyme]

Phrase: ":"

Phrase: "New Perspective"

Phrase: "(Turk,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337911:Turk [Population Group]

Phrase: "V.,"

Phrase: "ed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.558: 59-71, Birkhuser Publishing Ltd, Base, Switzerland 30. 

Phrase: "59-71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450389:71 [Intellectual Product]

Phrase: "Birkhuser Publishing Ltd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1136140:LTD [Organ or Tissue Function]

Phrase: "Base,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002055:base [Inorganic Chemical]
  1000   C0178499:Base [Chemical Viewed Functionally]
  1000   C1880279:Base [Biomedical or Dental Material]
   928 E C0205112:Basal [Spatial Concept]
   916 E C0016617:Foundation [Organization]
   916 E C1626935:Bases [Quantitative Concept]

Phrase: "Switzerland 30."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039021:Switzerland [Geographic Area]
Processing 00000000.tx.559: Haniu, M., Denis, P., Young, Y., Mendiaz, E. 

Phrase: "Haniu,"

Phrase: "M."

Phrase: ","

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Young,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332239:Young [Temporal Concept]

Phrase: "Y.,"

Phrase: "Mendiaz,"

Phrase: "E."
Processing 00000000.tx.560: A., Fuller, J., Hui, J. 

Phrase: "A.,"

Phrase: "Fuller,"

Phrase: "J.,"

Phrase: "Hui,"

Phrase: "J."
Processing 00000000.tx.561: O., Bennett, B. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Bennett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.562: D., Kahn, S., Ross, S., Burgess, T., Katta, V., Rogers, G., Vassar, R., and Citron, M. 

Phrase: "D."

Phrase: ","

Phrase: "Kahn,"

Phrase: "S."

Phrase: ","

Phrase: "Ross,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0331968:Ross [Health Care Related Organization]
  1000   C2699100:Ross [Bird]

Phrase: "S."

Phrase: ","

Phrase: "Burgess,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Katta,"

Phrase: "V.,"

Phrase: "Rogers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3463939:Roger [Eukaryote]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Vassar,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.563: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.564: Biol. 

Phrase: "Biol."
Processing 00000000.tx.565: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.566: 275, 21099-21106[Abstract/Free FullText] 31. 

Phrase: "275,"

Phrase: "21099-21106"

Phrase: "[Abstract/Free FullText"

Phrase: "] 31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.567: Authier, F., Posner, B. 

Phrase: "Authier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.568: I., and Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.569: J.M. 

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.570: (1994) in Cellular Proteolytic Systems (Ciechanover, A. , and Schwartz, A. L., eds), Vol. 

Phrase: "(1994"

Phrase: ")"

Phrase: "in Cellular Proteolytic Systems"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "(Ciechanover,"

Phrase: "A. ,"

Phrase: "and"

Phrase: "Schwartz,"

Phrase: "A. L., eds"

Phrase: ")"

Phrase: ","

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.571: 15 , pp. 

Phrase: "15 ,"

Phrase: "pp."
Processing 00000000.tx.572: 89-113, Wiley-Liss, Inc., New York 32. 

Phrase: "89-113,"

Phrase: "Wiley-Liss,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1508741:LISS [Laboratory Procedure]
   861   C2247545:LIS [Molecular Function]

Phrase: "Inc.,"

Phrase: "New York 32."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0027976:New York [Geographic Area]
   827   C0205314:New [Temporal Concept]
Processing 00000000.tx.573: Runquist, E. 

Phrase: "Runquist,"

Phrase: "E."
Processing 00000000.tx.574: A., and Havel, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Havel,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.575: J. 

Phrase: "J."
Processing 00000000.tx.576: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.577: Biol. 

Phrase: "Biol."
Processing 00000000.tx.578: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.579: 266, 22557-22563[Abstract/Free FullText] 33. 

Phrase: "266,"

Phrase: "22557-22563"

Phrase: "[Abstract/Free FullText"

Phrase: "] 33."
Processing 00000000.tx.580: Araki, N., Yokota, S., Takashima, Y., and Ogawa, K. 

Phrase: "Araki,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Yokota,"

Phrase: "S."

Phrase: ","

Phrase: "Takashima,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Ogawa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443037:Ogawa [Intellectual Product]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.581: (1995) Exp. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.582: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.583: 217, 469-476[CrossRef][Medline] [OrderarticleviaInfotrieve] 34. 

Phrase: "217,"

Phrase: "469-476"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 34."
Processing 00000000.tx.584: Ryan, M. 

Phrase: "Ryan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.585: P., Peavy, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Peavy,"

Phrase: "D."
Processing 00000000.tx.586: E., Frank, B. 

Phrase: "E.,"

Phrase: "Frank,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.587: H., and Duckworth, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.588: C. 

Phrase: "C."
Processing 00000000.tx.589: (1984) Endocrinology 115, 591-599[Abstract] 35. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Endocrinology 115,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: "591-599"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 35."
Processing 00000000.tx.590: Hamel, F. 

Phrase: "Hamel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.591: G., Mahoney, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Mahoney,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.592: J., and Duckworth, W. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.593: C. 

Phrase: "C."
Processing 00000000.tx.594: (1991) Diabetes 40, 436-443[Abstract] 36. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Diabetes 40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: "436-443"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 36."
Processing 00000000.tx.595: Hamel, F. 

Phrase: "Hamel,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.596: G., Posner, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Posner,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.597: I., Bergeron, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Bergeron,"

Phrase: "J."
Processing 00000000.tx.598: J.M., Frank, B. 

Phrase: "J."

Phrase: "M."

Phrase: ","

Phrase: "Frank,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.599: H., and Duckworth, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Duckworth,"

Phrase: "W."
Processing 00000000.tx.600: C. 

Phrase: "C."
Processing 00000000.tx.601: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.602: Biol. 

Phrase: "Biol."
Processing 00000000.tx.603: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.604: 263, 6703-6708[Abstract/Free FullText] 37. 

Phrase: "263,"

Phrase: "6703-6708"

Phrase: "[Abstract/Free FullText"

Phrase: "] 37."
Processing 00000000.tx.605: Clot, J. 

Phrase: "Clot,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009074:CLOT [Organic Chemical,Pharmacologic Substance]
  1000   C0302148:Clot [Acquired Abnormality]

Phrase: "J."
Processing 00000000.tx.606: P., Janicot, M., Fouque, F., Desbuquois, B., Haumont, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Janicot,"

Phrase: "M."

Phrase: ","

Phrase: "Fouque,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Haumont,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.607: Y., and Lederer, F. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Lederer,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.608: (1990) Mol. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.609: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.610: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.611: 72, 175-185[CrossRef][Medline] [OrderarticleviaInfotrieve] 38. 

Phrase: "72,"

Phrase: "175-185"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 38."
Processing 00000000.tx.612: Seabright, P. 

Phrase: "Seabright,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.613: J., and Smith, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.614: D. 

Phrase: "D."
Processing 00000000.tx.615: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.616: J. 

Phrase: "J."
Processing 00000000.tx.617: 320, 947-956[Medline] [OrderarticleviaInfotrieve] 39. 

Phrase: "320,"

Phrase: "947-956"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 39."
Processing 00000000.tx.618: Van Noort, J. 

Phrase: "Van Noort,"

Phrase: "J."
Processing 00000000.tx.619: M., and Van der Drift, A. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Van der Drift,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "A."
Processing 00000000.tx.620: C. 

Phrase: "C."
Processing 00000000.tx.621: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.622: Biol. 

Phrase: "Biol."
Processing 00000000.tx.623: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.624: 264, 14159-14164[Abstract/Free FullText] 40. 

Phrase: "264,"

Phrase: "14159-14164"

Phrase: "[Abstract/Free FullText"

Phrase: "] 40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.625: Kageyama, T., Yonezawa, S., Ichinose, M., Miki, K., and Moriyama, A. 

Phrase: "Kageyama,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yonezawa,"

Phrase: "S."

Phrase: ","

Phrase: "Ichinose,"

Phrase: "M."

Phrase: ","

Phrase: "Miki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2681565:MIKI [Gene or Genome]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Moriyama,"

Phrase: "A."
Processing 00000000.tx.626: (1996) Biochem. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.627: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.628: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.629: Commun. 

Phrase: "Commun."
Processing 00000000.tx.630: 223, 549-553[CrossRef][Medline] [OrderarticleviaInfotrieve] 41. 

Phrase: "223,"

Phrase: "549-553"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 41."
Processing 00000000.tx.631: Brostoff, S. 

Phrase: "Brostoff,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.632: W., Reuter, W., Hichens, M., and Eylar, E. 

Phrase: "W., Reuter,"

Phrase: "W.,"

Phrase: "Hichens,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Eylar,"

Phrase: "E."
Processing 00000000.tx.633: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.634: (1974) J. 

Phrase: "(1974"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.635: Biol. 

Phrase: "Biol."
Processing 00000000.tx.636: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.637: 249, 559-567[Abstract/Free FullText] 42. 

Phrase: "249,"

Phrase: "559-567"

Phrase: "[Abstract/Free FullText"

Phrase: "] 42."
Processing 00000000.tx.638: Jaskiewicz, E., Zhu, G., Bassi, R., Darling, D. 

Phrase: "Jaskiewicz,"

Phrase: "E.,"

Phrase: "Zhu,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bassi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Darling,"

Phrase: "D."
Processing 00000000.tx.639: S., and Young, W. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Young, W."
Processing 00000000.tx.640: W. 

Phrase: "W."
Processing 00000000.tx.641: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.642: Biol. 

Phrase: "Biol."
Processing 00000000.tx.643: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.644: 271, 26395-26403[Abstract/Free FullText] 43. 

Phrase: "271,"

Phrase: "26395-26403"

Phrase: "[Abstract/Free FullText"

Phrase: "] 43."
Processing 00000000.tx.645: Higaki, J., Catalano, R., Guzzetta, A. 

Phrase: "Higaki,"

Phrase: "J.,"

Phrase: "Catalano,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Guzzetta,"

Phrase: "A."
Processing 00000000.tx.646: W., Quon, D., Nav, J. 

Phrase: "W., Quon,"

Phrase: "D."

Phrase: ","

Phrase: "Nav,"

Phrase: "J."
Processing 00000000.tx.647: F., Tarnus, C., D'Orchymont, H., and Cordell, B. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Tarnus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3342437:Tarnus [Eukaryote]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "D'"

Phrase: "Orchymont,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Cordell,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.648: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.649: Biol. 

Phrase: "Biol."
Processing 00000000.tx.650: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.651: 271, 31885-31893[Abstract/Free FullText] 44. 

Phrase: "271,"

Phrase: "31885-31893"

Phrase: "[Abstract/Free FullText"

Phrase: "] 44."
Processing 00000000.tx.652: Pimenta, D. 

Phrase: "Pimenta,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949818:Pimenta [Plant]

Phrase: "D."
Processing 00000000.tx.653: C., Oliveira, A., Juliano, M. 

Phrase: "C., Oliveira,"

Phrase: "A.,"

Phrase: "Juliano,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.654: A., and Juliano, L. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Juliano,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.655: (2001) Biochim. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochim."
Processing 00000000.tx.656: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.657: Acta 1544, 113-122[Medline] [OrderarticleviaInfotrieve] 45. 

Phrase: "Acta 1544,"

Phrase: "113-122"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 45."
Processing 00000000.tx.658: Cascieri, M. 

Phrase: "Cascieri,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.659: A., Chicchi, G. 

Phrase: "A.,"

Phrase: "Chicchi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.660: G., Applebaum, J., Hayes, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Applebaum,"

Phrase: "J.,"

Phrase: "Hayes,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.661: S., Green, B. 

Phrase: "S."

Phrase: ","

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.662: G., and Bayne, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Bayne,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.663: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.664: (1989) J. 

Phrase: "(1989"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.665: Biol. 

Phrase: "Biol."
Processing 00000000.tx.666: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.667: 264, 2199-2202[Abstract/Free FullText] 46. 

Phrase: "264,"

Phrase: "2199-2202"

Phrase: "[Abstract/Free FullText"

Phrase: "] 46."
Processing 00000000.tx.668: Diment, S., Leech, M. 

Phrase: "Diment,"

Phrase: "S."

Phrase: ","

Phrase: "Leech,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023209:Leech [Eukaryote]
  1000   C0579183:Leech [Eukaryote]
  1000   C0885415:leech [Organic Chemical,Pharmacologic Substance]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.669: S., and Stahl, P. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Stahl,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.670: D. 

Phrase: "D."
Processing 00000000.tx.671: (1988) J. 

Phrase: "(1988"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.672: Biol. 

Phrase: "Biol."
Processing 00000000.tx.673: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.674: 263, 6901-6907[Abstract/Free FullText] 47. 

Phrase: "263,"

Phrase: "6901-6907"

Phrase: "[Abstract/Free FullText"

Phrase: "] 47."
Processing 00000000.tx.675: Rodman, J. 

Phrase: "Rodman,"

Phrase: "J."
Processing 00000000.tx.676: S., Levy, M. 

Phrase: "S."

Phrase: ","

Phrase: "Levy,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.677: A., Diment, S., and Stahl, P. 

Phrase: "A.,"

Phrase: "Diment,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Stahl,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.678: D. 

Phrase: "D."
Processing 00000000.tx.679: (1990) J. 

Phrase: "(1990"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.680: Leukocyte Biol. 

Phrase: "Leukocyte Biol."
Processing 00000000.tx.681: 48, 116-122[Abstract] 48. 

Phrase: "48,"

Phrase: "116-122"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 48."
Processing 00000000.tx.682: Guagliardi, L. 

Phrase: "Guagliardi,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.683: E., Koppelman, B., Blum, J. 

Phrase: "E.,"

Phrase: "Koppelman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Blum,"

Phrase: "J."
Processing 00000000.tx.684: S., Mark, M. 

Phrase: "S."

Phrase: ","

Phrase: "Mark,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]
   928 E C1706089:Marked [Qualitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: S., Cresswell, P., and Brodsky, F. 

Phrase: "S."

Phrase: ","

Phrase: "Cresswell,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Brodsky,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.686: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.687: (1990) Nature 343, 133-139[CrossRef][Medline] [OrderarticleviaInfotrieve] 49. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Nature 343,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "133-139"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 49."
Processing 00000000.tx.688: Meresse, S., Andre, P., Mishal, Z., Barad, M., Brun, N., Desjardins, M., and Gorvel, J. 

Phrase: "Meresse,"

Phrase: "S."

Phrase: ","

Phrase: "Andre,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Mishal,"

Phrase: "Z.,"

Phrase: "Barad,"

Phrase: "M."

Phrase: ","

Phrase: "Brun,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Desjardins,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Gorvel,"

Phrase: "J."
Processing 00000000.tx.689: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.690: (1997) Electrophoresis 18, 2682-2688[Medline] [OrderarticleviaInfotrieve] 50. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Electrophoresis 18,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "2682-2688"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 50."
Processing 00000000.tx.691: Rijnboutt, S., Kal, A. 

Phrase: "Rijnboutt,"

Phrase: "S."

Phrase: ","

Phrase: "Kal,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418550:KAL [Gene or Genome]
  1000   C2697833:KAL [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.692: J., Geuze, H. 

Phrase: "J.,"

Phrase: "Geuze,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.693: J., Aerts, H., and Strous, G. 

Phrase: "J.,"

Phrase: "Aerts,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Strous,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.694: J. 

Phrase: "J."
Processing 00000000.tx.695: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.696: Biol. 

Phrase: "Biol."
Processing 00000000.tx.697: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.698: 266, 23586-23592[Abstract/Free FullText] 51. 

Phrase: "266,"

Phrase: "23586-23592"

Phrase: "[Abstract/Free FullText"

Phrase: "] 51."
Processing 00000000.tx.699: Press, B., Feng, Y., Hoflack, B., and Wandinger-Ness, A. 

Phrase: "Press,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Feng,"

Phrase: "Y.,"

Phrase: "Hoflack,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Wandinger-Ness,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1417679:NES [Gene or Genome]
   827   C1504638:Nes [Fish]

Phrase: "A."
Processing 00000000.tx.700: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.701: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.702: 140, 1075-1089[Abstract/Free FullText] 52. 

Phrase: "140,"

Phrase: "1075-1089"

Phrase: "[Abstract/Free FullText"

Phrase: "] 52."
Processing 00000000.tx.703: Glickman, J. 

Phrase: "Glickman,"

Phrase: "J."
Processing 00000000.tx.704: N., and Kornfeld, S. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Kornfeld,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.705: (1993) J. 

Phrase: "(1993"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.706: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.707: 123, 99-108[Abstract] 53. 

Phrase: "123,"

Phrase: "99-108"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 53."
Processing 00000000.tx.708: McIntyre, G. 

Phrase: "McIntyre,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.709: F., and Erickson, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Erickson,"

Phrase: "A."
Processing 00000000.tx.710: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.711: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.712: Biol. 

Phrase: "Biol."
Processing 00000000.tx.713: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.714: 266, 15438-15445[Abstract/Free FullText] 54. 

Phrase: "266,"

Phrase: "15438-15445"

Phrase: "[Abstract/Free FullText"

Phrase: "] 54."
Processing 00000000.tx.715: Ludwig, T., Griffiths, G., and Hoflack, B. 

Phrase: "Ludwig,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Griffiths,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Hoflack,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.716: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.717: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.718: 115, 1561-1572[Abstract] 55. 

Phrase: "115,"

Phrase: "1561-1572"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 55."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]
Processing 00000000.tx.719: Rochefort, H., Garcia, M., Glondu, M., Laurent, V., Liaudet, E., Rey, J. 

Phrase: "Rochefort,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Glondu,"

Phrase: "M."

Phrase: ","

Phrase: "Laurent,"

Phrase: "V.,"

Phrase: "Liaudet,"

Phrase: "E.,"

Phrase: "Rey,"

Phrase: "J."
Processing 00000000.tx.720: M., and Roger, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Roger,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463939:Roger [Eukaryote]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.721: (2000) Clin. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.722: Chim. 

Phrase: "Chim."
Processing 00000000.tx.723: Acta 291, 157-170[CrossRef][Medline] [OrderarticleviaInfotrieve] 56. 

Phrase: "Acta 291,"

Phrase: "157-170"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 56."
Processing 00000000.tx.724: Kagedal, K., Johansson, U., and llinger, K. 

Phrase: "Kagedal,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Johansson,"

Phrase: "U.,"

Phrase: "and"

Phrase: "llinger,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.725: (2001) FASEB J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.726: 15, 1592-1594[Abstract/Free FullText] 57. 

Phrase: "15,"

Phrase: "1592-1594"

Phrase: "[Abstract/Free FullText"

Phrase: "] 57."
Processing 00000000.tx.727: Villadangos, J. 

Phrase: "Villadangos,"

Phrase: "J."
Processing 00000000.tx.728: A., Bryant, R. 

Phrase: "A.,"

Phrase: "Bryant,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.729: A., Deussing, J., Driessen, C., Lennon-Dumenil, A. 

Phrase: "A.,"

Phrase: "Deussing,"

Phrase: "J.,"

Phrase: "Driessen,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lennon-Dumenil,"

Phrase: "A."
Processing 00000000.tx.730: M., Riese, R. 

Phrase: "M."

Phrase: ","

Phrase: "Riese,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.731: J., Roth, W., Saftig, P., Shi, G. 

Phrase: "J.,"

Phrase: "Roth,"

Phrase: "W.,"

Phrase: "Saftig,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Shi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.732: P., Chapman, H. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chapman,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.733: A., Peters, C., and Ploegh, H. 

Phrase: "A.,"

Phrase: "Peters,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Ploegh,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.734: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.735: (1999) Immunol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.736: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.737: 172, 109-120[Medline] [OrderarticleviaInfotrieve] 58. 

Phrase: "172,"

Phrase: "109-120"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 58."
Processing 00000000.tx.738: Grninger-Leitch, F., Berndt, P., Langen, H., Nelboeck, P., and Dbeli, H. 

Phrase: "Grninger-Leitch,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Berndt,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Langen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nelboeck,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Dbeli,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.739: (2000) Nature Biotechnology 18, 66-70[CrossRef][Medline] [OrderarticleviaInfotrieve] 59. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nature Biotechnology 18,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   827   C0349590:Nature [Idea or Concept]
   827   C1262865:Nature [Functional Concept]
   755 E C0205296:Natural [Functional Concept]

Phrase: "66-70"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 59."
Processing 00000000.tx.740: Dean, R. 

Phrase: "Dean,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.741: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.742: (1979) Biochem. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.743: J. 

Phrase: "J."
Processing 00000000.tx.744: 180, 339-345[Medline] [OrderarticleviaInfotrieve] 60. 

Phrase: "180,"

Phrase: "339-345"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 60."
Processing 00000000.tx.745: Fallon, K., Bausch, K., Noonan, J., Huguenel, E., and Tamburini, P. 

Phrase: "Fallon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551604:Fallon [Population Group]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Bausch,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Noonan,"

Phrase: "J.,"

Phrase: "Huguenel,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Tamburini,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.746: (1997) Infect. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Infect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]
Processing 00000000.tx.747: Immun. 

Phrase: "Immun."
Processing 00000000.tx.748: 65, 551-556[Abstract] 61. 

Phrase: "65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "551-556"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] 61."
Processing 00000000.tx.749: Grant, D. 

Phrase: "Grant,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "D."
Processing 00000000.tx.750: A., Ford, T. 

Phrase: "A.,"

Phrase: "Ford,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.751: F., and McCulloch, R. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "McCulloch,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.752: J. 

Phrase: "J."
Processing 00000000.tx.753: (1982) Biochem. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.754: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.755: 31, 2302-2305[Medline] [OrderarticleviaInfotrieve] 62. 

Phrase: "31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "2302-2305"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 62."
Processing 00000000.tx.756: Tong, P., Thomas, T., Berrish, T., Humphriss, D., Barriocanal, L., Stewart, M., Walker, M., Wilkinson, R., and Alberti, K. 

Phrase: "Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Thomas,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Berrish,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Humphriss,"

Phrase: "D."

Phrase: ","

Phrase: "Barriocanal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Stewart,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551641:Stewart [Population Group]

Phrase: "M."

Phrase: ","

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "M."

Phrase: ","

Phrase: "Wilkinson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Alberti,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.757: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.758: (1995) Lancet 345, 357-358[CrossRef][Medline] [OrderarticleviaInfotrieve] 63. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Lancet 345,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "357-358"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] 63."
Processing 00000000.tx.759: Benzi, L., Cecchetti, P., Ciccarone, A. 

Phrase: "Benzi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cecchetti,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ciccarone,"

Phrase: "A."
Processing 00000000.tx.760: M., Nardone, A., Merola, E., Maggiorelli, R., Campi, F., Di, Cianni, G., and Navalesi, R. 

Phrase: "M."

Phrase: ","

Phrase: "Nardone,"

Phrase: "A.,"

Phrase: "Merola,"

Phrase: "E.,"

Phrase: "Maggiorelli,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Campi,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Di,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3538902:DI [Gene or Genome]
  1000   C3541881:DI [Idea or Concept]

Phrase: "Cianni,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Navalesi,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.761: (1997) Metabolism 46, 1259-1265[Medline] [OrderarticleviaInfotrieve] Copyright  2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Phrase: "(1997"

Phrase: ")"

Phrase: "Metabolism 46,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "1259-1265"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Copyright  2002 by The American Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009993:Copyright [Intellectual Product]
   753   C0037455:society [Organization]
   753   C0596070:American [Population Group]
   753   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Inc."

